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What Is New in 
Anesthesiology? 
The 25th Annual Stoneburner Lecture Series, 
held at the Medical College of Virginia, February 
25-26, 1972, was devoted, for the first time since its 
inception in 1946, to Anesthesiology. Nineteen out-
standing speakers from various parts of the country 
covered a wide range of pertinent subjects. 
Anesthesiology is a relatively new medical spe-
cialty and is expanding rapidly. Guided by the dictum 
"primum non nocere," the modern anesthesiologist 
has to evaluate thoroughly any new anesthetics or 
techniques before accepting them as the best and 
the safest . The Stoneburner Lecturer, Dr. C. Ronald 
Stephen , Mallinckrodt Professor of Anesthesiology, 
gave an in-depth description of the 1972 trends in 
anesthesia and made predictions for the future . 
I would like to extend my thanks to the Depart-
ment of Visual Education of the Medical College of 
Virginia, which under the able guidance of Mr . Mel-
vin Shafer, did an excellent job of taping the lectures 
and providing television coverage; to Dr. M. Pinson 
Neal, Jr. and Miss Erma L. Blanchard from the De-
partment of Continuing Education; to other members 
of the Department of Anesthesiology who gave freely 
of their expertise and time to make the 1972 Stone-
burner Lecture Series an outstanding success; and 
to the editorial staff of the M CV QUARTERLY who 
worked hard to edit this impressive issue containing 
most of the lectures presented at the symposium. 
C. PAUL BOY AN, M .D. 
Professor and Chairman, 
Department of Anesthesiology 
Medical College of Virginia 
Proper Use of Ketamine and lnnovar* 
GUENTER CORSSEN, M.D. 
Professor and Chairman, Department of Anesthesiology, 
University of Alabama School of Medicine, Birmingham, Alabama 
KETAMINE. Success or failure with the use of 
ketamine depends largely on three factors : 
1. Awareness that ketamine is different from 
traditional anesthetics. These differences in-
clude the following : 
Ketamine, unlike traditional anesthetics 
which cause total depression of the central 
nervous system, affects selectively pain con-
duction and perception systems, stimulating 
one area of the brain while simultaneously 
depressing another ("dissociation") . 
Ketamine stimulates the cardiovascular sys-
tem while traditional anesthetics depress car-
diovascular function. 
Ketamine has antiarrhythmic properties while 
traditional anesthetics do not. They may 
even precipitate arrhythmias. 
Ketamine maintains or even exaggerates pro-
tective reflexes while traditional anesthetics 
suppress them. 
Ketamine ensures airway patency, provided 
no mechanical airway obstruction is present, 
while traditional anesthetics require addi-
tional tools and techniques. 
Ketamine does not produce the traditional 
"anesthetized" appearance in the patient, but 
rather a characteristic "disconnected" ap-
pearance. 
2. Knowledge of the criteria used for selection 
of patients for ketamine anesthesia: 
* Presented at the 25th Annual Stoneburner Lecture 
Series, February 25, 1972, at the Medical College of Vir-
ginia, Richmond. 
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Use of ketamine predominantly in infants 
and children up to 14 years of age. 
The use of ketamine in adult patients is con-
fined to surgical conditions for which keta-
mine has proven to be particularly advan-
tageous, safe, and superior to conventional 
anesthetic agents and methods ( see under 3). 
Narcotic addicts and patients with a history 
of chronic alcohol abuse or suffering from 
acute alcohol intoxication are poor candi-
dates for ketamine anesthesia because in 
these patients even excessive doses of keta-
mine may fail to control body movements. 
3. Limiting the use of ketamine anesthesia to 
the following specific surgical areas and con-
ditions: 
Surgical treatment of burns* 
Neurodiagnostic procedures such as pneu-
moencephalography, ventriculography, mye-
lography, and carotid arteriography. 
Out-patient ophthalmology (tonometry, fun-
doscopy, gonioscopy). 
Out-patient oral surgery (tooth extraction, 
surgery on the gingiva). 
Out-patient otology ( myringotomy, insertion 
of myringeal tubes, removal of foreign body 
from ear canal) . 
Out-patient plastic surgery (removal of nevi, 
suturing of laceration, removal of scars). 
* Patients of all ages may be included. 
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Elective orthopedic surgery ( reduction of 
congenital hip luxation, spicacast applica-
tion) . 
Emergency orthopedic surgery ( closed re-
duction of fractures). 
Repeated manipulation under anes thesia ( ir-
radiation of inoperable int raocular or intra-
cranial les ions) . 
Induction of anesthesia in high-risk pa-
tients, including asthmatics, prior to the use 
of the principle anesthetic. Ketamine-in-
duced cardiovascular stimulation and its re-
laxant effect on bronchial musculature offer 
significant advantages over conventional an-
esthetic agents. * 
Cardiac catheteri zation. 
Open heart surgery, particul arly involving 
patients with minimal or no cardiac reserve. 
Cardiovascular stimulation and antiarrhyth-
mic affects of ketamine offer prime advan-
tages over traditional anesthetics.* 
Emergency surgery in patients suffering 
from hypovolemia or shock-like conditions. 
Ketamine may be used fo r induction or to 
enhance minim al conventional anesthesia. It 
offers the advantage of ensuring cardiovas-
cular support until conventional measures to 
control hypovolemia and shock can be in-
stituted and become effective.* 
Contraindications. Ketamine is contraindicated 
with hypertension, history of cerebrovascul ar acci-
dent , upper respiratory infection, increased cerebro-
spinal fluid pressure, abdominal surgery, and other 
surgery involving visceral pain ( unless supplemented 
with conventional anesthetics). 
Technique of Administration of Ketamine. 
Pre-anesthetic medication: Infants and children 
receive scopolamine 0.1 to 0.4 mg, depending on age 
and weight, given int ramuscularly 1/2 to 1 hour prior 
to surgery to counteract ketamine-induced hypersali-
vation. Pentobarbital or secobarbital (0.5 to 1 mg 
per pound) may be given fo r additional sedation. 
Adult patients receive a tranquilizer with anti-
psychotic properties, preferably droperidol ( 1 to 2 ml) 
or Innovar® ( 1 to 2 ml ) combined with 0.4 mg of 
atropine administered int ramuscularly 1/2 to 1 hour 
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prior to surgery. Other combinations of narcotic 
analges ics, tranquilizers, and ataractics have proven 
less effective as compared with the above-mentioned 
medication. 
Omitting narcotics or barbitu ra tes in the pre-
anesthetic medication will significantly shorten re-
covery time. No pre-anesthetic medication is given to 
patients undergoing ambul atory surgery provided 
that the surgical procedure is limited to 15 minutes. 
Induction: With the int ravenous route, the initial 
dose of ketamine ranges from 1 to 2 mg per kg de-
pending on the physical state of the patient. It is 
recommended that ketamine be administered slowly, 
over a period of 30 to 60 seconds. More rapid ad-
ministration may result in respi ratory depression . 
With the intramuscul ar route, the initial dose of 
ketamine ranges from 6 to 12 mg per kg. 
Main tenance: Supplemental increments of 1/ 2 
to 1/ 3 of the full induction dose may be administered 
intravenously every 8 to 10 minutes or intramuscu-
larly every 20 to 30 minutes, or when movements of 
head or extremities indicate lightening of anesthesia. 
Complications. The foll owing complications may 
be encountered : 
Temporary augmentation of pulse rate and 
blood pressure beginning shortly after injec tion of the 
drug. This cardiovascular-stimulating effect of keta-
mine may prove beneficial in certain circumstances, 
for example, in the presence of hypotension or shock-
like states . In hypertensive individuals, however, 
stimulation may be considered undesirable or unsafe. 
T ransient depression of respiration in response 
to rapid intravenous injection or in connection with 
an overdose of ketamine. 
Paroxysmal coughing in the presence of upper 
respi ratory infection, occurring immediately follow-
ing the initial injection of ketamine and recurring 
with supplemental increments. 
Vivid dreaming, with or without psychomotor 
activity, confusion, and irrational behavior occurring 
du ring emergence from anesthesia. This complication 
is more often observed in adults th an in children and 
infa nts. 
Tonic and clonic muscle movements resembling 
convulsive seizures occurring in certain patients with-
out electroenceph alographic evidence of seizure ac-
tivity. 
Erythema or morbillifo rm rash occurring subse-
quent to the initial injection of ketamine. The skin 
erupt ion is transient and usually confi ned to face, 
neck, and upper chest. 
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Treatment of Complications. Proper pre-anes-
thetic medication as outlined above may signficantly 
suppress or even eliminate most adverse reactions. 
This holds particularly true with regard to post-anes-
thetic emergence delirium reactions. The incidence 
and degree of these psychic disturbances can be fur-
ther minimized by avoiding premature verbal or 
tactile stimulation of the patient ( "sensory depriva-
tion") . 
Post-anesthetic emergence delirium reactions, 
should they occur in spite of proper pre-anesthetic 
medication, may be successfully treated with intra-
venous droperidol-1 to 2 ml. Also recommended 
are ultra short-acting barbiturates such as pentothal 
or surital administered intravenously at doses of 75 
to 100 mg. 
Tonic and clonic movements during anesthesia 
may be effectively treated with small intravenous 
doses (2 to 5 mg) of diazepam (Valium®). 
Ketamine does not provide adequate control of 
pain originating from the viscera. Therefore, the 
drug is not recommended for use as a sole anesthetic 
in abdominal or thoracic surgery or where visceral 
pain is expected to occur. In order to control visceral 
pain, ketamine may be supplemented with other gen-
eral anesthetic agents. 
In summary, ketamine, a phencyclidine deriva-
tive, is a unique and unusually safe, effective 
anesthetic agent. It is short-acting; it can be given 
either intravenously or intramuscularly; it is rela-
tively easy to control, requiring little in the way 
of adjunctive or supportive drugs or devices. It differs 
markedly from previously established general anes-
thetics because of its selectivity with respect to the 
central nervous system. Ketamine is capable of simul-
taneously depressing cortico-thalamic pathways and 
activating limbic areas, referred to as "dissociation," 
and the resulting state is, therefore, termed "dissocia-
tive" anesthesia. 
Profound analgesia is produced without con-
comitant respiratory depression and without inhibi-
ting reflexes that protect the air passages. The 
cardiovascular system is slightly stimulated. 
Ketamine has proved to be of unique value in 
the anesthetic management of patients, particularly 
infants and children, undergoing a variety of surgical 
and diagnostic procedures involving the head, neck, 
and extremities and those necessitating frequent posi-
tion changes such as are encountered in neurosurgical 
diagnostic procedures and in the treatment of se-
verely burned patients of any age. 
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Properly administered and with due regard for 
its specific advantages as well as its possible disad-
vantages, ketamine may prove superior to conven-
tional anesthetic agents and methods in a variety of 
specific surgical procedures. 
INNOVAR . Innovar is a mixture of two drugs : 
droperidol, a butyrophenone derivative, with strong 
tranquilizing, antiemetic, and adrenergic-blocking 
properties ; and fen/any/, a powerful narcotic analgesic 
related to meperidine which differs from conven-
tional narcotics by its high potency and its fast onset 
and short duration of action. The two drugs are 
mixed in a ratio of 50 to I. When administered in-
travenously in appropriate doses, a state of neuro-
leptanalgesia is produced in which the patient is 
rendered immobile and insensitive to pain. His face 
being expressionless, the patient appears detached 
from his surroundings, yet he remains alert and co-
operative. Respiratory function is depressed and it 
may be necessary to assist or control the respiration 
via a face mask or endotracheal tube. If nitrous 
oxide-oxygen mixtures are added to produce sleep 
and memory deficit, the state of neuroleptanesthesia 
is established. 
Innovar or its separate component drugs, drop-
eridol and fentanyl , can and will provide optimal 
conditions for the patient and surgeon provided 
that certain basic principles and rules are observed 
along with the use of the drugs which may be listed 
as follows: 
1. Adherence to minute details with regard to 
the technique of administering the neuro-
leptanalgesic drugs. 
2. Employing neuroleptanalgesia and anes-
thesia preferably in poor-risk, debilitated, or 
geriatric patients undergoing major, trau-
matic, and prolonged surgery, and avoiding 
their use in pediatric surgery and in short-
lasting, uncomplicated, and minor surgery. 
Technique of Administration of Innovar or Its 
Separate Components, Droperidol and Fentanyl, to 
Produce Neuroleptanalgesia. 
Pre-anesthetic medication: Droperidol alone 
(2.5 to IO mg, depending on age and physical state) 
or Innovar (1 to 2 ml) is given intramuscularly 30 
to 60 minutes prior to surgery. Atropine or scopola-
mine (0.4 to 0.6 mg i.m.) may be added to con-
trol secretions. 
Induction using Innovar: The recommended 
dose of Innovar is 1.0 ml per 25 pounds of body 
weight. This may be reduced to 0.5 ml per 25 pounds 
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of body weight in extremely poor-ri sk and debilitated 
patients. Individuals in good physical state may re-
ceive 1.5 to 2.0 ml per 25 pounds of body weight. 
In a patient of average weight th e total ca lculated 
dose of Innovar ranges from 6 to 8 ml. Debilitated 
and reduced patients may receive 5, 4 , or 3 ml , 
while patients in a satisfacto ry physical state may 
receive 9 or 10 ml. The total dose of lnnovar will 
rarely exceed 10 ml. 
A test dose of I to 2 ml of Innovar injected 
intravenously over a period of 1 minute is always 
used prior to the administration of the full calcul ated 
dose. One to two minutes following the injection of 
the test dose, the blood pressure is recorded , and if 
unchanged, the remainder of the dose is admin-
istered. A blood pressure drop of more than 25 mm 
Hg in response to the intravenous test dose 
usually indicates in adequate circulatory volume re-
quiring rapid intra venous infusion of 500 to 1,000 mm 
of fluids before proceeding with furth er administra-
tion of Innovar. 
The compounded total dose of lnnovar may be 
administered as follows: 
a. Intra venous drip: The solution to be infused 
should contain 10 ml of Innovar added to 
250 ml of 5 % dextrose in water or saline. 
This mi xture is administered by the micro-
drip technique at the rate of 150 to 200 
drops per minute. When increased somnol-
ence and psychic detachment are noticeable 
-usually within 3 to 5 minutes after start 
of the infusion-a local anesthetic ( cocaine 
5 % , lidocaine 4 % ) is topically applied 
either by intralaryngeal spray or by injection 
through the crico-thyroid membrane. When 
the patient's respiratory rate has slowed to 
10 per minute, the intravenous drip is slowed 
to 100 drops per minute. At this point , 
psychic indifference is further enhanced, and 
analges ia has usu ally reached the optim al 
level. The int ravenous drip is then discon-
tinued and the patient is ready for the 
surgical procedure while still responding to 
commands such as "take a deep breath" or 
"open your mouth. " 
b. Intra venous injection: The calculated dose of 
Innovar is injected intravenously in incre-
ments of 1.0 to 2.0 ml over a period of two 
to three minutes. 
Maintenance: In order to hold the level of sur-
gical ana lgesia, fentanyl in doses of 0.05 to 0.1 mg ( 1 
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to 2 ml) is administered intravenously when ch anges 
in vital signs such as increased heart rate, elevated 
blood pressure, increased respiratory rate, or irreg-
ul ar breathing indicate lowering of the pain thresh-
old. It is not recommended th at Jnnovar be admin-
istered fo r maintenance of surgical analges ia because 
of poss ible cumul ative effects of the longer-acting 
droperidol which may result in over-tranquilization 
postoperatively. 
Postoperative period: Usually, analges ia extends 
well into the postoperative period . Therefore, pa-
tients rarely require narcotic analges ics for pain re-
lief. If narcotic analgesics a re administered , their 
dose should be reduced to 114 or 1/ 3 of the usually 
recommended dose. 
Induction using droperidol and fentanyl as 
separate drugs: Induction is started with the intra-
venous administrat ion of droperidol (0 .15 mg per 
kg). The patient 's vital signs are observed for 5 to 6 
minutes and if no change is noted, an initial dose of 
20 to 60 mcg of fentan yl is administered intraven-
ously followed by 20 to 40 mcg doses of fentanyl , 
given at about two-minute intervals at which time 
the patient is considered ready for the operative pro-
cedure. 
Indications. Neuroleptanalgesia should be lim-
ited to patients in whom retention of consciousness 
and cooperation during the surgical procedure is 
desired. Such procedures include: bronchoscopy, 
laryngoscopy. and esophagoscopy; neurodiagnostic 
procedures such as pneumoencephalography and 
carotid arteriography; cardiac catheteri za tion ; stereo-
tactic procedures including cryothalamotomy; resec-
tion of epileptogenic focus; ophthalmic surgery ( in 
conjunction with regiona l anesthesia); middle and 
inner ear surgery ( in conjunction with local anes-
thesia); and oral surgery including tooth extraction 
and other intrao ral surgical procedures involving the 
gingiva and th e tongue. 
Contraindications. Neuroleptanalgesia is con-
traindicated for ambulatory surgery , surgery in in-
fants and chi ldren, acute alcohol delirium or history 
of alcoholism, and narcotic addicts. 
Technique of Administration of lnnovar or Its 
Separate Components, Droperidol and Fentanyl, to 
Produce Neuroleptanesthesia. 
Pre-anesthetic m edicatio n: This is the same as 
th at described under neuroleptanalgesia as is the 
composition of the total dose to be administered for 
producing the neurolept anesthetic state. 
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Ind11ction: Innovar may be administered as fo l-
lows: 
a. Intra venous drip: Prepara tion of th e solut ion 
to be infused and induction are identical with 
the method desc ribed under neuroleptana/gesia. A t 
the time the patient shows signs of somnolence 
and obtundation in response to the infusion, the 
intravenous d rip is slowed to I 00 d rops pe r minute 
and continued at this rate throughout the anes-
thesia course. Ad ministration of nit rous ox ide-oxy-
gen ( 4: 2 ) by face mask is begun , and the pa tient is 
encouraged to take dee p breaths. Within one minute 
the patient usually lapses into unconsciousness with-
out excitement. An int ravenous dose of short-ac ting 
muscle relaxant is administered to fac ilitate endo-
tracheal intubation and to counteract muscle rigidity 
which may develop during this ph ase. As a rule , the 
patient resumes spont aneous brea thing within fi ve to 
eight minutes. D-tubocura rine is admini stered intra-
venously at conventional dosages if muscle relaxa tion 
is needed fo r surgery. When ch anges in vita l signs 
indicate lightening of anes thesia , the dri p rate is in-
creased until vital signs return to norm al. 
b. Intra venous injection: Simil a r to the method 
of neuroleptanalges ia, a tes t dose of I to 2 ml of 
Innova r is administered intravenously ove r a period 
of I minute. Blood pressure is reco rded subsequent to 
this injection and, if found essentially unchanged , 
furth er increments of I to 2 ml of Innovar are ad-
ministered intravenously at 1- to 2-minute intervals. 
By the time the to tal calculated dose has been admin-
istered, the patient shows signs of drows iness and in-
creasing tranquiliza tion. While the patient still is able 
to respond to questioning, the brea thing mask is 
applied and nit rous oxide-oxygen, a t the flow of 4 
liters of nitrous oxide and 2 liters of oxygen per 
minute, is administered. While spontaneous breathing 
is increasingly more depressed, positive pressure 
ventilation via the face mask is begun with the patient 
responding to the comm and to take deep breaths. As 
a rule, after 5 to 8 breath s the patient lapses into un-
consciousness without excitement. Immedi ately prior 
to the loss of consciousness, an intravenous dose of a 
snort-acting muscle relaxant is administe red to fac ili-
tate endotracheal intubation and avoid the develop-
ment of fentanyl-induced muscle rigidity. 
Maintenance: For maintenance of the neuro-
leptanesthetic state, administration of nit rous oxide-
oxygen ( 4 : 2) is continued. F entanyl is administered 
intravenously at doses to l to 2 ml (0.05 to 0 . 1 mg ) 
when changes in vital signs ( increased heart rate, 
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elevated blood pressure, increased respiratory rate, 
or irregul a r brea thing ) indicate lowering of the pain 
threshold . The response to the administration of 
fe ntanyl is usually prompt, and signs of inadequ ate 
pain th reshold elevation disa ppear within 45 to 60 
seco nd s. If the vital sign s continue to indicate insuffi-
c ient analges ia, ano ther increment of I to 2 ml of 
fent anyl is administered intravenously. In an aver-
age patient , administration of supplemental intrave-
nous fentanyl doses is required at 45 to 60 minute 
intervals. F entanyl for maintenance of anes thesia may 
also be given intramuscularly at the same dose as 
mentioned above. Adequate pain threshold eleva-
tion usually is accomplished with this route of ad-
mini stration within 7 to 8 minutes and may last up to 
2 hours. 
In abdominal surgery or oth er procedures re-
quiring muscle relaxation, d-tubocurarine may be ad-
ministe red a t conventional intravenous doses . 
Emergence: Return to consciousness is rapid , as 
soon as the administration of nit rous oxide-oxygen is 
discontinued . Within 3 to 5 minutes the patient is 
usually in contact and ca n answer questions. If respi-
ratory exchange is in adequate, the endotracheal tube 
may be left in pl ace in order to mech anically support 
ventilation until sati sfactory respiratory function is 
rees tablished, at which time the endotracheal tube is 
removed. Levallorph an ( Lorfa n®) may also be given 
at int ravenous doses of I mg to counteract fentanyl-
induced respiratory depress ion. If Lorfan fail s to re-
sto re adequate respiratory function, other factors 
causing respi ratory depress ion should be examined. 
Complete analges ia usually is maintained for 4 
to 6 hours. Nausea and vomiting are rarely en-
countered. 
Indications. Neuroleptanesthesia is indicated for 
the foll owing: bili ary surgery for which halogenated 
a nesthetics may be contraindicated; major, trau-
matic, prolonged surgery involving poor-ri sk patients; 
neurosurgery; cardiovascu lar surgery including open 
heart procedures ; surgery for organ transplantation, 
particul arly kidney transpl ants; middle and inner ear 
surgery ; and emergency surgery involving elderly, 
debilitated, and reduced patients; and patients in 
shock-like states. 
Contraindications. T he cont ra indications for 
neuroleptanesthes ia a re the same as those under 
neuroleptanalgesia. In addition, the use of Innovar 
may be contraindica ted in asthm atic patients since 
it may precipitate an attack. 
Complications. Hypotension is most commonly 
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encountered during induction of neuroleptanes thesia, 
indicat ing inadequate circulatory volume and inabil-
ity of the patient to compensate for peripheral vaso-
dilatation caused by droperidol-induced alpha-adren-
ergic blockade. Treatment should consist of rapid 
infusion of 500 to 1,000 ml of lactated Ringer's solu-
tion or 5 % dextrose in water solution in preference 
of the use of vasopressors. 
Excessive blood pressure elevation, the etiology 
of which is undetermined, has occurred in rare in-
stances. Intermittent admini stration of halothane at 
conventional concentrations or small int ravenous 
doses of chlorpromazine (7.5 to 15 mg i.v.) have 
proved to be effec tive in restoring acceptable blood 
pressm e levels. 
Droperidol may induce extrapyramidal muscle 
acltv//y which may be controlled with anti-
Parkinson agents such as Cogentin®. 
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How Safe 1s Halothane? * 
PETER J. COHEN, M.D. 
Chairman, Department of Anesthesia 
University of Colorado Medical Center, Denver, Colorado 
Halothane (2-bromo-2 -chloro- l , I , 1-trifluoro-
ethane) is the most popular inhalation agent in today's 
anesthetic prac tice. Its desirable properties include 
high potency, nonflammabil ity, patient acceptance, 
a low incidence of nausea and vomiting, ability to 
produce bronchod ilatation, and ease of mainten ance. 
Prior to its introduction in 1956, it was subjected 
to an intense examination for both general and he-
patic toxicity. Although these investigations disclosed 
no evidence of adverse effects, reports of liver 
dysfunction after halothane administ ra tion have ap-
peared constantly in the literature. Thus, although 
the general safety of this drug continues to be excel-
lent, the clinician is confronted with a dilemma each 
time he elects to use this agent. I hope to give some 
perspective to this question . 
The first thing to understand is that administra-
tion of any of the anesthetics currently in use may 
be followed by mild and reversible evidence of liver 
derangement. Studies conducted over twenty years 
ago showed that administration of diethyl ether or 
cyclopropane was followed by significant brom-
sulfalein retention, a phenomenon also observed 
when spinal anesthesia was used . Subsequent in-
vestigations have shown this to be true in the case 
of methoxyflu rane and halothane. Other work has 
indicated that clearance of indocyanine green ( ICG ) 
is markedly diminished during anes thesia. It would 
thus appear that all anesthetics have the ability to 
produce mild and reversible evidence of hepatic 
abnormalities; findings which are probably of no 
physiologic significance. This property is shared by 
halothane. 
H alothane also produces reversible abnormali-
ties of hepatic mitochondrial function. Oxygen up-
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take of mitochondria stimulated by adenosine di-
phosphate is diminished in the presence of clinically 
effec ti ve concent rations of halothane. Haloth ane, 
however, is no different from methoxyflurane, diethyl 
ether, and ethrane which also produce these ch anges. 
Thus, although halothane has spec ific metabolic ef-
fects , it shares these in common with other inhalation 
agents. 
Perh aps haloth ane exerts its effects th rough 
altered hepatic circulation . Studies performed in man 
during halothane anesthesia indicate that splanchnic 
blood fl ow decreases as mean arterial pressure is 
lowered; !CG clearance is diminished also. How-
ever, when arteri al carbon dioxide tension is ele-
vated, spl anchnic vasodilatation occurs and splanch-
nic blood fl ow is increased. In spite of the return 
of blood flow to normal, ICG clearance remains 
depressed . Cyclopropane, on the other hand, in-
creases arterial pressure while hepatic blood flow 
is decreased. Again, ICG clearance is lowered. When 
hexa methonium is infused, splanchnic vascular re-
sistance decreases and spl anchnic flow is elevated. As 
in the case of halothane, the return of hepatic per-
fusion to normal does not result in a normal ICG 
clearance . Agai n, we must consider the abnormality 
in !CG clearance to be a nonspecific anesthetic ef-
fect rather than the pathologic manifestation of a 
low perfusion state. We must also realize that halo-
th ane does not have a specific effect , and that this 
phenomenon is observed with all the inhalation 
agents. 
It is clear that the major question which must 
be answered for any anesthetic agent concerns its 
overall safe ty . It is because of this problem that a 
retrospective study of anesthetic safety during the 
years 1959-1963 was undertaken. This study, known 
as the National H alothane Study, evaluated the 
records of 865,5 15 anesthetics. In this group, I 6,840 
deaths were reported of which 11 ,289 underwent 
autopsy. There were two significant questions which 
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were posed: ( 1) Were there differences among 
anesthetic agents and techniques in overall death 
rates and in the incidence of massive hepatic necro-
sis? (2) Were there any differences among anes-
thetic agents and techniques in the death rate or in-
cidence of massive hepatic necrosis when surgery in 
the biliary tract was performed? The overall results 
of the study suggested that halothane was at least as 
safe as the other agents examined . Furthermore, it 
was no less safe th an the other drugs when biliary 
surgery was performed. 
Although the data suggested that halothane's 
safety was at least equal to th at of other drugs and 
techniques, a certain nagging doubt persisted . Most 
of the cases of hepatic necrosis were obviously 
caused by factors such as hemorrhagic shock, sepsis, 
or previous transfusion. However, in nine cases no 
etiology was obvious and of these, seven had re-
ceived halothane . Furthermore, four of these seven 
had been exposed previously to halothane. It must 
be realized that the National Halothane Study had 
an element of volunteer bias in that several of the 
unexplained cases of massive hepatic necrosis had 
already been published, and most probably the 
institution volunteered to participate in the study 
because of this. Nonetheless, the possibility was con-
sidered that halothane might be responsible for cer-
tain cases of hepat ic dysfunction . 
In subsequent years, a number of events were 
reported which indicated that exposure of unoperated 
man to extremely low concentrations of the agent 
might rarely produce hepatic abnormalities. It was 
from a consideration of such events that the con-
cept of halothane hypersensitivity arose. This theory 
stated that halothane is not a direct hepatotoxin. In 
the rare cases (the incidence of unexplained hepatic 
necrosis following halothane was 1 :35,000), the in-
dividual might be hypersensitive or "allergic" to the 
agent. This would explain the increased likelihood of 
observing the phenomenon after more than one ex-
posure, and might also explain the occurrence in un-
operated man receiving sub-anesthetic concentrations 
of the drug. Additional support to this theory was 
evidence of lymphocyte transformation produced by 
incubating lymphocytes of affected man with halo-
thane. It should be noted that many individu als with 
what appears to be halothane-induced hepatitis did 
not show positive lymphocyte transformation. Fur-
thermore, occasional false positive results have been 
reported . Thus, although the hypersensitivity theory 
is not unreasonable, it should not be considered to 
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be the sole explanation of this unfortunate phenome-
non. 
We have recently studied the concentrations of · 
immunoglobulins in man following surgery per- . 
formed during halothane anesthesia. Observations 
were made prior to and up to 30 days after surgery; 
data obtained was compared with similar studies 
when anesthesia was provided by nitrous oxide sup-
plemented with narcotic. No significant changes 
were produced by either nitrous oxide-narcotic or 
nitrous oxide-halothane. In another group of in-
dividuals receiving halothane anesthesia, measure-
ments of serum glutamic oxaloacetic transaminase 
concentratibn and bromsulfalein retention accom-
panied the assays of immunoglobulin concentrations. 
Although transient abnormalities of hepatic function 
were observed, no alterations in the immunoglobulin 
pattern were noted during observations lasting as 
long as 60 days. 
Although these data do not definitely rule out 
an immunologic basis for halothane-induced hepatic 
necrosis, they do suggest that a systematic immu-
nologic abnormality does not occur usually follow-
ing anesthesia with this agent. Furthermore , they 
indicate that short-lived abnormalities of hepatic 
function following halothane anesthesia are similar 
to those observed with other anesthetic drugs and 
are not the result of immunologic factors . Finally, 
these observations furnish a base line should the 
opportunity arise to obtain samples from a patient 
with severe hepatic failure following halothane anes-
thesia. 
Are there any other mechanisms which might 
be responsible? In the past few years, increasing 
emphasis has been placed on the ability of the he-
patic microsomal system to detoxify a wide variety 
of drugs. Many of the inhalation anesthetics, among 
them halothane, are so metabolized . Furthermore, 
prior exposure to halothane produces enzyme in-
duction which results in a more rapid rate of halo-
thane biodegradation. It is not inconceivable that 
abnormal pathways of biodegradation might produce 
toxic metabolites which could result in hepatic necro-
sis. 
At the present time, the evidence is not clear as 
to what might be the mechanism for the extremely 
rare case of halothane-induced hepatic necrosis. In-
deed, it is still a moot point as to whether this entity 
can be definitely proven to exist. However, the 
answer to the question of this lecture can be easily 
made. The National Halothane Study supplied excel-
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Jent data indicating that in the overwhelming ma-
jority of patients the drug is as safe as any currently 
used. I would sugges t th at the mai n factor determining 
patient safety is the individual ad ministering the 
anesthetic rather than the specific agent itself. How-
ever, although the drug is exceedingly safe, a small 
number of patients may be at risk . It is the task of 
future investigation to delineate these individuals so 
as to prevent the occurrence of this syndrome. 
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Health Care and the Anesthesiologist: 
Influence and Factors* 
ROBERT G. HICKS, M.D. 
Immediate Past-President, A merican Society of A nesthesiologists 
Director, Department of A nesthesiology 
St. Vincent's Hospital, New York , New Y ork 
When one asks me today what are the special 
factors that influence the health care delivery of 
anesthesiologists, I am compelled to say that they 
are almost identical wi th those factors which in-
flu ence the delive ry of health care fo r all phys icians. 
The fi rst and major infl uence is the role of gov-
ernment. Probably the most beneficial impact of 
government ac tivity in the past decade has been 
the advent of Medicare in June of 1966. This is an 
excellent program which has truly prov ided marked 
beneficial results fo r the elderly. It has brought more 
talented medical care to the aged at a minimum of 
cost and, up to now, at a reasonable reimburse ment 
level. On the other hand , the Medicaid or Title 19 
activity which was added to the Medicare legisla-
tion at the last moment has proven itself to be a 
colossal fraud. This was simply overpromising and 
underfunding. In many areas of the country, insti tu-
tions and health care providers are underfunded to 
the extent that billing for services is not worthwhi le. 
Hence, this large poor segment of the popula-
tion is left with no better health care delivery than 
it had before the inception of the Medicaid proposi-
tion. 
Attendant to the Medicare legislation was the 
establishment in each major hea lth care inst itution of 
a utilization rev iew committee which would study the 
effectiveness of medical care delivery of its pract i-
tioners. This was geared to increase product ivity of 
overcrowded hospi tal faci liti es. In many areas this 
has proved extremely effect ive. Hospitalization pe-
riods have been reduced, many unnecessary costs 
have been limi ted, and hospi ta l beds are more readily 
ava ilable so th at there is a more efficient turnover of 
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ac ute care patients. In this regard, one of the ch al-
lenging problems affecting government and health 
professions in general is the accuracy of predicted 
demographic project ions fo r the immediate and re-
mote future. At present , our country of over 
200,000,000 people has 11 ,000 anesthesiologists and 
some 15,000 nu rse anesthetists delivering anesthesia 
care fo r some 15,000,000 major surgical procedures 
perfo rmed in this nation each year. Initial projections 
before the concern with population growth were 
that we should have a total popul ation of some 
275 ,000,000 people by 1985. With the recent changes 
in bi rth rate, it is projected that we shall not have 
such a population abundance until closer to the year 
2000. This problem ties in very directly with the 
utiliza tion efficiency of the numbers of anesthetists, 
both anesthesiologists and nurse anesthetists, that we 
now have in ratio to populat ion and our concerns fo r 
projec ting our adequate fu ture supply. In both of 
these areas, manpower has been increasing ade-
qu ate ly over the past decade. One thought has been 
to supply physicians' assistants in this area. There 
are several schools where physicians' assistants in 
anesthesia and job identifica tion of anesthesiologists' 
func tions are being developed. I cannot conceive that 
this is a universal need, fo r the physicians and nurse 
anes thetists are presently doing a most adequate job 
and have a depth and scope of info rmation which 
leads to a more adequate judgment so necessary for 
qu ality patient care in the operating amphitheater. In 
a study of ten hospitals conducted by the American 
Society of Anesthesiologists in 1969 and repeated in 
1970 with almost ident ical results, the surgical anes-
thesia committee of th is society found that the operat-
ing room efficiency in terms of operating rooms 
utilized per man hour of anesthesiologists and anes-
thetists available and per eight-hour working day was 
somewhat below 50 % . Effi ciency seemed to increase 
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with the increase in hospital size, and where a teach-
ing setting was involved. In such institutions the mode 
curve ran as high as 55 to 60%. It stands to reason, 
therefore, that with our present numbers we can 
simply double our efficiency and effective delivery 
of health care by a more careful scheduling of opera-
tive procedures. The anesthesiologist has extended 
his arm outside of the operating room, particularly 
in intensive care, emergency care , and coronary care 
facilities. It is here that his specia l talents have 
proved so successful. It is here also that the im-
mediate continued attention of the anesthesiologist 
is not necessary in the same degree or in the same 
manner as 1t 1s necessary in the operating room. It 
is here, therefore, that I believe a physician's as-
sistant in anesthesiology will be a very effective 
mechanism for improvement of anesthesia care in 
general. Studies in the effective utilizat ion of operat-
ing rooms and demographic projections of man-
power within the speciality are presently being con-
tinued under the auspices of the American Society 
of Anesthesiologists. 
"Peer review" is something everyone seems to 
be talking about. There does not seem to be a con-
sensus of application with the exception that every-
one understands it is a quality analysis of the ef-
fectiveness of the health professional, both in terms 
of the capacity of his professional competence and 
his socio-economic delivery. Needless to say, any 
regulation of the quality of the professional activity 
of physicians and other professionals can only be 
effectively established by those professionals them-
selves. No lay government bureaucrat can expect 
to succeed in this area. They have neither the 
knowledge nor the know-how. 
One of the most recent influences in health 
care delivery th at is affecting the government, the 
patients, and the anesthesiologists as well as phy-
sicians in general is the mounting cost of mal-
practice . When I started in medical practice some 
twenty-odd-years ago, my premiums for $100,000-
$300,000 malpractice coverage were $102.00 per 
year. Today, in New York, a policy with $2,000,000-
$6,000,000 coverage, which is necessary because of 
the frequency and increas ing fees of malpractice 
defense, is $6,000 per year. This has been one of the 
most troublesome areas in rising costs of medical de-
livery by professionals. The professional cannot be 
expected to absorb all of this expense, and a great 
deal of it has been passed on to the patient as evi-
denced by increasing fees. Malpractice coverage 
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costs have also increased health costs in general by 
creating the need for more expensive laboratory 
tests and by limiting a certain professional thera-
peutic act ivity to very costly methods where there 
is a high degree of safety. At present, there is a 
presidential commission studying this problem. All 
we can say is th at we urge their haste before mal-
practice premiums raise the rate of health care de-
livery beyond any reasonable expectation. 
There has been a recent surge toward prepaid 
clinic development. This is taking several different 
direc tions . Basically we are talking of that which is 
known as health maintenance organizations. These 
may be institutional and they may be individual. 
The Department of Health , Education, and Welfare 
over the past year has been actively involved in the 
development and planning of such HMO's on a pilot 
bas is. Needless to say, of the eleven functioning at 
this time all are in serious fin anci al straits, with one 
exception, and a much more extensive review of 
this HMO problem and projection of financi al opera-
tion must be undertaken before any reliable results 
might be expected. 
The second major influencing factor in health 
care delivery in the United States is the activity of 
the American Medical Associ ation. I think it is 
important to say that there has been a great swing 
in the philosophy of activity within this organization, 
particul arly regarding scientific and educational op-
portunities. This has been all for the good. The most 
interesting of the changes is in the fact that as of July 
of this year, the specialty organizations within medi-
cine will take over most of the responsibility for 
scientific programming at annual and clinical meet-
ings of the AMA. 
There also has been an extension of the lines 
of communication within the AMA between the 
medical specialties and the officers, trustees and 
delegates . The first of these has been the develop-
ment of the Section Councils which will be chosen 
for the most part by the parent specialty organiza-
tions. It is these Section Councils that will augment, 
authorize, and be responsible for the scientific ac-
tivities presented as educational efforts of the AMA. 
The second line of communication has been the 
development of the Interspecialty Committee of the 
AMA's Board of Trustees so that specialties now 
have direct representation and voice channeled to 
the trustees of the organization. This provides for a 
rapid, informed dialogue between both organizations 
involved and the specialties at large. 
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Another important change in the American 
Medical Association has been the ac ti vity of its 
Council on Education. The Council has been in-
strumental in implementing the thinking published 
in the Millis Report. As you all know, internships 
are being phased out. There is an attempt to shorten 
the medical curriculum. In this rega rd . the AMA , 
the American Hospital Association . The American 
Association of Medical Colleges, Th e Am erican 
Medical Specialty Boards, and the Council of Med i-
cal Specialties Socie ties are in the process of agree-
ing on a projected development of li aison committees 
fo r undergraduate and pos tgraduate medical educa-
tion. There is no doubt th at their thinking will 
eventually ex tend to Continuing Education and to 
Allied Health Profess ionals with the development of 
li aison committees in each of these groups together 
wi th representation from each of the parent organiz-
ing groups. O verseeing all of this will be a coordin at -
ing council which will have representation from each 
of the liaison committees and will be responsible as 
a single voice for medicine to the United States Com-
missioner of Education. This wi ll probably prove to 
be one of the most effecti ve links American med icine 
has ever had for a producti ve coordin ated delivery. 
Of course, it is important at this time to realize th at 
the early locking-in of a young medica l specia li st, 
whether he be in one of th e surgica l. medical. or 
fa mily practice specialties , may influence the ab ility 
of future grad uates in medicine and postgraduate 
trai ning in their ability to pass present medical exa m-
inations. They may not easily swing from one med ical 
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specialty to another with the same freedom of license 
to practice medicine. Consequently, there are many 
areas now where it is thought th at an M.D. degree 
might eve ntu ally have to be modified so that it would 
speci fy a particular parameter of act ivity such as a 
med ica l specialty. Hence, in the future one might see 
M.D. (Anesthes iology) or M.D . (Surgery). This will 
also probably ca ll for a complete ch ange in licensing 
exam inations on a nationwide basis unless there is 
a very adequate and broad depth of medica l infor-
mation funded to a young medical graduate with 
a fo resho rtened curriculum who is locked into a par-
ticula r specialty earl y in his medica l existence. 
The third major influence on health care de-
livery of anesthes iology is the American Soci ety of 
Anes thesiologists. This is a national federation of 
twe nty-four component societies . It is extremely 
effec ti ve organizationally as a unifying force for edu-
cation, for combined efforts, and for the production 
of standa rds within the specialty. The ASA is also a 
very effec tive li aison o rgan iza tion with the other 
specia lties of medic in e and with government where it 
speaks with one voice. It has just adop ted a require-
ment for Continuing Education for continued mem-
bership. 
In summ ary, then. let us say th at there are many 
fac tors influencing health care delivery of anes-
thesia in the United States. The people of this 
cou ntry expect improved delive ry of medical care. 
The med ical profess ion stands ready to do its part. 
And it expects the gove rnment to assume its liability. 
Simply stated. that means adequate funding. 
The Anesthesiologist-Anesthetist T earn* 
BERNARD A KUZA VA, C.R. N. A 
Assistant Professor of Anesthesiology, 
Chairman, Department of Nurse Anesthesia, 
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How ironic it is that we should be presenting 
the team concept of anesthesia practice at a confer-
ence whose format is "What Is New in Anesthesiol-
ogy. " Ironic because the team concept is not new in 
medicine in 1972. It has evolved in many areas 
with outstanding success in all. For example: coro-
nary care units could not function so efficiently and 
excellently without teamwork; patients requiring 
acute and chronic respiratory care would probably 
be doomed without a team of physicians, nurses , 
and technicians; and stroke victims requiring the 
expertise of the physician during the acute phase of 
their illness, could not realize their full potential once 
again without a team of nurses, speech therapists, 
physical therapists, and other Allied Health Profes-
sionals. So also in anesthesiology, the concept of a 
team of anesthetists and anesthesiologists must 
evolve to enable us to adequately meet the needs of 
our consumer-the patient. 
Let us for a moment digress and think about 
the patient, after all he is the reason why we do 
what we do. Have you noticed how sophisticated 
he has become lately? Insurance companies cer-
tainly have. No longer are we afforded the luxury of 
mysticism in medical practice. Medical knowledge, 
little as it may be, is possessed by a significantly 
greater segment of the population than ever before. 
The patient now demands his money's worth from 
the high cost of medical care. Magazines and news-
papers, such as the Wall Street Journal, with their 
tremendous circulations make sensational headlines 
about the occasionally disastrous, albeit rare, effects 
of drugs or therapy. When reading such information, 
the patient more often than not becomes actually 
• Presented at the 25th Annual Stoneburner Lecture 
Series, February 25, 1972, at the Medica l College of Vir-
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more misinformed than informed. Nevertheless, he 
takes this information ( or misinformation) to the 
hospital with him practically demanding that we 
guarantee him safe passage through his illness. 
Anesthesiology has by no means been able to 
escape the well-informed patient. In fact, it seems 
to me that as a specialty we have been practically 
singled out by the intellectual patient and his at-
torney. With the increasing onslaught of medical 
pseudo-education available to the consumer and our 
lack of ability or desire to set the record straight 
for him , our clinical judgment in many instances is 
in jeopardy of being compromised by our legal 
judgment. Because of the more sophisticated con-
sumer and the trend towards team medicine in gen-
eral, it is absolutely essential that where physicians 
and nurses work together to deliver this health care 
service they do so as a team. 
Unfortunately, the team concept is not com-
monplace in anesthesia today. This situation pre-
va ils because relations between the anesthesiologist 
and the anesthetist have not been good over the 
years. Anesthesiologists have claimed that they 
should be the only professionals to deliver this type 
of health care; nurse anesthetists have made similar 
claims. Anes.thesiologists have not enjoyed the pres-
tige that their colleagues in surgery or other special-
ties have received. After all , what self-respecting 
doctor would want to devote his professional life to 
the same task that could be performed just as well 
by a nurse? On the other hand, nurses have not en-
joyed the greatest acceptance into the specialty by 
their colleagues who, to this day, do not consider 
schools of anesthesia as offering post-graduate nurs-
ing education. Animosity and bad relations have 
through the years been the rule rather than the 
exception between CRNA's and M.D. 's. In many 
local areas today, nurse anesthetists feel threatened 
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by the presence of anesthesiologists and vice ve rsa. 
We cannot deny that in some areas there is good 
reason fo r these feelings to exist. Unethical pract ices 
on the part of both groups have not served any 
benefici al purposes except those of the practitioners. 
In 1970, the American Soc iety of Anesthes i-
ologists invited several nurse anesthetist educato rs 
to participate in a symposium conducted at the 
annual meeting. I was honored to have been the 
first speaker on that program, and at that time I 
saw great hope fo r the future inte rrelations of our 
respective groups. My view has not changed in 1972 . 
Recent steps taken by both the A merican Associa-
tion of Nurse Anesthetists and the American Society 
of Anesthesiologists to assure better relations be-
tween the two have convinced me that a team of 
well-t ra ined nurse anestheti sts and anesthesiologists 
is the single best answer to the challenges the future 
will bring. 
The trend toward development of programs 
to train nonprofessional anesthesia technicians to 
supply manpower in thi s health care a rea is in my 
opinion an unnecessary endeavor and a mistake. 
There is no shortage of applicants to our program 
fo r nurse anestheti sts, and I am sure this situ ation 
exists in most other schools as well. There is, how-
ever, a limit to ava ilable space in all schools, 
and this will probably continue as long as the teacher 
shortage exists and until more faciliti es are con-
structed . The establishment of technical programs to 
educate ass istants whose functions a re limited, back-
grounds di ve rse, motivation uncerta in, and whose 
pl ace is still ill-defined is beyond my comprehen-
sion. 
Anesthesiology is the one speci ality which has 
had fo r yea rs physici ans' idea l ass istants but has 
failed to utili ze them. Nurse anestheti st prog rams 
have evolved to high degrees of excell ence th rough 
the efforts of many talented individu als, and the full 
potential of these programs is still to be realized. The 
awarding of an academic degree in conjunction with 
professional certi fica tion is now a reality. This trend 
must and will continu e. U niversity offi cials are 
now beginning to recogni ze their obliga tion to 
educate as well as train nurse anesthetists so that 
they may not only be prepared fo r clinical practice, 
but also be qualified by degree to teach others in 
the field. In short , the nurse anestheti st and anesthesi-
ologist learning together and practicing together are 
the future of anesthesia health care delivery in this 
country. 
How is such a team to be suddenly imple-
mented after yea rs of indifference? The answer is 
both complex and simple. It requires maturity and 
a rea li za tion of limitations, capabilities, and poten-
ti al of all members of the group. 
Just as a football team requires a quarterback 
to call signals and make pl ays, so the anesthesia 
team requires a leader. The quarterback of the anes-
thesia team is acknowledged to be the phys ician; 
however, without lineman for defense and pass 
rece ivers to carry the ball , the qu arterback would 
not get ve ry fa r befo re being inundated by the 
opposing line. In our anesthesia team, the nurse 
anestheti st backfield often carries the ball. Never-
theless, we must never fo rget that in all successful 
football teams the qu arterback has been not only a 
playmaker, but also a scrambler who is capable and 
willing to take the ball downfie ld himself. 
The Anesthesiologist. An important part of 
res idency tra ining, it would seem to me, should be 
spent in learning how to supervise. This is the most 
neglected ph ase of res ident teaching, but its im-
portance must not be underestim ated . All too often 
the anes thesiologist find s himself in a situation where 
he is responsible for two or three operating rooms 
at one time. If he has ex perienced this during his 
res idency, he will be much better prepared to act 
as the consultant and overseer of the anesthetists 
who a re actually admini stering the anesthetics. I 
submit that it is much more difficult to supervise 
two or three anesthetic administrations than to be 
responsible fo r the ac tual administration of only one. 
If the anesthesiologist is to be an effective 
supervisor, he mu st be an accomplished clinician. 
C urrently, most residencies o ffer an abund ance of 
clinical experience, thereby meeting this require-
ment. The anesthesiologist must know the problems 
of the indi vidual patients whose anesthetics he is 
supervising. This knowledge can be ga ined during 
the preoperative visits. He must be able to identify 
which of these patients is most likely to require the 
closest attention. Fin ally, he must know the limita-
tions and capabilities of the individual anesthetist 
ass igned to administer the anesthetics. This all -
important knowledge will enable him to provide all 
of the patients with the best possible care ava il able. 
Teaching the res ident to supervise would be 
best accomplished in the latter part of the fin al year 
of a two- or three-year res idency. At this time. the 
clinical ex perience should be adequate and the 
knowledge of individu al capabilities should be known. 
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It would probably be best to assign the resident 
supervisor to cases which would be performed by ex-
' perienced staff members rather than other students 
or residents in the department. Experienced staff 
members are generally more mature, and rapport 
with them can be established more easily than with 
students who may not readily accept supervision by 
someone other than the clinical instructors and at-
tending physicians with whom they are accustomed 
to working. Also, the beginning supervisor should not 
have the added burden of work ing with inexperienced 
persons while he himself is learning. In my opinion, 
teaching proper clinical supervision to residents is 
a necessary part of anesthesia education and a must 
if the team concept of anesthesia care is to be 
successful. 
The Nurse Anesthetist. With the organization 
of colleges of Allied Health Professions, nurse anes-
thetist programs have finally found a place where 
they can grow and develop independently, yet in 
conjunction with the university. A program based 
in Allied Health can offer students the benefits 
of university level basic science courses for which 
academic credit can be awarded. No longer must 
the nurse anesthetist program be chained to the 
hospital where the temptation is to utilize its 
students to provide service in return for education. 
The potential for obtaining federal funding for such 
programs is yet to be put to the full test; however, a 
program structured within the university will be in an 
extremely good position to obtain such funding when 
it is available. 
I am, of course, vitally interested in sound 
education for nurse anesthetists . I am devoting my 
professional life to seeing its development progress. 
At the Medical College of Virginia, we are com-
mitted to elevating standards for nurse anesthetist 
education. With the cooperation of the University 
officials, we are seeking to develop a meaningful 
curriculum around which we will train and educate 
the nurse anesthetist of the future at the bacca-
laureate level. My colleagues in similar positions 
are no less dedicated. We foresee the day when all 
Schools for Nurse Anesthetists will have faculties 
trained at the university-based schools, with the 
credentials to provide sound educational experi-
ences for their students. We foresee the day when all 
nurse anesthetists will be assured of equivalent edu-
cation. We encourage the cooperation and guidance 
of the American College of Anesthesiologists to play 
a greater role in the development of these programs. 
It has been said that an anesthesiology resi-
dency cannot be successfully conducted within a 
hospital where nurse anesthetists are also being 
trained . I believe we have shown that it can be 
done. If anything, dual programs can serve to rein-
force and complement each other, and it is the most 
practical way to develop the attitude of team prac-
tice at an early stage. Nurse anesthetists and resi-
dents trained together quickly see the advantages 
of each other. This serves to develop a healthy atti-
tude among the trainees working together. 
Currently, our nurse anesthetist program re-
quires a two-semester intensive basic science course 
during which clinical experience is limited to de-
veloping basic techniques. Following this, the stu-
dents' education is oriented to the clinical situation 
where they spend a period of one year administering 
approximately 750 anesthetics. The clinical instruc-
tion also includes affiliation with community and mil-
itary hospitals so experience may be gained with all 
types of anesthesia techniques in various environ-
mental situations. We would like to think that this 
program will serve as a model for emerging uni-
versity-based programs. At the same time, however, 
we stand ready to learn from others if such learning 
will improve our standards. 
In summary, I call upon anesthesia educators 
to abandon technician-training programs and instead 
help us develop nurse anesthetist programs to a 
higher level nationally. Let us remove our finger 
from the panic button and begin working together 
as a team , acknowledging our shortcomings and lim-
itations. The time for us to establish the strongest 
possible ties both in our educational systems and 
our service-oriented institutions is right now. Mutual 
respect and cooperation are the keys to a smooth, 
efficient operation of an anesthesiologist-anesthetist 
team. And finally , let us be certain that the next 
meeting with the format of "What Is New in Anes-
thesiology" does not require a lecture on the anes-
thesia team. 
Anesthesia, 1972* 
C. RONALD STEPHEN, M. D. 
Professor and Chairman, Department of Anesthesiology , 
Washington University School of M edicine, 
St. Louis, Missouri 
Implied in a title such as this one is an obliga-
tion to determine the present "state of the art," or 
science, if you will , and to elucidate, in a manner 
of speaking, where we are, why we are, and in 
which direc tion we may be going. To perfo rm such a 
function in perspective, we must return to the past. 
Then one wonders, how fa r into the past? How 
much of the past is rea lly relevant to today? 
Our reflec tion will go back thirty years to 1942, 
in Mont real, Canada, to the sphere of McGill U ni-
versity. In those days, Montreal was on a full war-
time basis: there was rationing of food and gasoline; 
soldiers, sa ilors, and airmen were nudging each 
other on the streets; the news on the rad io was 
grim except for the occas ional sparkle and lift from 
Winston Churchill ; and in the midst of this, four 
young men, of whom only one is alive today, had 
been directed by the Canadian Army to pursue a 
course in anesthesia. The instructors have now be-
come legend . Wesley Bourne was a teacher supreme, 
whose every sentence and intonation added knowl-
edge to those who would listen, whose every move-
ment at the head of the table was a superb action 
on a stage . Digby Leigh was the man who breathed 
life into the pedi atric patient when it would appear 
none was there; he is the man who fo rged the sub-
specialty of pedi atric anes thesia to make it what it 
is today. And Harold R . G riffith who is best known 
to all of us, probably not because of his quiet, lov-
able, unassuming, Rock-of-Gibralter charac ter , but 
because in that year, 1942, he demonstrated to the 
world that curare, or intocostrin , as the preparation 
was called, could produce reve rsible relaxation of 
muscles and so immeasurably aid the perfo rmance 
of anesthesia and surgery. 
• Prese nted at the 25th Annu al Stoneburne r Lectu re 
Series, Febru ary 25 , 1972 , at the Medica l Coll ege of V ir-
ginia, Ri chmond. 
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In pass ing, it is worth noting that "Uncle" 
H arold, as he is known, was prim arily a clinician. 
If he had been a habitue of the laboratory, the intro-
duction of curare into practice might have been 
delayed. Doctor Lew is Wright , the eminent anesthes i-
ologist from New York, had told him that curare 
had a bad record in dogs, producing marked saliva-
tion a nd significant hypotension. But Dr. G riffi th, 
with his clinical acumen, recognizing that humans 
are indeed differe nt from dogs, assayed the drug 
in his patients, hi s surgeon brother being a coopera-
tive partner, and found it not wanting in desirable 
attributes. 
It is fa ir to say that 1942 was a major turning 
point in our philosophy concerning anesthesia care 
fo r pa tients. Today it is rare fo r a pat ient to undergo 
major surge ry without the benefit of muscle relaxant 
drugs. But other fac tors helped to shape the dest iny 
which makes anesthesia the independent specialty 
it is at present. Out of the misery and suffe ring of 
the Second Wo rld War was spawned the anesthes i-
ologist as a specialist ; the man or woman who 
could preserve vital fun ctions both during and 
after the ordeal of surgery, the individual who could 
balance, by dint of pharmacologic knowledge, a mix-
ture of drugs, none to a toxic level, which would 
provide the correct degree of hypnosis, analgesia, 
muscular relaxat ion, and obtundation of reflexes for 
the performance of surgery. 
The ubiquitous cautery forced a change in the 
habits of the anesthetist also. The standard ethyl 
ether, which had served so well for so long, and the 
almost angelic properties of cyclopropane were 
pushed into the background, albeit with some mea-
sure of distaste in certa in qu arters. The value of 
int ravenous narcot ic analges ics, to supplement the 
analges ia of nit rous ox ide, became established first 
in 1953, and then wi th a vengeance in recent times. 
Bu t in th e interim ca me the overwhelming tide of 
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the halogenated compounds best exemplified by 
halothane, which to some anesthetists has been all 
things to all patients, except for a little thiopental 
and muscle relaxant thrown in from time to time . 
This period of growth and development was 
paralleled by a sharpened interest in what effects 
anesthetic drugs had on the vital functions of respira-
tion, circulation, and renal and hepatic metabolism. 
Sophisticated experimentation in laboratories be-
came the order of the day, and much valuable 
insight has been gained . In the operating rooms, 
monitoring has become a concomitant of drug 
administration, and the variables associated with 
arterial blood determinations and central venous 
pressures, to say nothing of an infinite variety of ven-
tilators, are lending an aura of science to our pur-
suits. 
And so we come to February 25 , 1972. Where 
do we find ourselves today? If one looks at this pro-
gram, if one listens to any series of papers discussing 
anesthesia practice, one finds a querulous note, a 
feeling approaching dismay, an uncertainness of atti-
tude, a tone of belief that almost encourages dis-
belief. It appears that we are standing on the brink 
of change. But what change and in what manner? 
As one surveys the scene, it is discouraging to 
see that a significant mortality still is attached to 
the process of anesthesia. One out of every 2,000 to 
2,500 patients who submits to anesthesia becomes a 
statistic due in part to what anesthetists do or do not 
do. However effective the anesthesia administered, it 
is still not safe to the degree to which air travel , for 
example, has become. As a matter of fact, the risk 
of anesthesia today is probably of the same order 
as it was in 1942. There is pride that more extensive 
surgical procedures can be accomplished and that 
the elderly can survive a sojourn in the operating 
room, but cardiac arrest carts seldom manage to 
accumulate dust, and the morbidity-mortality con-
ferences are still an active feature of training pro-
grams. 
Of course, an element of risk will probably 
exist until the secret of the state called anesthesia 
becomes unraveled to some extent. Whatever we do 
now is associated with physiologic trespass, and 
what is needed is specificity of action that will not 
be associated with deterrents such as cardiovascular 
or respiratory depression. 
We are losing faith in cherished pharmacologic 
traditions. Until seven or eight years ago, the stabil-
ity of the inhalation anesthetics, except for trichloro-
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ethylene, was accepted as an inviolate statute. Then 
it became recognized that biodegradation was a 
problem with which to reckon, and that such metab-
olism could be influenced by numerous factors. 
Some of these were perhaps genetic in origin, some 
were related to other drugs acting as enzyme in-
ducers, and at times even an anesthetic was ac ting 
as its own inducer of metabolism. The full signif-
icance of the fact that so-called stable anesthetics 
can be metabolized has yet to be delineated, but 
in the mea ntime the caution fl ags are being displayed, 
and our former confidence in these drugs is being 
shaken. 
Not so many years ago, America's leadership 
in pharmaceutical discoveries was second to none. 
In 1958, for example, some 60 diagnostic and thera-
peutic compounds were marketed; by 1969, how-
ever, this number had dwindled to five or six. The 
principal stumbling block in this decline and fall has 
been the federal Food and Drug Administration. 
Efforts to satisfy the requirements and demands of 
this agency relative to a New Drug Application have 
become so frustrating that few pharmaceutical com-
panies believe realistically that the time and work 
involved are worth the problems which must be 
surmounted. Anesthesiology is one of the specialities 
suffering from this frustration . The situation at the 
moment is that a number of new drugs are in 
actual use in many parts of the world but are not 
available to physicians in the United States. For 
example, a new muscle-relaxant drug, pancuronium, 
has supplanted d-tubocurarine in a number of coun-
tries, and bupivacaine, a long-acting local anesthetic, 
has been heralded in Europe; but both drugs are 
banned from general use in this country at the mo-
ment. Inability to participate in clinical trials of 
therapeutic compounds has dampened the enthusi-
asm of many anesthesiologists. 
Also of deep concern to practicing anesthesiol-
ogists is the almost lackluster interest in the specialty 
by both the public and neophyte physicians even 
though, and perhaps because, our malpractice pre-
miums are the highest in the medical profession, 
ranking with those of our surgical colleagues. It is 
discouraging to see some of our leaders forsaking the 
field for administrative pursuits. Paradoxically, oth-
ers are fleeing the operating room to become spe-
cialists in intensive care or inhalation therapy. The 
rationale for this escape is that the graduating med-
ical student is more likely to be attracted to this 
specialty if the anesthesiologist accepts more re-
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sponsibility outside the operating room, if he be-
comes recognized as the authority in acu te medicine 
th roughout the hospital. But what about the patient 
with the "cardi ac a rrest" back in the operating 
room? 
Because of the fo regoing, it is appropriate to 
say that in 1972 everything in anesthesiology is not 
wine and roses. Nor is it, of course, in the enti re 
medical profession. The specter of National Health 
Insurance hangs heavy in the offi ng, the peer review 
system is rearing its head, and the recerti fication 
threat is ru ffl ing the equili brium of some. But how 
can we set our sights in anesthesia so as to rid our-
selves of the indec isions, the frustrations, the lac k 
of sati sfac tion with what we are do ing, and move 
fo rward to prov ide safe pain relief fo r all patients in 
this country? 
As noted, the a rse nal of drugs upon which we 
have come to rely is be ing reduced in nu mber and 
breadth of application. A nd one find s a trend in 
many centers toward the use of drugs which a re 
administered parente rally. It is perhaps worthwhile 
to explo re this shi ft to see if indeed safe and effici ent 
anesthesia can be prov ided by this means. 
For purposes of disc uss ion, certain ground rules 
wi ll be established which will serve to shape the 
nature of the search . F irst, let us suppose potent 
inhalation anesthetics will be d iscarded. Second, it 
wi ll be assumed that the anesthet ists can adequ ately 
ass ist or control ventil atory exchange. Third , a pri-
mary aim will be to mainta in card iovascular dy-
namics, with preservation of the preex isting blood 
pressure and, one hopes, perfusion of blood to the 
organs in the norm al prefe rent ia l manner. Fourth , 
the central nervous system will be sufficiently ob-
tunded so the patient will have no memory of the 
anesthetic o r surgical procedure, and pain ful stimuli 
will not be reflec ted in abnormal reflex reactions. 
F ifth, adequ ate conditions will be prov ided fo r the 
contempl ated surgery, with sufficient signs being pre-
sented earl y to indicate the need for blood volume 
replacement . And last, there will be rapid restora-
tion of central ne rvous system functi on at the con-
clusion of surgery, with the patient oriented to time, 
place, and person, and showing evidence of norm al 
respi ratory and cardiovasc ul a r functions. Idea ll y, 
analges ia will be ex tended into the postoperative 
period. 
Actua lly, there is nothing rea lly novel in these 
a ims. In 1953, in L iverpool, England, Cec il Gray 
desc ribed in detail what has come to be known as 
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the "Liverpool Tec hnique," whic h incorporates a 
" sleep" dose of thiopental, approx imately 250 mg 
fo r a 70 kg adult ; a moderate dose of d-tubocurarine 
( 35 to 40 mg) to fac ilitate endotracheal intubation 
and prov ide muscle relaxation; and a 70:30 high-
fl ow mi xture of nit rous ox ide and oxygen, plus 
hyperve ntil ation, to prov ide analges ia and central 
nervous system obtunclation. The hyperventilation is 
important in this sequence as it contributes to the 
cerebral obfusca tion. A nesthesiologists in A merica 
have questioned this technique on several counts. 
T hiopental is a di rect cardi ac depressant and is cap-
able, eve n in small closes, of produc ing cardio-
vascular depress ion, particul arly in geriatric patients. 
Relatively large closes of cl-tuboc urarine can also 
produce marked reducti ons of blood pressure in 
some pa tients , particul arly when used in associa-
tion with thiopental. Administra tion of only 30 % 
oxygen, especially in patients with preex isting pul-
monary dysfun ction, has been shown to result in 
c ritically low arte ri al oxyge n tensions during the 
course of anesthesia. Hyperventil ation, if carried to 
the point of reducing a rte rial carbon d ioxide tension 
to less th an 25 mm Hg, may result in a degree of 
cerebral hypox ia. A nd fin ally, there a re a number 
of reports in the literature which attest to the fact 
that with th is tec hnique patients can on occasion 
recall eve nts which transpired during surgery. 
Because of questions such as these, anesthes i-
ologists a re modi fy ing their. approach to the Liver-
pool T echnique. T he basic soundness of using 
nit rous ox ide fo r its amnes ic and analgesic prop-
erties is not being questioned, and indeed it fo rms 
the fo undation upon which the anesthetic structure 
is mounted. (Incidentally, there is no evidence at 
the moment that nit rous ox ide undergoes bioclegra-
dation in the body.) However, it is recognized that 
nit rous ox ide is not all things to all patients and that 
the degree of amnesia and analges ia which it confers 
va ries from one person to another. Moreover, its 
ac tions a re dose-related, so that if it is believed 
necessary to prov ide a pati ent with 40 or 50 % 
oxygen during surgery, the benefit s from nitrous 
ox ide will be reduced accordingly. 
One of the more striking applica tions of an 
intravenous d rug to modern surgery has been the 
use of the tried-and-tru e morphine in open heart 
procedu res, certa inly a type of surgery which taxes 
the sk ill of all concerned. The doses employed a re 
not nigga rdly ( 1 to 3 mg per kg ) , and there is now 
reasonable ev idence th at, at least in the normal 
STEPHEN: ANESTHESIA, 1972 
heart, doses of this order have little effect in depress-
ing cardiac output. However, problems can arise 
with this approach. Some patients in incipient car-
diac failure develop hypotension with only small 
doses of the drug, and careful titration is necessary. 
Although the analgesic properties of morphine are 
obvious, its propensity to produce amnesia is not 
great, and one wonders at times about recall by the 
patient. Another difficulty which is seen frequently, 
particularly in patients having coronary artery by-
pass procedures, is a worrisome degree of hyper-
tension. There is concern about such increases in 
blood pressure; something which we have not had 
to worry about since the days of cyclopropane . One 
wonders if there is to be an alteration of blood pres-
sure under anesthesia whether it is safer to have 
an increase rather than a decrease of 30 to 40 mm 
Hg. The reason for the increase in blood pressure 
is unknown at present. The two most likely causes 
are an augmentation in cardiac output and / or pe-
ripheral vascular resistance. The underlying etiology 
could be an increase in catecholamine release, per-
haps due to the direct action of the drug or to reflex 
responses , which would imply an inadequate degree 
of anesthe_sia. Whatever the reasons, various ways 
of reducing the blood pressure have been employed. 
The administration of a low concentration of hal-
othane (0.5 % ) is corrective, perh aps because of 
its sympatholytic effect or because of the added 
anesthesia it provides. The ganglion-blocking action 
of trimetaphan (Arfonad®) will often result in a 
reduction of blood pressure, and the adrenergic-
blocking effect produced by chlorpromazine, and to 
a lesser extent by droperidol, will tend to restore the 
pressure toward normal levels. 
The use of morphine in large doses also poses a 
problem related to metabolism in that its respiratory 
depressant effects persist beyond its period of use-
fulness in the operating room . This prolonged effect 
may be advantageous in open heart surgery in which 
it is planned to maintain the patient on artificial 
ventilation for a period of time, but it does present 
difficulties in other types of major surgery when one 
would like to have the patient self-sufficient in the 
recovery room. Perhaps the properties of the specific 
narcotic antagonist, naloxone, can be used to ad-
vantage under such circumstances. 
Another narcotic combination, lnnovar®, has 
met with varying degrees of success in its applica-
tion to the state of anesthesia. The advantage of its 
narcotic component, the potent analgesic fentanyl, 
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lies in its relatively rap id rate of metabolism, a given 
dose being effective for not more than 30 or 40 
minutes. Therefore, with attention being paid to its 
titration, respiratory depressant effects need not be 
a problem in the postoperative period. The other 
component of Innova r, the butyrophenone droper-
idol , has brought an exciting new dimension to what 
we are trying to accomplish in anesthesia. Probably 
acting at the level of the reticular act ivating system, 
this drug serves to disconnect the patient from the 
fear and concerns associated with his immediate 
environment. However, the degree of associated 
amnesia is variable from one patient to another, and 
one cannot count on a given dose of droperidol 
blotting out remembrance of a procedure. Although 
it has mild adrenergic-blocking properties, there is 
no ev idence that it is a direct depressant to the 
myocardium and, if the patient remains supine and 
does not have a reduced circulating blood volume, 
vascular homeostasis is preserved with its adminis-
tration. It also possesses anti-arrhythmic properties 
which help to stabilize cardiac rhythm during sur-
gery. Unlike fentanyl , droperidol is metabolized 
slowly in the body, its effects lasting six to eight 
hours, so that its actions are apparent in the re-
covery room. These effects are deemed advantageous 
by some: it is not a respiratory depressant, nor is it 
an analgesic, but it does appear to alter the patient's 
reaction to pain so that he does not demand narcotic 
analgesics. 
So far, the drugs discussed have not demon-
strated evidence of potent amnesia, or ability to 
prevent recall-the best has probably been nitrous 
oxide. But a relative newcomer on the scene, dia-
zepam, shows evidence of providing the desired 
potency. Administered intravenously, the dose of 
diazepam required to produce a lack of subjective 
response by the patient is highly variable, ranging 
from 5 to 30 mg or more, but amnesia for associ-
ated events is usually present after a dose of 10 mg. 
Best described as an amnestic and hypnotic, in that 
order, diazepam can produce respiratory depression 
but has little effect on cardiovascular hemodynamics 
in the doses required for hypnosis . It can be used 
safely and with merit in association with narcotics 
and muscle relaxants. 
One compound which has had a mixed recep-
tion since its introduction in 1970 is ketamine. 
Enthusiasts have embraced it because it produces 
unconsciousness and intense analgesia without as-
sociated depression of respiration , except mo-
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menta ril y in some patients, o r circulation. As a 
matter of fact , cardiovascul ar dynam ics appear to 
be enhanced, as reflec ted in a moderate increase in 
pulse rate and blood pressure. Interest ingly enough, 
this ca rdi ac stim ul ati on is not assoc iated with an 
increase in myocardi al irritability; in fact, the drug 
possesses anti-arrhythmic prope rties. Equally im-
portant is the safety of the compound : more than 
five times the recommended clinical dose can be 
given intravenously without untoward effec ts in a 
healthy patient. Detrac tors point to the relati ve ly 
high incidence of halluci natory phenomena in adults 
as they are recove ring from the effec ts of the drug 
when it has been used as the principal anesthetic . 
They also emphas ize the random movements and 
increase in muscle tone seen in many patients. 
The mechanisms of the action of ketamine have 
not been we ll defined. no r is its sphe re of useful-
ness in the field of anesthes ia clear at the moment. 
Does the lack of respiratory and cardiovascular 
depress ion in the presence of apparent unconscious-
ness and intense ana lgesia imply th at this class ifi-
cation of chem ical compound allows one to narrow 
down the act ions which one wishes to provide for 
the anesthetic state? Does the wide marg in of safety 
in dosage imply an inborn com pensation for e rrors 
of admin istration? One could validly criticize the 
upsurge in card iovascular dynamics assoc iated with 
administra tion, as one does with the narcot ic drugs. 
But is such a change as deleterious as the cardio-
vascul a r depress ion so often noted wi th conven-
tional anesthes ia? 
If the reasons fo r the increase in vascular dy-
namics were known, one might be able to compen-
sa te for it directly. Such an increase could result 
from direct stimul ation of the vasomotor center; it 
could be secondary to an increase in catecholamine 
secretion ; o r as Dowdy has suggested, it could be 
due to an alte ra tion in the baroreceptor mechani sm. 
Whateve r the cause , small doses of droperidol (2 .5 
to 5 mg I.V.) tend to retu rn the blood pressure 
toward no rm al levels. 
With the intravenous drugs which are at present 
being used to suppl ement the Li ve rpool T echnique, 
it is apparent that full reliance must be placed on 
muscle relaxant compounds to prov ide sati sfactory 
operating cond itions for the surgeon. What Griffith 
began in 1942 will probably continue in full force, 
no doubt with substitutions for d-tuboc urarine from 
time to time. 
One would like to elaborate on one modifica-
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tion of the nitrous oxide, curare technique which is 
being prese ntly evaluated. It perta ins to the substi-
tution of ketamine fo r thiopental. Following con-
ventional narcotic or Innovar premedication , induc-
tion of anesthes ia is with ketamine 2 mg per kg 
intravenously, followed by d-tubocurarine approxi-
mately 0 .5 mg per kg, endoct racheal intubation in 
about three minutes with topical analgesia to the 
la rynx and trachea with lidoca ine 4.0 % solution, 
and then maintenance with nitrous ox ide and oxygen 
in a 60 :40 mi xture. Increments of ketamine 20 
to 30 mg are give n just before the skin incision 
and at intervals thereafter. Total dose of keta-
mine fo r a three-hour procedure is about 300 mg. 
Controlled respiration with moderate hyperventi-
lation is mainta ined, and increments of d-tubo-
curarine 6 to 9 mg are administered as required 
to mai ntain muscle relaxation . Neostigmine reve rsal 
is carr ied out at the end of surgery, and the patient 
is usually oriented a nd answering quest ions before 
leav ing the operating room. In 50 such experiences, 
there have been no instances of hypotension. In a 
few patients, increase of systolic pressures of the 
orde r o f 30 to 40 mm Hg has been controlled by 
small doses of droperidol (2 .5 to 5.0 mg 1.V.). In 
no patient has there been unusual react ion follow-
ing surge ry, and in none has recall of the surgical 
procedure been elicited. 
It is apparent that there a re a number of ways 
in which one can approach fulfillment of the criteria 
posed . None is perfec t, and probably none will be 
until the secret of anesth esia is unm asked. In the 
interim , each of us can and mu st work toward the 
goal o f effecti ve and safe anesthesia. 
If indeed we turn our backs on the potent inha-
lation anesthetics, or use them perhaps only as a 
second line of defense, we will no longer have need 
for the cumbersome anesthetic apparatus in use at 
present. Our gas machines a re imposing and perhaps 
awesome to the non-a nestheti sts in the operating 
room, maybe even lending an aura of mystery to our 
operations at the head of the table. But such displays 
of one- upmanship are rea lly no longer necessary in 
our profess ion. So one would propose scrapping the 
conventional fl owmeters and de-emphas izing the 
anest hetic machine as a central foc us and substitut-
ing prim arily a ve ntil at ing apparatus. Such a venti-
lator would be vo lume controlled, pressure va riable, 
simple and foolproof in construction , and cap-
abl e of be ing ste rili zed with ease. It would also be 
capable of providing positive to atmospheric, positive 
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to nega tive, or positive to positive pressures, with 
such pressu res immediately identifiable on a rugged 
but accurate pressure gauge. The rate of respiration 
per minute would be under the control of the anes-
thetist , as would the tidal volume to be delivered, 
this tidal volume being constantly displayed on a 
ventilation meter. The length of the inspiratory and 
expiratory phases of ventilation would a lso be sub-
ject to variation by the anesthetist , although the 
standard to be employed would be the 1 : 2 ratio 
proven to be so sati sfactory by Cournand a number 
of years ago. Of vital importance would be a means 
of manually ventilating the patient at a moment's 
notice , and of bei ng able to a lte rnate in a simple 
manner between mechanical and manu al ventilation. 
The gases to be supplied to the ve ntil ator would 
be nitrous oxide and oxygen, utili zing one meter to 
determine the total flow rate per minute and a 
mixing valve by means of which one could vary the 
percentage of each gas being supplied to the patient. 
This mixing valve would be unable to provide less 
'than 25 % oxygen and would of course have a 
fail-safe mechanism incorporated into it. In the 
gas supply line distal to the mixing valve would be 
an oxygen analyzer which would constan tly reco rd 
the percentage of oxygen in the mixture being de-
live red to the patient. 
It is unlikely that a carbon diox ide absorber 
would be necessary in this ve ntilato r-o riented appa-
ratus-particularly with our present knowledge re-
garding controlled ventilation in the anestheti zed 
patient-if the flow rate of the mi xture supplied to 
the patient were not less than six liters per minute. 
However, an important monitor in thi s apparatus 
would be a carbon dioxide analyzer which would 
intermittently , or on demand , record on a scale both 
the inspired and expired concentrations of carbon 
dioxide. 
Such would be the bas ic components of a new 
anesthetic apparatus. It would be mechanically sim-
ple and incorporate a number of monito rs vital to 
the welfare of the patient which are not an integral 
part of present-day equipment. Of course, for those 
who wished to rely in part on the potent inhalation 
anesthetics , calibrated vaporizers could be placed in 
series on the patient side of the mixing valve. 
One would hope that more spec ific means of 
monitoring the integrity of the ca rdiovascula r sys tem 
in a non-invasive manner will become ava ilable in 
the operating room. Today we rely prim arily on the 
blood pressure and the electrocardiogram. The blood 
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pressure is the result of the interaction between the 
cardi ac output , the peri pheral vascular resistance, 
and the circulating blood volume, and therefore, 
changes which occur cannot be specifica lly diag-
nosed. The electrocardi ogram merely reflects the 
elec tric al ac tivity within the conduction system of 
the heart ; it reveals littl e concerning myocardial 
function o r cardi ac output per se . The closest one can 
come to determining the adequacy of perfusion of 
blood to o rgans is to observe the urinary output. 
An adeq uate flow of urine during surgery reflec ts 
continuing renal function and presumably reasonable 
perfusion of that organ. 
In proper care of the patient, increasing reli-
ance is being placed on determinations of arterial 
pH and blood gas values, and rightly so. But obtain-
ing comparative inform at ion over a period of hours 
o r days requires an arterial puncture and usually an 
indwelling catheter, and because of this degree of 
invas ive sophistication , many patients are being 
denied therapeutic measures which they might other-
wise rece ive. A non-in vas ive technique of determin-
ing these values is sorely needed and capable of 
being perfected. 
There is one other aspect of anesthetic practice 
in this country today which demands attention in 
the effort to enhance the safe ty and efficiency of our 
services . We have the unique situation of two groups 
of profess ionals, anesthesiologists, some I 0 ,000 in 
number, and nurse anesthetists, some 14,000 in num-
ber, being responsible for anesthetic care. Unfortu-
nately, until recently, for reasons which one hopes 
a re now past hi story , there was littl e li a ison or 
rapport between these two groups, even though their 
daily objec tive was the same-to provide the best 
anesthetic care possible for the patient. It is high 
time we began to communicate meaningfully with 
eac h o ther, recognizi ng the concept that by work-
ing together, by sharing mutual problems, better 
care will be provided for the patient. 
Beginnings have been made in these directions. 
There is a Liaison Committee of the American 
Soc iety of Anesthesiologists and the American Asso-
c iat ion of Nurse Anesthetists which meets regularly 
in a growing spirit of mutual exchange. Both so-
c ieties have recognized a jo int statement of over all 
a ims and objectives. Meetings such as this one attest 
to the fact that not only a re nurse anestheti sts shar-
ing as participants in sc ientific programs, but they 
a re also attending in greate r numbers suc h programs 
throughout the country. 
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But there is more to be done. We need to work 
together as individuals, as small groups within a 
hospital, as larger groups within a city or state, and 
on a national level. Each of these groups has become 
a national entity in the realm of medicine and will 
remain so. The proper admini stration of anesthesia 
could not survive in th is country without the full 
ac tivities of both groups, and patients who require 
surgery are dependent on the knowledge and practice 
of both the nurse anesthet ist and the anesthesiologist . 
It is my sincere belief that by talking together, work-
ing together, acquiring knowledge together, the prac-
tice of anesthesia in this country will become safer 
and more effici ent. 
There is one concrete way in which these mu-
tual efforts could be enhanced . T o increase our 
knowledge and abilities in this day and age, reliance 
is placed primarily on reading books and journals, 
and on attending meetings. workshops, and seminars. 
The latter efforts usually involve leaving one's place 
of practice and traveling some distance. What one 
would propose is that the teacher travel to one's 
place of work, spend a few days in the operating 
rooms at the head of the table, showing and telling, 
to put it in the vern acul ar, and discuss ing actual 
or potential problems which could ar ise. There is 
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a precedent fo r this type of endeavor in at least 
one state of the Union in the speciality of obstetrics. 
I t would be worthy of a trial in anesthesiology. 
One recognizes, of course, the numerous logistical 
and economic problems surrounding such a sug-
gestion, but a national society or a national founda-
tion could lend its support less wi sely in other 
endeavors. 
And so we end the survey of Anesthesia, 1972. 
If it has fa iled to be glowing and full of sparkle, it 
is not for lack of confidence that this, the youngest 
of the true speci alties, has inherent within it the 
greatest challenge fo r the future . Today we are 
standing on the threshold of significant discoveries 
and developments. Everyone in this room will have 
an opportunity to participate in the exciting ad-
vances that are all about us. But while we work and 
extend our knowledge, may we keep in the fo re-
ground the hope and prayer that Sir Robert Hutchi-
son left fo r us : "From inability to let we ll alone; 
fro m too much zeal fo r the new and contempt for 
what is old ; from putting knowledge before wisdom, 
science before art , and cleverness before common 
sense; fro m treating patients as caM, and from 
making the cure of the disease more grievous than 
the endurance of the same-good Lord, deliver us. " 
Recent Developments 1n Anesthesia Malpractice* 
JACK B. RUSSELL, LL. B. 
Lecturer in L egal M edicine, M edical College of Virginia, 
Richmond, Virginia ; Member of the firm of Browder, Russell, 
Little and Morris , Richmond, Virginia 
The very fact that I have been asked to par-
ticipate in a program of thi s s ignificance is indicative 
of an ever increasing problem that is facing all face ts 
of the medical profession-that is, how to stay in the 
hospital and out of the courtroom. I shall be talking 
about some of the general considerations all of you, 
as anesthesiologists, anestheti sts. and phys icians, 
should keep in mind in o rder to understand your 
legal responsibilities to the patient. 
The topic ·'Recent Developments" is partially 
a misnomer because what I am going to address 
myself to is the recent trends or developments in 
three particul ar areas of the law as it affects the 
field of medicine, and then attempt to relate these 
particularly to the field of anesthesiology. You must 
also understand that "recent" medic ally and " recent" 
legally may in fact be years apart. What are com-
monly referred to as recent legal theories, freq uently 
find their origin in court dec isions several decades 
old. At the same time, some of what follows is of 
such recent vintage as to be classified by a vintner 
as green. 
First, I would like to discuss the phys ici an's 
duty to inform his patient and the recent legal de-
velopments in the area of informed consent. Sec-
ond, I will discuss briefly the area of potential 
contract liab ility which is somewhat rela ted to in-
formed consent. And last, some of the more class ical 
legal problems involving a ph ysic ian and his patient , 
with special emphas is on the Captain of the Ship 
Doctrine and respondeat superior. 
While the time has not yet ar rived, and hope-
fully never will , when a physician cannot go about 
his daily tasks without having a copy of Gray's 
Anatomy in one hand plus Corpus Juris in the o ther, 
* Presented at the 25th Annual Stoneburner Lecture 
Series, February 25 , 1972, a t the Med ical Co llege of Vir-
ginia, Richmond . 
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education as to the legal aspects of the practice of 
med icine in rece nt years has or should become a 
required co urse of study in our nation's medical 
schools and colleges. It is with thi s thought in mind 
that I prese nt to you today's disc ussion. 
Informed Consent. The Doct rine of Informed 
Consent is the child of the Doctrine of the Inviola-
b ility of the Individual Body, a concept born of the 
common law. Thus, it was stated in a recent case 
that " Anglo-American law starts with the premise 
of thorough-going self-determination; each man is 
considered to be master of his own body and he 
may, if of sound mind, expressly prohibit the per-
fo rm ance of life-saving surgery, or other medical 
t reatment , and while a doctor might well believe 
that an operat ion or a form of treatment is desirable 
or necessary, the law does not permit him to sub-
stitute his own judgment for that of the patient by 
any form of artifice or deception" (I) . 
It is because of this deep-rooted concept th at, 
prior to any trea tment , a phys ici an must obtain his 
patient's conse nt. Valid consent to treatment can be 
obtained in any of several ways. First, the physician 
can obtain th e express consent of the patient. This 
is done either ora lly or in writing, and most hospitals 
now have some type of consent form , though fre-
quently inadequate. Second , consent may be implied 
in fact. Implied in fact consent occurs when a pa-
tient knowingly accepts trea tment , as in rolling up 
his sleeve fo r an injection or agrees to an examina-
tion by lying on the examining table. Third, consent 
may be implied in law. Such consent occurs when 
the patient comes to a hospital unconscious or an 
emergency condition arises whereby he is unable to 
acknowledge his consent to treat ment. Finally , con-
sent may be given by a parent or guardian in the 
case of a child or incompetent. 
For various reasons, the consent given may be 
a nullity. For instance, the consent may have been 
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given by one who had no autho rity to give it , or it 
may have been obtained by fraud o r misrepresenta-
tion on the part of th e phys ician. While most phy-
sicians are aware of these traditional reasons fo r 
invalidat ing a consent , a re lati ve ly new reason fo r 
such has developed in recent yea rs. Thus, courts 
have held with increasing frequency th at a pati ent 's 
consent must be in fo rmed and in te lligent in orde r 
to be va lid . The patient must have a clea r under-
standing of what procedure is to be performed on 
him and the risks and poss ible compl ications in-
volved . A d isclosure that fa ll s short of this test can 
inva lidate the consent given just as thoroughly as 
if it had been obtained th rough fraud. 
While actions at law have always been avail -
a ble to pa tients aga inst thei r phys icians fo r fraudu-
lentl y induced consent o r fo r operat ions perfo rmed 
without consent , o nly recently have actions at law 
bee n maintained by patients who allege that although 
the ir consent was given, it was inva lid due to the 
phys ic ian's fa lling short of his duty to inform . This 
new right of ac tion appea rs to have its genesis in 
the dictum' of a V irginia case, Hunter v. Burroughs 
(2), decided in 19 18. In this case, the pl aintiff was 
suffering from ecze ma and the defendant/ phys ician 
recommended x- ray trea tment as a cure. Back in 
19 14 such a trea tment was revolutiona ry, and the 
defendant fa iled to wa rn the plainti ff of the ri sk of 
poss ible burn involved in its use. The pa tient suf-
fe red severe burns and sued his phys ician on two 
theories. Fi rst, he alleged th at the trea tment had 
been admin is tered negligently; and second. he a l-
leged th at the phys ic ian fa iled to wa rn him of the 
poss ible dangers o f x-ray trea tment. The court af-
fi rmed a judgment fo r the pla in tiff on h is negligence 
th eory and thus did not have to reac h the issue of 
informed consent. However, in a d ictum, the court 
laid the ground work fo r later court decisions on in-
fo rmed conse nt ( 3). 
The bas is of such an action is that a patient 
cannot give a va lid consent to a treatment which he 
knows little o r nothing about. The inviolab ility of 
the indi vid ua l body necess itates tha t any consent 
given must be based on in fo rm ation necessary to 
make the consent intelligent and freely given. This 
includes the dut y of the phys ic ian to d isc lose to his 
patient all relevant in formation concerning a p ro-
t Dictum-a statement o f a principle of law in a de-
ci sion by a court whi ch was suggested by the case but was 
no t necessa ry fo r a dec ision o f th e case as dec ided. 
posed treatment , including the collateral ri sks and 
complications attendant to the treatment , so that 
the patient's consent would be an intelligent one 
based on complete info rmation. The modern action 
based on a lack of info rmed consent did not fully 
develo p until 1960 in the case of Natanson v. Kline 
( 4), a case very simil ar factu all y to the Hu nter case. 
In the Natanson case, M rs. Natanson had un-
dergone surgery for the removal of a cancerous 
les ion in her left breast. A s a precautionary measure, 
her phys ic ian. Dr. Kline, advised that she undergo 
radiation therapy to prevent further spread of the 
cancer. Mrs. Natanson consented to such treatment , 
but as a resul t of it , suffered seve re burns. Subse-
quentl y, Mrs. Natanson brought an action aga inst 
her phys ici an on th e theory th at the consent to 
trea tment was not info rmed. The Supreme Court 
of Kansas held th at Dr. Kline was under the affirma-
tive duty to make reasonable disclosure to Mrs. 
Na tanson, allowing her to make an intelligent de-
cision whether o r not to take cobalt treatment. This 
duty included disclos ing the ri sk inherent in the 
proposed course of trea tment, bu t was limited to 
the disc losu re only of facts necessary to form the 
bas is of an intelligent consent. 
In defin ing this bas is, the court held th at the 
degree of disclosure is to be measured by the stand-
ard of what a reasonable medical practitioner would 
disclose to his patient under the same or similar cir-
cumstances. Thus, th e patient must introduce expert 
medical testimony in o rder to establish the commu-
nity standard as to di sclosure. Once such testimony 
is p roduced, it becomes a jury question as to whether 
the defend ant/ phys ic ian fa ll s sho rt of this standard. 
Acknowledging the li ab ility of a phys ician to 
his patient fo r failure to prov ide sufficient informa-
tion necessa ry fo r an info rmed consent , the question 
arises as to what type of action is to be main tained 
by the patient. Th e courts th emselves are somewh at 
confused in this rega rd but generally the- action is 
b rought on one of two theories : th at of assault 1 or 
th at of neglige nce. It is important to understand 
th e d ifference between an action fo r assault and an 
action for neg ligence. In the fo rmer, the essence 
of the action being the un authori zed touching of the 
patient 's body, the consent given, if there is any, 
I T he term tec hnica ll y should be .. battery .. which is an 
unau th or ized to uching of a no the r·s pe rson : however, the 
co urt s have no t bee n co nsiste nt in the use of thi s term , 
freque ntl y using .. assa ult .. in pl ace of it. The word .. assault .. 
is used ge nerica ll y to in clude both . 
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must be a complete nullity due to some misrepre-
sentation or omission by the physician. On the other 
hand, negligence connotes the breach of some duty 
or standard of care imposed upon the physician. An 
example of an action for assault or un authorized op-
eration is the case of Bang v. Charles T. Miller 
Hospital (5) , in which the patient was suffering 
from a urin ary problem and, after consultation with 
the attending physician, consented to a transuretheral 
prosta tic resection . The physician, however, fa iled to 
inform the patient that in doing the operation the 
spermatic cords would be cut and that the operation 
would render him sterile. The court held th at the 
failure of the physici an to disclose this essential 
fact rendered the plaintiff's consent invalid and 
hence, supported an action for assa ult. One of the 
key fac tors in an action based on assault is that lack 
of skill in performance of the opera tion or procedure 
is of no concern . The operation or trea tment may 
have been performed in the most sk illful manner 
but if there was no consent-informed consent-the 
plaintiff is entitled to recover damages from the 
physician. No expert testimony is needed in such 
a case. 
A case closer to home is that of Woodson v. 
Huey ( 6), where prior to an operation the patient 
informed his physician that under no circumstances 
did he want a spinal anesthetic administered to him 
and was assured by the phys ician th at he would 
receive a general anesthetic. The patient's wish was 
entered in his record by the physic ian . However , the 
anesthetist administered a spinal anesthetic following 
which the patient suffered paralys is. The court held 
the anesthetist liable for assault but not the surgeon. 
The fact th at the spinal was given in a perfectly 
proper manner was of no consequence in an ac tion 
for assault (7). 
A negligence action, on the o ther hand , requires 
the pl aintiff to show that (a) the ri sk was recog-
nizable and the physician's duty of care required 
the disclosure of that ri sk; (b) had the patient 
known of the ri sk, he would not have consented ; 
and ( c) no justification existed for the physician's 
failure to disclose the risk ( 8). Th e plaintiff must 
prove the first element by expert testimony estab-
lishing the community standard and showing that the 
physician's ac tions fell short of that standard . The 
second element necessarily involves the subjective 
intent of the patient and can be established by his 
simply testifying that had he known of the ri sk, 
he would not have agreed . The third element comes 
into pl ay only if the pl aintiff can establish the first 
and even then would require expert testimony to 
establish the requirement of disclosure. ( A few 
courts have placed the burden of proving this third 
element on the phys ician rather th an on the patient, 
the effect of which is to create a jury issue in such 
cases.) 
If these three elements are shown by the plaint-
iff, he has made out a prim a facie case, and the 
defendant must counter by showing that he in fact 
did make adequate disclosure or that under the 
accepted standards, disclosure was not required . 
Although a few courts still treat informed con-
sent cases as an action for assault , the great majority 
of jurisdictions are getting away from this theory and 
are trea ting such as actions sounding in negligence; 
thus putting them in the same category as an 
action for mistrea tment (9). Thus, in the case where 
the community standard is to secure consent to the 
administration of a spin al anesthetic during child-
birth, it may be malpractice, th at is, an action for 
negligence, where such consent is not procured prior 
to the ac tu al giving of the spinal anesthetic (IO). 
Exactly what the courts require to make con-
sent effectual is at the present time in a state of 
confusion . The Arizona Supreme Court has set down 
a good rule in defining consent : 
Consen t is effectual if the co nsentor under-
stands substant ia ll y the na ture of the surgica l pro-
cedure attempted a nd the probable results of the 
ope ration. Thi s, as a matter of law, constitutes an 
informed conse nt. Given a n informed con-
sent, liability if any must be predicated in mal-
practice ( I I ) . 
Coupled with the foregoing rule is the corollary 
being adopted by more and more courts that the 
primary duty of a physician is to do what is best 
for his patient , and th at a physician may withhold 
disclosure of information regarding any risks or com-
plications of the operation or treatment where a full 
disclosure would be detrimental to the patient's 
total care and best interest ( 12) . Thus, when in the 
physici an's professional opinion, informing the pa-
tient of certain of the risks or complications would 
make the patient unduly apprehensive and increase 
the ri sk of complications during surgery, informa-
tion may be withheld . However, let me emphas ize 
th e importance of making a notation of such action 
on the patient's chart and, if appropriate, informing 
the patient as soon as possible after the surgery has 
been completed. 
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What then, as a nesthesio logists, should you do , 
and tell your pa tients prior to the administra tion of 
anesthes ia? Unfor tuna tely, there is no ha rd and fast 
rule which can be sta ted as to the circumstances 
unde r which you can withhold mak ing a full dis-
closure and as to the kind of info rmation which can 
be wi thh eld . Each case must of necess ity depend o n 
its own particul ar fac ts. 
However, there are some bas ic guides th at 
should be kept in mind: 
I. Examine the pa ti ent prio r to administering 
a nes thes ia. prefe rab ly the night before and 
this should be mo re tha n a cu rsory exam i-
nat io n. Make a no tat ion in the cha rt of the 
date and ti me of your exa min atio n, the fi nd-
ings. and any appropri ate orde rs. Any doubt 
as to the patient 's condition should be cla ri-
fied beca use you will be held responsible fo r 
what could have been d iscovered by a 
proper phys ical examinat io n. In the case of 
Butler v. Layton. ( 13) negligence was fou nd 
in the administrat ion of ether to a pa tient 
suffering from a bad cold when the pat ient 
developed acute bro nchiti s which was ca used 
by the a nes thetic. H owever, whe re evidence 
is produced by the phys icia n th at a pro per 
physica l exa mination was give n to the pa-
tient pr ior to administering the anes thet ic , 
liability on this ground is usua ll y avo ided 
( 14 ). 
2. Expl a in ge ne rally th e type of anest hetic to 
be administered, what will happe n. and th at 
there are ri sks a nd complica tions atte ndant 
to any medica l procedure . Depending upon 
the pat ient's condition and emotio nal sta-
b ility, ma ke your dec isio n as to how fu ll a 
di sc losure should be made. A fa irly detailed 
expl anation of what will take place may be 
of inva lu able help si nce fear of the unknown 
is a lways much worse than fear o f the 
known. 
3. H ave the consent fo rm exec uted by the 
patient with any restrictions im posed by the 
pa tient noted th ereon. If there are any re-
~trictions these should also be noted in the 
chart. Incide ntally, if there is any subse-
quent cha nge as to any limitations o n the 
previo usly given consent , thi s sho uld be 
thoroughly and completely doc umented in 
the cha rt. 
Contract Liability. As a n adjunct to informed 
consent, let me give you a word o f caution with 
respec t to the assurances given to a patient. Courts 
have bee n seve re in judging phys ic ians who mi slead , 
in ad vertentl y o r otherwise, the ir pati ents in regard 
to the po tenti al se riousness o r re lati ve sim plic ity of 
a proposed p rocedure o r ope rati o n. Thus, the phy-
sic ian who ma kes such statements as, " No danger 
can result " or " It 's a perfectl y safe trea tment ," 
may be held liable eve n though the operation 
he pe rfo rm s is done with all due care and compe-
te ncy. Illustrati ve of thi s is a rece nt case from 
M ichigan ( 15), dec ided in 197 1, in which the 
pl a intiff was suffe ring fro m a peptic ulcer a nd con-
tac ted the defenda nt phys ic ia ns regarding a poss ible 
operation. The pa tient was never told th at he must 
have the operatio n, but the gist of what the defe ndant 
phys ic ia ns told him is the following: 
O nce you have an ope ra tion it take s ca re o f a ll 
your troubles. Y ou can eat as you wa nt to. you 
ca n drink as you wa nt to. you can go as you 
please. Dr . [XI a nd I are spec ia li sts. there is 
nothing to it at all - it 's a very si mple operation. 
Y o u'II be o ut o f wo rk three to fo ur wee ks at the 
most. T here is no da nge r a t a ll in thi s o pe ra ti o n. 
Afte r the o peratio n you ca n th row away yo ur pill 
box. In twenty years if yo u fig ure ou t what you 
spent fo r Maa lox pill s a nd doc to r ca ll s. you could 
buy a n awfu l lo t. Weigh it agai nst an o perati o n. 
The court held that such words a mo unted to an 
offer of a contrac t to achieve by the operation the 
conditi on desc ribed ; that in reliance on the desc rip-
t ion. the pl a intiff accepted the o ffer ; a nd that whe n 
these res ults in fact were not ac hieved . the contract 
cond itio n desc ribed was breached. A substantial jury 
verdict fo r the pla intiff based o n breach of contrac t 
was affi rmed. 
The majo rity op inion held that the question 
o f whethe r a contrac t ex ists is a question of fact 
fo r a jury in every insta nce. Obvio usly, if J his dec i-
sio n were to be fo llowed by other co urts, the effect 
could be d isastrous beca use it would severely limit 
phys ic ia ns in the ir effort s to assure patients and 
calm the ir norm al fea rs. There was a ve ry stro ng and 
well -reasoned dissent , and I would ho pe and expect 
that the attitude o f the majo rity o f the courts would 
not ex tend this holding to the normal p ractice of 
e nco uraging the patient with reasonable assurances 
which altho ugh they may at times be somewh at 
exagge rated , a re made with a the rapeutic intent. 
Captain-of-the-Ship or Respondeat Superior. 
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This now brings us to our next area of discussion . 
It involves a straight malpractice case with special 
emphasis on the Captain-of-the-Ship Doctrine or 
respondeat superior. The Captain-of-the-Ship Doc-
trine is based upon the long-accepted premise that 
the surgeon is in charge of all that takes place in the 
operating room and is, therefore , liable for it all. 
Respondeat superior simply means let the master 
respond for anything that his servants or employees 
may do. 
By way of illustration , let me refer to a case that 
occurred in California which clearly illustrates the 
broad umbrella of responsibility that is frequently 
applied. The anesthesia was being administered by 
a first-year resident who was under the immediate 
supervision of an anesthesiologist who was respon-
sible for supervising other operations at the same 
time. The anesthesiologist was a sala ried member of 
a private group of anesthesiologists , which group 
through its chief was responsible for the anesthesiol-
ogy training program. The residency program was 
under the joint sponsorship of the local hospital, the 
county hospital, and the state university. The chief 
of the anesthesiology group was out of the country 
at the time the incident occurred, but was ultimately 
responsible for the program and all that went on 
in connection with it . When suit was filed , the 
defendants included the resident, the supervising 
anesthesiologist, another anesthesiologist who came 
to their assistance, the chief of the group, the group 
itself, the local hospital, the county hospital, the state 
university, and the surgeons performing the opera-
tion. The case was ultim ately settled prior to trial 
with all parties contributing with the exception of 
the surgeons. Anoxia and cardiac arrest developed 
during surgery apparently due to several factors, 
all of which were the responsibility of those admin-
istering the anesthesia. Recognizing the distinct 
areas of separate responsibility which is gaining 
wider acceptance by the courts, the surgeons did 
not contribute to the ultimate settlement of the case. 
The right to control is the basis for liability in situ-
ations of this type, and it can be traced from the 
resident all the way through the various people or 
organizations participating in the training program. 
In spite of the broad implications of the Cap-
tain-of-the-Ship Doctrine, the courts pretty uniformly 
recognize the expertise of anesthesiologists and ex-
cept in very unusual situations, do not impose lia-
bility upon surgeons for anesthesia malpractice nor 
upon anesthesiologists for surgical malpractice. 
When the anesthesia is being administered by 
an anesthetist, we find less uniformity in the deci-
sions and a greater willingness on the part of some 
courts to impose liability upon the surgeon for the 
negligent administration of the anesthetic . There are 
two cases in point. One, Jackson v. Joyner (16), is a 
North Carolina case in which a nurse who was an 
employee of the hospital negligently administered the 
a nesthetic. The court held that while the operation 
was in progress, the surgeon had full power and 
control over all assisting nurses and that hence, the 
nurse administering the anesthetic stood in the posi-
tion of a borrowed servant to the surgeon for the 
purpose and duration of the operation . In the case 
of McKenney v. Tromly (17) the court held that it 
was an admitted fact that the surgeon had the abso-
1 ute right of control of all personnel in the operating 
room during the operation and hence, was liable for 
the negligence of any of these persons. These cases 
represent the extreme position and find their origin 
in the ready willingness of surgeons to testify that 
they are in absolute control of all that goes on in the 
operating room during the performance of the opera-
tion . This certainly is no longer true, and they are 
doi ng themselves a disservice by failing to recognize 
the distinct areas of responsibility that exist in present 
day medicine. 
Certified Regi stered Nurse Anesthetists 
(CRNA) are highly trained specialists with more 
training and experience in the field of anesthesiology 
than the vast majority of the surgeons. Thus, even 
in si tuations where CRNAs have administered the 
anesthetic , courts are recognizing their expertise and 
the separateness of their function. They follow the 
principle that where several doctors or nurses have 
distinct and separate parts to take which require 
the undivided attention of each, only the one who 
failed to use due care in the performance of the part 
assigned to him should be held responsible. This is 
true unless it can be shown that one exercises or has 
the right to control the other (18). 
In Virginia, the question of whether a hospital-
employed nurse/ anesthetist is an agent of the operat-
ing physician or the hospital is a question of fact to 
be determined by the jury and the main test, as in 
all agency situations, is who has the right to control 
(19). 
As you can see, all of the illustrations that have 
been given were not necessarily anesthesia cases. 
However, the legal principles involved would apply 
equally to you as anesthesiologists, and they do illus-
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tratc some of the more troublesome areas from a 
med ical legal poin t of view. 
J hope you will all become keenly aware of 
the problem of info rmed consent , and when you re-
turn to your respec ti ve hospitals, chec k and see 
what type consent fo rm s are now being used; see 
that they are updated, and do as some groups of 
anesthesiologists are doing and use your own con-
sent fo rm. Litigati on in the area of in fo rmed consent 
has only been going on fo r approxim ately 20 yea rs, 
and each year there has bee n an increase in the num-
ber of suits fil ed involving this problem. A good 
consent fo rm and an appropri ate di scuss ion between 
anesthesiologist and patient would go a long way in 
red uc ing the amount of litigation on thi s point. 
With respect to respondeat superior and vicari-
ous li ability. it is di ffi cult to predict how the courts 
will treat this in the future. However, I am certain 
there will be more and more judicial recogniti on of 
the ··a rea of expertise" principle. thus limiting li a-
bility to those ac tu ally performing a spec ific task. 
At the same time, you should not overl ook the fac t 
th at one negli gent ac t by a first-year res ident can 
start a domino th eory of li ability, and this is par-
ticul arl y true in the teac hing institutions. In such 
situations. there is no substitute fo r acti ve and cl oser 
supervision by th e teaching staff . 
Finally, let me remind you th at it is an integ ral 
part of your responsibility to keep your patients 
assured and their fea rs to a minimum. Howeve r, 
don't let your ex uberance and self-confidence ge t the 
best of you to the point th at you find yourself as the 
defend ant in a breach of contract ac ti on as did the 
phys icians in the Michigan case referred to. 
Thank you fo r your kind attention and I trust 
that you can continue to avoid the legal pit fa ll s some 
of my colleagues are constantly putting in your paths. 
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Oxygen Toxicity and Anesthesia: A Ten-Year 
Review and Overview* 
JOHN Q. DURFEY, M.D. 
Professor of Anesthesiology, 
Medical College of Virginia , Richmond, Virginia 
The awareness o f anesthes ia personne l in the 
entity of "oxygen tox ic ity" has bee n increased in the 
last ten yea rs by the grea te r involve ment in p ro-
longed respiratory ca re, and concomitantly inc reased 
complexity of opera ti ve manage ment. The rea liza tio n 
that cyanotic hea rt disease and primary pulmonary 
insuffic iency does no t necessaril y protec t the indi-
vidual aga inst the occurrence of the pulmonary mani-
festations of the disease, and that furth er realistic 
delinea tion of the pa rameters of cont rol is necessa ry, 
has focused an intense beam of critica l reevaluation 
on present methods of anesthet ic manage ment and 
postoperative ca re. It is important to no te that "oxy-
gen toxicity" as commonly discussed. that is. th e 
CNS, pulmonary, and eye manifestati ons, represents 
advanced stages of the body's adve rse responses. 
More frequent and subtle ch anges a re prese nt . bu t 
often overlooked. This is particula rly true in the less 
easily discernible effects upon e lect ron transpo rt sys-
tems, and inte rference with basic membrane and 
enzymatic functi on. 
As individuals tra ined in the management of 
cardio-respi ra to ry emergencies, anes thes ia personnel 
may expect to be ca ll ed upon professionally regard-
ing problems related to the management of dysbari sm 
and oxygen toxic ity; particul arly in view of the cur-
rently develo ping underwater industria l and ag ricul-
tura l interests producing grea ter numbers o f exposed 
individuals and radically different environmental 
conditions co mplica ting acute medica l ca re . The 
fe as ibility o f returning individu als to the surface 
is poor. This wo uld necess itate prolonged periods o f 
decompress ion and would introduce serious prob-
lems of logistics. 
A good deal more emph as is should be pl aced 
,:, Prese nted a t the 25 th Ann ua l Stoneb urne r Lect ure 
Series, Feb ru a ry 26, I 972, at the Medica l Coll ege of Vir-
gin ia, Richmond . 
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on the continuing study of oxyge n effec ts by anes-
thesia labo rator ies and the poss ibl e interaction of the 
gas with o ther drugs as related to li ve r and kidney 
function, enzy me ac ti vity, membrane functi on, and 
e lec tron transport. The info rmation obtained will 
have broad ramifica tions in our total understand ing 
of uptake and distribution, ra te, a nd excretion of the 
anesth etic agents currently utili zed , and ho pefully 
will lead the way to the int roduction of less nox ious 
and more eas ily cont rolled agents and a more careful 
and logical phys iological approach to patient man-
agement. 
Historical Review. The concept of "oxygen tox-
ic ity" is anyth ing but new, dating back to the time of 
Lavoisie r, and fo llowed in 1849 by Smith's desc rip-
ti on of a fa tal pulmonary " inflamm ation" after ex-
posu re to o xygen at 3-5 atm fo r approximately 24 
hours. 
Insofa r as the impact on anesthes ia is con-
cerned, in the last 15 yea rs, during which time the 
problems began to affect the ca re of patients, the 
prim ary conside ration was the pulmonary manifesta-
tions of the "d isease ." Pe rh aps, " iatrogenically 
induced disease" would be a more appropriate ex-
press ion. This conce nt ration on the pulmonary mani -
festations was natu ra l in a nonhyperbaric environ-
ment , pa rticula rly since anesthes iologists had been 
more intim ately involved with suffici ent oxygenation 
of the patient during surgery, and the maintenance of 
a proper a irway. 
Although equa lly concerned about acid-base 
balance, carbon diox ide retention, prevention of at-
electas is, and a reasonably reactive and phys io logi-
ca ll y intact pos toperative patient , it was not until 
fo ur major a lterations occurred in patte rns of patient 
ca re th at the dynamic characteristics of oxygen tox-
ic ity and its relationship to this particular speci alt y 
became more obvious. These changes were: ( I ) The 
advent of o pen heart surgery, using the pump-oxy-
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genator, with the special problems resulting there-
from , (hemolysis, air embolism, and marked ac i-
dosis). (2) The use of hyperbaric faci lities for the 
surgical and medical trea tment of pati en ts with surgi-
cal , medical, infectious, and cardiovascular diseases, 
and their attendant acute threa t of oxygen toxicity; 
that is, central nervous system oxygen toxicity ( as 
well as pulmonary toxicity) . ( 3) The progressive in-
volvement in prolonged postoperative ventilatory care, 
using continuously ass isted and / or controlled respira-
tion by ventilators equipped with only limited con-
trols governing inspired oxyge n tensions; and th e 
nonconcomitant realization th at such care was induc-
ing or producing toxic pulmonary and / o r othe r mani-
festations, or a t least it was increas ing the risk of such 
problems. ( 4) The current interest in " halothane 
hepatitis," enzymatic ac tiva tion and inactivati on, and 
the bas ic metabolic consequences produced by anes-
thetic agen ts. Some of the biophysica l-electro-chemi-
cal-enzymatic and substrate actions may indeed be 
simil ar, as will be di scussed further. The fa scinating. 
multifaceted , and increas ingly complex interwoven 
nature of the spectrum of oxygen tox icity is now only 
bare ly apprec iated. It seems obvious, and reasonable, 
that the answers lie in the most bas ic biochemical 
processes. The comments in this pape r wi ll be ori-
ented primarily toward the clinical aspects of oxygen 
tox icity as it rela tes to the practice of anesthesia. 
To contin ue historica lly, in 1927 the observa-
tion was made th at cold-blooded anim als were much 
less susceptible to the toxic effects of oxygen unless 
they were warmed to 37 .5 °C. At that temperature . 
even turtles deve loped fulmin ating pulmon ary man i-
festations after exposure. 
It is known tha t increased oxygen tension pro-
duces ch anges in the transmembrane pote nti al of 
frog skin , as contras ted to frog sc iatic ne rve, and 
that these changes are irreversible ( Gott lieb and 
Cymerman, 1970). These in vestigators postulate 
that the membrane changes are produced by ad-
vanced oxidation of the SH groups; th at membrane 
lipids and lipid complexes may have been altered; 
and that ATP synthes is was inactivated. In a monu-
mentally inform ative experi ment ca rried out by 
Ch apin and Hohl , one lung of a dog was infl ated 
with l 00 % oxygen for seven days. Th e o ther lun g 
was infl ated wit h air. Only the lung infl ated with 
oxygen showed th e cha racte ri stic pulmon ary changes 
of oxygen toxicity which shall be desc ribed in more 
detail below. 
Dr. Phillip C. Pratt , a pathologist, now at Duke 
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University and previously associa ted with the Ohio 
Tuberculosis H ospital in Columbus, was one of the 
first clinicians to fully appreci ate the early onset and 
progress ive course of pulmonary changes in patients 
exposed to relati ve ly " innocuou s" amounts of oxygen 
for a period of time. In 1958, he pointed out the simi-
larity of morphological findings in a series of patients, 
some of whom had received oxygen, fo r as little as 
two and one-half days, administered via nasal ca the-
ter-not ventilators. H e demonstrated capillary con-
gest ion and proliferation, followed by the appearance 
of diffuse fibrosis after a period of about two weeks. 
Other changes previously noted in experimentally 
induced pulmonary manifes tations were hyperemia, 
hemorrhage, edema, atelec tas is, and " inflammation." 
These changes had to be differentiated from atelec-
tasis, intrapulmonary hemorrh age, infection , and 
postmortem alterations due to absorption of gas. A 
brief experiment followed wherein mice were ex-
posed to I 00 % oxygen for 4 8 hours at approximately 
740 mm Hg, controlling humidity and temperature. 
Some of these mice were sacrificed, then autopsied 
immediately while still in oxygen ; others were au-
topsied aft er 3 hours in oxygen. There was a signifi-
cant diffe rence in the appearance of the lungs at 
postmortem. Air cont rol groups were also used. The 
lungs of the mice exposed to oxygen, killed in oxy-
gen, and delayed 3 hours before postmortem were 
hemorrhagic and liver-l ike in consistency and did 
not float, thus simulating the characteristic , classical 
changes of advanced oxygen toxici ty, usually thought 
to occu r after more prolonged exposures. Pratt pre-
sented the above info rmation at the hyperbaric con-
ference in New York in 1964. and it is particularly 
noteworthy that he made the fo llowing ve ry pertinent 
comment: "Since this occurs in hospitalized patients 
rece iving oxygen by standard methods such as oxy-
ge n tents and nasa l catheters, it is apparent that the 
pulmonary response ca n result from exposure to 
atmospheres conta ining we ll below I 00 % oxygen 
and probably in the range of only 50 % oxygen." 
Pratt went on to discuss the releva nt points in mak-
ing th e morphological differentiation between capil-
lary proliferation and the ope ning of previously " un-
recognized" capi llaries . (Author's note: " Unused" 
capill aries. High-oxyge n tensions seem to decrease 
the size and number of capillaries utilized, at least in 
myocardi al pe rfusion and in th e b ra in , as will be 
discussed late r). Pratt felt that vasodi lation leading 
to capillary proliferation was the probable cha in 
of events; that continuous exposure for 24 hours at a 
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time was necessary; and that intermittent exposures 
were not cumulative in nature. 
In 1964, Heppleston and Simnett found that 
tissue cultures of pulmonary alveola r epithelium were 
especially sensitive to oxygen under o ne atmosphere 
and equ ated this exposure to air at 5 atmospheres. 
They surmised oxygen ac ts through enzyme inhibi-
tion and preferentially affec ts enzymes possess ing SH 
groups (NS: the statement made previ ously regard-
ing the transmembrane potentials in frog sk ins ) . 
Pontoppidan and o thers have demonstrated sim-
ilar changes, including the postmortem appeara nce of 
hyaline membranes, in patients fo llowing ventil ation 
with high-oxygen concentrations. A great deal of 
emphasis in the last three or fo ur yea rs has been 
placed on this possible causa l fac to r of patient mor-
bidity and mortal ity. In 1970, this hypothesis was ac-
centuated by H amilton and Singer in a study of post-
operative cardiac surgery patients . It was their 
conclusion that fear of " toxici ty" should no t preclud e 
the administrat ion of oxygen in th ose pat ients who 
needed it. A general opinion still seems to preva il at 
this time that cyanotic heart disease. and other cond i-
tions leading to ventil ation-perfu sion inequ alities, 
shunting. venous admixtures. and subsequent low-
oxygen tensions (and/ or hem oglobin satura tion). 
have a protective effec t for the patient . and that high-
inspired oxygen tensions can be used with consider-
ably less concern. This conclusion is not necessar il y 
valid. as shown by a case report from the M assa-
chusetts General Hospital (New England Journ al. 
May 1970), where it was disclosed that a patient 
died from pulmonary insuffic iency with de monstrated 
fibrosis fo llowing prolonged artifici al ventilation. Fur-
thermore, a very important study by Hills indicates 
that the creat ion of an a rtific ial shunt producing 
cyanosis does not necessarily pro tec t an animal from 
pulmonary injury secondary to high-oxygen tension. 
It appears that certain conditions ca n depri ve 
the individual of protective mechanisms. Artifici ally 
altered physiology can produce changes in th e reac-
tion of molecul ar oxygen with SH groups and o ther 
enzyme substrates. This effect in turn upsets elec tron 
transfer balance and results in additional effects in 
certain types of cells and subsequently in ce rta in 
organ systems or " target a reas ." These effec ts occur 
following the ad ministration of such compounds as 
dipyridylium dichloride (Clements, Fisher, and Ken-
neth , 1970); o r result from the interaction of other 
compounds producing changes in certain trace metals 
and inorganic phosphorous. Mn " and Zn " may have 
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some effect in preventing the occurence of lung 
edema. Mg" seems to have a protec tive effect aga inst 
se izures resulting from high-oxygen pressures OHP 
( Radomski and Wood, 1970) . M anga nese may act 
by inhibition of mitochondrial swelling and lipid per-
ox ide fo rm ation in th e mitochondria ; that is, an anti-
ox idant effect. However, simil ar reactions may also 
occur producing an opposite effec t ; that is, sensitiza-
ti on of ce lls ( see below). 
The cumul at ive end results as fa r as the lung 
is concerned a re: the ch anges in epitheli al ce ll popu-
lation; the accumulation of both interstiti al and alveo-
lar flu id; and / or proteinaceous material; the deposi-
tion of hya line membrane materi al; and changes in 
"surfactant" and its properti es. Diffusion is altered, 
an "alveolar-capill ary block" situat ion develops, 
shun ting occurs. and the patient then has a need fo r 
higher-inspired oxyge n tensions to achieve any sa ti s-
fac to ry sa turation, while the "cure" is worsening the 
disease process! 
The warning seems fa irl y obvious : A minimum 
oxygen concentration ( inspired oxygen tension ) 
should be used to produce an arteri al tension of ap-
p rox im ately 100 mm Hg and / or a norm al hemo-
globin saturation depending upon the individual. 
Individu al va riations are ve ry important and 
should be taken into considerat ion. Th ese factors 
include: age, sex. tempera ture. acid-base balance. 
type and amount of hemoglobin . MHCH. diet , vita-
min leve ls. and the ad ministration of other drugs. 
Aspirin and ascorbic ac id seem to augment toxicity 
(Serrill. et al. , 197 1). Tocopherol defic ient animals 
appea r less sensitive to lipid peroxidation in the 
lung until ascorbic ac id and ferrous ions a re added 
( R ask in, et al., 1971 ). Other fac tors such as 
smoking and resultant carbon monoxide levels 
( Rodkey, et al., 197 1) affect the response of 
the lung. Simple immersion to the head great ly inten-
si fi es the pulmonary react ion, primarily by promoting 
the formation of ate lectasis (B alldin , et al ., 1971 ). 
Stress and its effects, especiall y increased adrenal 
output , all adversely affec t the individual, as does 
increased thyroxin . 
Conversely. thyroid blockers seem to have a 
protective effect , as does the administrat ion of sulf-
hydryl grou p donors. Others compounds such as 
ANTU (alpha naphthylthiourea) may ac t by both 
actions; that is, by affectin g thy roid hormone release, 
and by providing cellular sulfhydryl enzymes and 
cofactors in active red uced states ( Mounta in , 1963) . 
If one can logically accept the a rgument that there 
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are individuals who are hypersusceptible to certain 
noxic or toxic stimuli or compounds, such as those 
individuals whose susceptible targe t areas are the 
red blood cells, which subsequently undergo hemol-
ysis by the interaction with other drugs, then it is just 
as likely th at certain individuals are " pneumonicall y 
sensitive." These individuals may react adversely to 
similar circumstances with the lung as the "targe t 
organ. " 
Opposite circumstances may apply. Certain in-
dividuals are hyposensi tive. They may react with 
increased resistance, or decreased susceptibility, to 
the ac tion of what are usually considered to be 
" toxic" concentrations of oxygen. This concept would 
certainly account for variations from the " usual re-
sponse," such as the one reported by Kydd : Mice 
exposed to 550 mm Hg oxygen for 30 days showed 
only a few of the classical pulmonary changes, but 
did develop changes in the blood vessels. 
Some individuals are susceptible to the occur-
rence of atel ectasis presumably due to absorption of 
gas (oxygen) , plus other fac tors yet to be deter-
mined (Burger, 1967) . 
A good deal of work has been devoted to the 
effect of oxygen on succinic dehydrogenase activity 
in the lung. Until recently it was thought that this 
was the most important enzyme system affec ted . 
However, Barde ll and Fowler concluded that other 
dehydrogenases in lung ti ssue seem to be more ad-
versely affected . At any ra te, return of activity is 
slow compared to exposure tim es; that is, 6 hours 
of exposure to oxygen produced inhibition of the 
enzymes which returned to normal only after 12 to 
48 hours. Interestingly enough in one study pento-
barbital seemed to have a protect ive effect. This 
conclusion is in contrad istinction to the usual non-
protective effec ts of anesthetics agai nst damage to 
the CNS (see below): Residual effect s may occur 
even though convulsions are masked . 
Viral and bacterial diseases may grossly alter 
the individual's sensitivity to toxic agents such as 
oxygen , and may produce changes in " ta rget areas ." 
(Mountain, 1963 ). Smoking has a marked additive 
effect for atelec tasis to occur following oxygen 
exposure. One study indicates that smokers had 
an in-Hight vital capac ity loss three times th at of 
nonsmokers ( Browning, 1970). Adrenalectomy, 
chlorpromazine, and sympathetic-blocking agents 
may have a protective effect, as does hypothermia 
(Burrows and Edwards, 1970). 
There seems to be a cross-tolerance between 
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some compounds which are considered to be toxic 
themselves, such as Ozone and N02 (Mountain, 
1963). Ozone is quite toxic and produces striking 
epithelial changes includ ing hyperchromatism , hyper-
plasia, and inflammatory changes. Central nervous 
system effec ts also result. Some changes may occur 
after only a few hours of exposure (Suskind, et al. , 
1970). 
A number of interes ting concepts have devel-
oped in regard to the pulmonary changes and the 
manifesta tions related to oxygen toxicity. A great 
deal of weight has been given to changes in "surfac-
tant." Earlier, in 1962 , the emph asis was on surfac-
tant changes, modification, depletion , and interfer-
ence with its formation. However, with increasing 
knowledge in the field , and increasing reliab ility of 
investigative techniques, it is beginning to appear that 
surfactant (changes) may very well be another 
" ta rget," or, if not a "target," a "system," directly 
and indirec tly involved ; resulting from more basic 
biochemical alterations such as those mentioned 
above. 
"Nitroge n osmosis" is a term referring to an 
effect produced by the " inert gas" nitrogen, wherein 
it can pull water away from other solutions of inert 
gases through certain types of membranes. This is 
now a popular concept in hyperbaric gas physiology. 
Such biophysical al teration may very well have some 
bearing on the mechanism of oxyge n toxicity, and 
the narcotic action of certain " inert anesthet ic gases" 
( neon, argon, etc.). During increased-inspired ox-
ygen tension ( thus increased arterial oxygen tensions 
[pO, J) a gradient develops between the arterial 
tension of p02 and ti ssues. This has been called 
a "steady-state gradient. '' If certain physical cir-
cumstances are prevailing, the movement of water 
molecules may occur ( Hills, 1971). Niinikoski and 
coworkers a re under the impression that the pri-
mary effect of oxygen is on the capillary endothelium, 
producing an increased capillary permeability and 
a secondary "washout" causing a depletion of sur-
factant and other phospholipids not heretofore con-
sidered to be part of normal "surfactants." The 
mere presence or increase of lipids in such a "wash-
out" does not therefore connote adequ ate surfactant 
activity. It may indicate only a "washout," and a de-
pletion of a lveolar surface tension reducing materials. 
Furthermore, one need not find peroxides of lipids, 
ye t detrimental effects of high oxygen may have 
alte red the structural lipids of cells by peroxidation 
and ox idation and produced subsequent ch anges in 
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cellular membranes. These in turn may lead to the 
release o f proteolytic enzymes and even co nnective 
tissue elements may be released into the alveoli. 
So fin ally having reached a discussion of "surfac-
tant" after all o f the above, it is with th e realiza tion 
that every aspec t of "oxygen toxicity" is tied up with 
the mechanisms and biochemical utili zat ion of the 
transport of oxygen. 
Let us quickly consider the va rio us aspects of 
alveola r-capillary diffusion pertinent to this discus-
sion ( Rankin , 1969). Diffusion can be defined as 
the movement of molecules of gas from an area of 
high concentration to an a rea of lower concentration. 
As mentioned above, there is direct bearing in rel a-
tionship to arterial gas tens ions. The movements of 
gases across the alveolar-capilla ry memb rane is de-
termined by : ( I ) the mean difference in partial pres-
sures of gas on either side of the membrane; (2) the 
surface area of the membrane ; and ( 3) the permea-
bility of the gas th rough the membrane. The third is 
inversely related to the thickness o f the membrane. 
It should be noted at the outse t that the tota l distance 
for perfusion through the normal a lveolar-capillary 
membrane and the surface lining layer, etc ., is of very 
small magnitude in the normal lung; that is, in the 
order much less than one micron. The pulmonary 
diffusi ng capacity of any gas is determined by 
the ratio of the quantity of gas transferred per unit 
time over the mean differences in partia l pressure. 
and is directly proportiona l to the solubility of the 
gas and inversely proportional to the square root of 
the molecular weight (density) of the gas. It is not 
easy to calculate either the a lveolar oxygen tension 
or the pulmonary capillary tensions. Oxygen tension 
differences between the alveolar gas and arte ria l, end-
capillary blood are due to incomplete eq uilibration 
between the gas and a rterial , end-capill ar ies, and 
due to the effect of venous admixtures from a reas of 
poor ventilation to perfusion rat ios. It should be re-
membered that pulmonary diffusing capacity must 
be reduced by ¥3 before normal arteria l oxygen 
satu ra tion will be affected. This fac t should be kept 
in mind in considering the so called " latent periods" 
involved in oxygen toxicity in regard to the lung 
as well as other organs. Diffusing capac ity varies 
with whole body size, metabolic rate , age , levels of 
lung inflation , alveolar ventilation, intrathoracic pres-
sure, body position, and distribution of inspired gas. 
The H amman-Rich syndrome is a class ical example 
of the unfortunate patient who requires increas ing 
amounts of oxygen to his own detriment. There ap-
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pears to be excellent correlation between problems in 
diffusing ca paci ty and pulmonary membrane damage 
(etc.). Do the inc reases in areas of poor V /0. which 
account for much of th e loss o r decrease in diffusing 
capacity result from changes in surfactant alone with 
increased sur face tension, o r does there occur an in-
crease in pulmonary vascular resistance secondary 
to the capillary pro liferat ion and "granulation tissue" 
for ma tion noted by Pra tt as one of the toxic effects 
of oxygen ( not the cl assica l effec ts of hypoxia)? 
Capillary congestion, an earlier manifestation, may 
mask problems of diffusion since it will tend to bal-
ance them out. 
What then is "surfac tant ," and how does it apply 
to the concept of oxygen tox icity as we know it in 
the lung? Many workers have been invo lved in the 
fi eld for a number of years: these include Pattie, 
Clements and Fisher, Morgan, Sutnick, Said, Scar-
pelli , Tooley, and others mentioned above. A brief 
summary of their observations and conclusions as it 
applies to the topic under discussion is now in order. 
Surfactant. It would be more appropriate to use 
the termino logy "surfactant systems," "surfacta nts," 
or "alveolar lining materials ." Unfortunately, until 
recently at least, the approach has been most ly an 
anatomica l one, utilizing electron microscopy. The 
elec tron microscope has enabled investigators to find 
va rious structures not heretofore known and has led 
to certain hypotheses about the o rigin, function , and 
elimination of th ese lining materials. At the outset, 
it is very important to realize th at the lung is not a 
passive organ responding to filling and emptying, but 
is a very active one in the body. With a surface area 
of approximate ly 70 meters square, and an esti-
mated 300,000,000 alveoli , this fact is quite signifi-
cant ( Scarpelli , 1970). 
In 1929, Yon Neergaard no ticed the differences 
between fluid-filled and a ir-filled lungs in the forces 
needed to ventilate, and pressure-volume relation-
ships. Pa ttie , in 1955, noted the characteristics of 
pulmonary edema foam were such as to indicate 
lowered surface tension. This was followed by the 
work of Clements and others which showed that a 
surface-tension-lowering substance was present in 
lung tissue. Since then, biochemical analysis has in-
dicated that the material is made up of a complex 
mixture of lipids, protein , and carbohydrates , chief 
among which is dipalmitoyl phosphatidyl choline 
(DPL) (palmitic acid) . DPL makes up about 50% 
of the lipid frac tion of the laye r. This named lipid 
has been used inte rchangeably with " lecithin ." It is 
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important to note that the surface-tension-lowering 
properties depend upon the presence of two .rn1u-
ra1ed fatty acid res idues. Included in the complex are 
albumin and ca rbohydrates (po lysacc harides). In the 
lung. or alveo li as the case may be. a surface inte r-
face exists between a ir and a liquid o r hypophase. 
lining the alveo li . The surface tension a long the 
alveolar lining results prim aril y from molecula r 
cohesive forces which produce a tendency toward 
collapse. Thi s force is related to La Place's theorem 
which in turn relates surface tension (T) inversely 
to the radii of spheres and proportionately to 
the pressure of gas within the spheres or, as in 
this case. the alveoli . ( P = 2T / R ). Th e result is 
a tendency fo r liquid to form increas ingly smaller 
spheres, leading to an ever-increas ing tendency for 
collapse . This fo rce is counterac ted by the effects o f 
the "surfac tant groups." so that a new end-surface-
/ension, in ac tu alit y a surface pressure. result s. Thi s 
sur face pressure force opposes the fo rces o f plasma 
and other ti ssue fluids which have a surface tension of 
about 50 dynes per cm. Considerable elas ti c recoil 
results for the lungs. Fo rtun ately, the tendency of th e 
larger alveoli to become larger and larger as the 
smaller alveo li empty into them (fo llowi ng the above 
physical laws) is offset. Theore ti ca ll y, at least, there 
is some uni fo rmity to a lveolar configuration and size, 
although there is now some doubt as to whether o r 
not alveo li ac tu all y exist as tru e spheres. Max imum 
intra-alveolar pressures probably ex ist at the prec ise 
moment when th e developing hemi sphere at the end 
of the respirato ry bronchiole has a diameter equ al to 
that of the terminal respira tory bronchiole. Follow-
ing this point , some instability and dec rease in pres-
sure occurs, with limits o f expa nsion se t by the elasti c 
ti ssue of the lung. and so fo rth . 
Surfac tants are considered to be bipo la r in na-
ture and to assume th is configuration anatomica ll y in 
the hypo ph ase bound ary area. The choline, or h vdro-
phi/ic, group is ass umed to assoc iate with the p~ote in 
area of the hypoph ase: and the two hyd rophobic 
fa tty acid side cha ins become oriented toward the 
alveola r a ir side. fo rming a compress ible film or 
surface-tension-lowering film . Increased compres-
sion, such as would res ult from coll apse of a lveoli , 
actually produces a decrease in surface tension. The 
result is an equi libration of tensions between th e 
la rge r and smaller a lveoli . The choline group, stated 
to be assoc iated with protein , contains an io nized 
qu arternary ammonium group which is stabilized by 
the presence of both calcium and sodium ions. 
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T o summarize bri efl y : Th e activity and struc-
ture of surfactants is affected by a number of factors, 
including : (I) heat , which will reversibly inactivate 
it; (2) changes in pH ; (3) the presence of blood ; 
( 4 ) elect ro lyte concentrations. 
It is ge nerally thought th at surfac tants are pro-
duced by " type II " alveolar ce ll s and are secreted 
into the alveoli where they become inco rpo rated into 
the lining laye r. These are presumed by some to be 
found as cytoplasmic inclusion bodies, or osmiophilic 
lamell ar inclusions. The inclusions are found in much 
lower numbers in those species (non-mammali an ) 
lacking o r having decreased surfactant levels. T wo 
main theories exist: (I ) th at the giant alveolar cell s 
form and secrete these o rganelles o r inclusion bodies ; 
or ( 2) th at the opposite is true, the giant cells are 
responsible for the ph agocytos is and breakdown of 
th e surfac tants, production bei ng elsewh ere-the 
nonciliated bronchiolar cell for example. 
Nonetheless. synthes is turnover is rapid , C 14 
labeled phosph olipids appea r in pulmon ary phos-
pholipids within 5 minutes aft er intravenous injec-
tion , and a half-li fe of 14 hours is estim ated fo r the 
surface active lec ithins. It is poss ible that the entire 
lipid synthesis of lecithin occurs within the lung itself. 
The mechani sms of lec ithin synthes is can take sev-
eral paths, as has been nicely described by Morgan. 
Of import , in regard to the poss ibl e effect of oxygen 
on the system, is the rapidity o f metabolism. equ ating 
the lung to the li ve r in some respects. This could 
produce a result so th at any occurrence. phys ical or 
chemical. interfering with metabolic generation of 
e ither the lipids and / or carbohydrate and protein 
moieties might throw a natural " monkey wrench" 
into the system, thus accounting for the so-called 
" /a1en1 period" said to ex ist in the development of 
oxygen toxicity. The term " latent period" has very 
little compatibility with basic tox icological hypoth-
eses. The presence of packets of surfactant might 
slow down the depleti on rates and subsequent altera-
tions in ac tivity until such lack of activity produced 
a fair ly rapid onse t of symptoms and signs. There 
is no doubt th at the situation is complex. Even the 
simple concept of a single laye r of surfactant is 
under scrutin y and revision at thi s time. 
Thus indirectly, oxygen may affect organ sys-
tems such as the lung through direct action at 
a ve ry basic metabo lic leve l. Surfactant changes 
are rela ted to other clinical conditions such as the 
Respiratory Distress Syndrome of the newborn , 
changes fo llowing pulmonary a rterial occlusion with 
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decrease in surfactant ac tivity ; and an excess of sur-
fac tant has been postulated in the disease of pul-
mona ry alveolar proteinosis. One must bear in mind 
that multi-causal factors operate in th ese diseases, 
and that the inappropri ate admin is tration of " higher 
than needed" concentrations of oxygen ( a somewhat 
ambiguous phrase ) may contribute to the problems 
developing in various organs through the mechanisms 
discussed above. 
Toxic Effects on Other Systems. Although the 
primary toxic effects of oxygen at less than one at-
mosphere (7 60 mm H g) seem to be prim arily mani-
fested by changes in the lungs, or at least appear 
to be so orientated fro m the standpoint of an-
esthesiology, it is rather illogical to assume th at all 
systems and organs in the body are not involved. 
The appearance of signs and symptoms is related 
to a time-dose fac tor, that is, related to exposure 
and/ or circulation. 
Two fund amental factors pertain regarding 
oxygen toxicity: (I) The metabolic consequences 
occur at the most basic levels of cellular and mito-
chondrial or membrane ac tivity, and , consequently, 
must involve all areas of physiology and biochemistry 
within the body. (2) The "l atency" of reaction 
should more appropri ately be called the " time" of 
reaction. These considerations are certainly more in 
keeping with the basic tox icological principles of 
time-dose response. The intensity, duration, suscepti-
bility of the subject, type of exposure, temperature, 
thyroid activity, presence or absence of other drugs, 
elements, and trace metals, the condition of the 
acid-base status, carbon dioxide elimination , 2-3 
DPG levels, hemoglobin levels and types. sex, in-
teraction and state of the adrenal-pituitary system 
and the sympathetic nervous system, perfusion, and 
other fac tors all determine which organ system will 
be affected and at what time. 
Central Nervous System Toxicity. The toxic 
effect of oxygen at higher than ambient ( 760mm) 
pressures on the CNS ordinarily does not concern 
anesthesiologists unless they are operating under 
specific conditions of OHP in speci al chambers. 
However, the entrance of industry , agriculture, and 
other interests into underwater living and working 
conditions will produce a much larger popul ation 
of individuals exposed to dysbarism and oxygen 
toxicity. It is logical to assume that medical per-
sonnel specially trained in cardio-pulmonary re-
suscitation, and so forth , will be called upon to 
ass ist in the diagnosi s and therapy of such in-
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dividu als. Furthermore, considering the basic nature 
of the processes of oxygen toxicity, one must have 
some reservations about the possible adverse effects 
of oxygen on the CNS at 760 mm or less, other than 
the well-known vasoconstrictive effects upon cerebral 
vasculature, and the tendency fo r hyperventilation 
which is commonly seen. 
Class ically, the CNS ex pression appears as a 
convulsion, usually beginning with more foc al signs 
such as twitching about the mouth and eyes, and 
perhaps the small muscles of the hand . It is im-
portant to remember that mentation may be quite 
clear until the abrupt onset of the convulsion, which 
proceeds through usual tonic-clonic stages. Attempts 
at decompression during periods of glottic spasm 
may result in rupture of the lungs . Unlike the usual 
seizure, blood arterial oxygen tends to remain at 
normal or higher than usual levels if the patient is 
under OHP ( oxygen-high pressure ) . Central nervous 
system toxic reactions are intimately involved with 
pC02 levels and acid-base balance, including lac-
ta te/ pyruvate levels and ratios. Fac tors other than 
metabolic ones also pertain, such as circadian 
rhythms, which may alter the susceptibility to con-
vulsions ( Hof, et al., 197 1) . At th ree atmospheres 
(OHP) , animals treated with acetylsalicylic acid 
and/ or ascorbic ac id, and tocopherol defici ent an-
imals, began seizures earlier and died sooner than 
others (Serrill , et al., 197 1) . The protective effect 
of magnesium has already been mentioned. 
Anesthetic agents may mask the convulsions of 
oxygen toxicity, but do not appear to prevent the 
C NS damage produced by it which commonly re-
sults in spastic paralysis, and so forth . In fac t, a 
recent and disturbing study by Lassiter has indi-
cated that in the presence of only 5 psi, exposure 
to oxygen for two weeks (233 mm H g) greatly re-
duced levels of acetylated and un acetylated co-
enzyme A in the bra ins of the anim als. This occurred 
in the absence of overt signs of CNS toxicity. Ap-
parently, nitrogen seems to have a " masking" or 
"quenching" effect, casting further doubt about its 
presumed " inertness." Coenzyme inactivation is post-
ulated to result from : (a ) direct oxidation of the 
sulhydryl groups; (b) from a block in synthesis, 
produced by oxygen itself th rough fo rmation of 
oxygen-metal ion complexes; and ( c) by the form a-
tion of free radicals elsewhere. These changes 
produce interference with the transfer of two-carbon 
units, with a subsequent block of glycolysis, and mal-
functioning of the tricarboxylic acid cycle. 
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A recent pa per by Kuperm an has shown that 
the administration o f oxygen fo llowing bil ateral 
cordotomy may produce slee p-ind uced apnea, or 
" Ondine's curse," possibly through effects on the 
aortic-carotid reflex mechanisms. It can be seen fro m 
the above that the effec t of oxygen o n the CNS is 
quite complex and onl y now becoming mo re fully 
appreciated. 
Effect of Oxygen on Red Blood Cells. As pre-
viously mentioned, o ne of the keys to understanding 
oxygen tox icity is a clear comprehensio n of the very 
complex and. up to now, not entire ly clear mech-
a nisms of oxygen transport a nd it s relat ionship to 
membrane function. 
If one acknowl edges the fac t that hypox ia per 
se is a ma rk ed st imulant to erythropoeisis. o ne would 
assume de press ion of bone marrow function upo n 
exposure to hi gh concent rations of oxyge n. This is 
not necessarily the case, and the effec t of high-
oxygen tensions o n DPG levels is not en tirely clear. 
There are combined effects o f increased pC02 
levels, difficulties in " un sa turating" oxyhemoglobin , 
and resultant decreased pH levels (Astrup. 1970 ). 
Further influences of the pituitary and th yroid must 
be conside red (Rodriquez and Sh ahidi . 1971) . 
Ascorbic ac id and ASA may se nsitize the red 
blood cells to lys is (Serrill , et al. , 197 1) . Vitamin E 
deficient anim als are markedly sensitive to the rapid 
dest ructi on of rbcs , wh ich in part is caused by the 
ac tual peroxidation of lipids in the rbc membrane. 
There appears to be a selective effect o n older rbcs 
(Sabine a nd Leon. 1971) . In certa in susceptibl e 
a nimals, such lytic act ivity may occur at less than 
one a tmosphere, manifesting itse lf by immediate 
effects o n old ce ll s. and delayed effec ts on the 
younger cells which de monstrate decreased mean 
potential life spans. A diet of alpha tocopherol , an 
antagon ist to lipid perox idation will abolish o r pre-
vent thi s lyti c activity. Several a reas a re involved , 
including anerobic glycol ys is, hexokinase ac ti vity, 
glucose 6-phosphate dehydrogenase activity , acety l-
cholinesterasc ac ti vi ty, a nd spec ific grav it y. It ap-
pears to be a me mbra ne phenom eno n. T o confuse 
the issue even more, one stud y of angin a pcc tori s 
and oxygen tra nspo rt has indicated that its occur-
rence may actually decrease oxygen aflinity o f the 
hemoglobin without changes in DPG levels, poss ibl y 
secondary to " hum era l factors" (Shappell , et al., 
1970) . One thing is certa in , the va rio us metabolic 
activities invo lved in oxygen tra nsport a nd mem-
bra ne function are no t a lways predictable nor finite , 
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and changes which occur unde r one se t of circum-
stances may va ry considerably under a slightly dif-
ferent set of parameters, adding to the complexity 
of response and interacti on. 
Toxic Effects of Oxygen on Liver and Kidney. 
With the current interest in " haloth ane hepatiti s," 
and the renal effec ts of Penthra ne:!D, more emphasis 
sho uld be given to the possibl e tox ic effects of other 
drugs and age nts, a nd their poss ible interaction. The 
multiplicity of facto rs operating have been discussed 
a bove. In 1965, Feli g reviewed the literature ava il-
able on oxygen tox icity at that time and , supported 
by experiments in Wright Patterson Aeromedical 
Research L aborator ies , came to the co nclusio n that 
evidence indicated the fo ll owing : Exposures to only 
258 mm H g o f oxygen fo r one week produced sub-
cellul ar hepatic and rena l alteratio ns, visible on 
elec tron microscopy, in the absence of pulmonary 
histopathology . These changes included mitochon-
dria l enl argement , clumping, and degenerat io n of 
membranes. Sodium lactate seemed to have a pro-
tective effect; lactate metabolism occurs through 
oxidation and th e transfer of electrons to DPN. 
Oxygen at tensions higher th an one atmosphere 
increases lipid biosynthesis (Adams and Norton , 
1971). On the other hand , oxygen may indirectl y 
a ffect protein synthes is by a ltering dieta ry habits 
( L eon. et al. , 197 1). This could be considered a 
subtle for m of oxygen toxicity. 
Insofar as the kidney is concerned . important 
findin gs releva nt to kidney structure and function 
were reported by Hess a nd Menzel in 1971 . In 
anim als subjec ted to dietary de pletion. particularl y 
Vitamin A , a 35-day exposure to I 00 % oxygen 
produced ch anges in the proximal convoluted tu-
bules, leading to an increase in lipid levels. These 
c ha nges were presumed secondary to decreased 
fatty acid metaboli sm. 
Conclusion. The adverse effect of overexposure 
to oxygen, that is, "oxyge n toxicity," involves vir-
tuall y every organ system in th e body, including the 
lung. eye, kidney, liver. and erythropoetic systems. 
The effect follows c lass ic toxicological principles, for 
the most part relating to time a nd dose of ex posure, 
which in turn alte red by the relati ve proximity of 
a ny particul ar organ to hi gh-oxygen tensio ns. Ob-
viously, the lung has the greates t exposure directly. 
The effect o n other orga n syste ms is primarily deter-
mined by the circulation a nd oxygen carrying and 
transport systems ( Skinner. 1972; Siekevitz. 1970). 
Most o f the emphasis in this paper has been 
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upon the basic effects of high-oxygen tensions on 
enzymatic membrane and substrate systems. since 
it appears that altered biochemistry at these levels 
determines the ultimate manifestations of the toxic 
response. be it pulmonary, hepatic. ophthalmologic. 
and so forth. 
More definitive criteria for controlling inspired 
and transported oxygen are needed. Even the pres-
ence of cyanotic heart disease with shunting and 
desaturation , or primary pulmonary failure per se, 
do not necessarily protect the individual against th e 
deleterious effects of over-oxygenation . Thus a 
paradoxical situation develops wherein the admin-
istration of oxygen as a lifesaving measure eventually 
may produce fatal consequences. 
Anesthesia personnel will become increasingly 
involved in situations related to such exposures to 
oxygen at high pressure (OHP) such as will be 
found in the new fields of industry and agriculture 
now being developed underwater, sometimes at great 
depths. It is the responsibility of the specialty to 
continue basic and clinical research in these areas 
and to expand clinical teaching to encompass the 
management of related problems. 
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Proper Use of Mechanical Ventilators* 
JAMES P. BAKER, M. D. 
Associate Professor of M edicine, 
Director, R espiratory Intensive Care Unit , 
Medical College of Virginia. Richmond , Virginia 
The widespread use of mechanical ve ntil ators 
over the past ten to fifteen years has grea tl y com-
plicated respiratory ca re. As ven til ators become 
more sophisticated, the requi re ment for physician 
knowledge becomes grea ter, since most of thi s equip-
ment can cause major harm as well as provide ade-
quate ventilation. 
There are two basic types of mec han ical venti-
lators: the pressure cycled and the vol ume cycled . 
Each has inherent asse ts and problems. The pressure 
cycled ventilator is generally operated from a com-
pressed gas source and delive rs to the patient vary-
ing mixtures of oxygen , depending upon the source 
gas and the pressure-flow relati ons of the machine 
and the patient's a irways . This is a major problem 
with most pressure cycled ventil ators. The concen-
trations of oxygen are unknown unless they are care-
fully measured and controlled. In add itio n, the pres-
sure cycled ventil ator cycles off when it arrives at a 
pressure set by the operator, thus tidal volumes can 
be greatly varied as lung compliance changes . There-
fore , one must measure the oxygen delivery and tidal 
volume generated by such ven til ators to provide 
adequate oxygenation and ventilation. The major 
assets of pressure cycled ventilators are th at they 
are relatively inexpensive, small in size, and very 
versatile. 
The volume ventilators, by contrast, deliver to 
the patient a controlled tidal volume, independent 
of the pressure required to generate such a volum e. 
With constant volume delivery, minor variati ons in 
lung compliance and airways resistance are less 
likely to result in major ventil ato ry changes. Most 
volume ventil ators have a device which directly con-
trols oxygen delivery to the pat ient , or a system with 
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a nomogram which allows one to arrive at the in-
spired oxyge n percentage. However, there are some 
which req uire that oxygen percentage also be meas-
ured as in the pressure cycled ventilators. 
It can be recognized that the primary factor in 
the proper use of mechanical ventilators is physi-
cian and / or inhalat ion therapist knowledge of a par-
t ic ular machine, and their ability to relate the patient 
to such a machine . In considering what a mechanical 
ventil ato r should do, the following equation demon-
strates that to increase a patient's alveolar oxygen 
percentage, one can either increase the inspired 
oxygen percentage, decrease oxygen consumption, or 
increase alveolar ventilation. 
F ., o, = Fro, - vo,/V.,. 
F.,u, = <';O alveolar 0 2. 
~, ., , = (Ila inspired Oz. 
Yo, = O, consumption. 
V_, = effective alveolar ventilation . 
Mechanical ventil ators function in several ways to 
provide these changes. The inspired oxygen concen-
tration can be controlled at any level necessary for a 
given patient. By assuming part of the work of 
breathing, mechanical ventilators will decrease 
oxygen consumption, particul arly in those patients 
who have a remarkable increase in the work of 
b reat hing. Additionally, alveolar ventilation can be 
increased or decreased with a mechanical ventilator 
by adjusting the patient's tidal volume and/ or 
respiratory rate. Since all of these factors are of 
direct importance in oxygenation, it is valuable to 
remember this equation. Also important to keep in 
mind is that the level of ca rbon dioxide tension is 
controlled by the level of alveolar ventilation. As 
alveolar ventil ation is increased, carbon dioxide ten-
sion will be decreased and vice versa. (Since we are 
discussing the proper use of mechanical ventilators, 
I have chosen to disregard the use of ventilators for 
intermittent positive pressure breathing therapy.) 
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Jn considering the mechanical venti lators, one 
must think of the indication for their use: 
I. To substitute for the normal work of breath-
ing. 
2. To assume a n increased work of breathing 
with increased airway or ti ssue resistance 
or increased dead space ventilation . 
3. To change to a more effecti ve pattern of 
ventil ation . 
4 . T o stabilize the chest wall aft er chest trauma. 
5. To manage pulmo na ry congestion or edema. 
6. T o improve oxygenation when severe hypox-
emia cannot be corrected by other means. 
Although some of these indications might be better 
sati sfi ed with a particular type of respirator, with 
proper knowledge and experience a pressure or 
volume cycled ventilator might reasonably well pro-
vide for any of these indic ations. This is a very im-
portant consideration as people become more and 
more dependent upo n the more expensive volume 
cycled venti lators. It may be easier to ma nage a 
patient with multipl e complications wi th these types 
of ve ntil ators, however, it is in many circumstances 
unnecessary. Therefore, it is appropriate to contrast 
the complications which occur with these two types 
of ventilators. 
Complications of Mechanical Ventilation 
I . Problem s of tubes or trac heostomies 
2 . Reduction of venous return 
3. Atelectas is 
4 . Oxygen tox icity 
5. Infection 
6. Acid-base abnormalities 
7. Gastrointestinal co mplications 
8. T echnical a nd mechanical co mplications 
9 . Emotional problems 
I 0. Miscellaneous 
Intubation of a major bronchus leading to ate-
lectasis of the other lung, tube dislodgment, laryn-
geal damage or edema, or post-ex tubation laryngeal 
problems are well known to anesthesiologists. The 
tracheosto my avoids these problems which occur 
above the tracheostomy site; however, it co ntributes 
the additio nal problems of an open wound and a rigid 
tube through the neck, which might lead to bleeding, 
tracheostomy-s ite infec tion , o r necrosis with erosion 
of vessels . Tracheal stenosis may foll ow either 
tracheostomy or indotracheal tube intubatio n. There 
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is little difference in the frequency of these complica-
tions with a pressure or volume cycled venti lator. 
Reduction in venous return resulting in de-
creased cardiac output, in our experience, has been 
much more commonly a problem in patients who 
are hypo vo lemic. Auto nomic dysfunction and pro-
longed hypoxemia also a re factors with this com-
plication. To avoid this, one must monitor the blood 
pressure and urine output , and reduce mean inspira-
tory pressure, in addit io n to providing adequate fluid 
volume. This is probably the major indication for 
the use of a volume ventilator to deliver the tidal 
volume rapidly, pa rticularly in patients with high 
compliance losses or high a irway resista nce. In these 
insta nces, a pressure cycled ventilator may require 
too lo ng a time to provide an adequate inspiration 
ma inta ining a positive intrathorac ic pressure for ex-
cessive pe riods. M ost ventilators are fitted with a 
negat ive pressure device which operates du ring the 
end of ex ha lation to enh ance venous return. This 
in our hands has been of little o r no value and , at 
least in patients with chron ic obstructive pulmonary 
disease, is rel atively contraindicated since it produces 
closure of the poorly supported a irways, leading to 
miliary atelectasis. 
Atelectasis occurs in patients on prolonged me-
chanical ventil ation , particularly in those with a 
high-inspired oxygen percentage. It may be mani-
fested in numerous ways; however, typically it is 
indic ated by an increase in oxygen requirement and 
decreas ing compliance . Compliance loss is indicated 
by increasing inspiratory pressures to provide the 
same tidal volume or a decrease in tidal volume with 
a fixed inspiratory pressure . To avoid this problem, 
a proper respiratory pattern which provides for over-
all venti lation of the lungs must be established. Con-
tinuous pos itive pressure ventil ation , infl ation hold , 
and intermittent sighing a re all approaches to this 
problem . Most volume ventilators have the abil ity 
to perform one or mo re of these functions . However, 
they can also be readily handled with a pressure 
cycled ve ntil ator with proper inhalation therapy or 
nursing ca re to provide for intermittent deep breath-
ing of patients and adequate a irway toilet . A very 
impo rtant factor in prevention of atelectasis is ade-
quate humidification of inspired gases. Chest physio-
the ra py, suctio n, a nd bronchoscopy a re also helpful 
in the avoidance a nd treatment of this problem. 
I would like to mention that oxygen toxicity 
usually occurs only with high-inspired oxygen per-
centages a nd it is greatly enhanced by prolonged 
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exposure. There are obviously multiple factors in-
volved. It is of interest in our experience that if it 
does occur, it appears largely reversible if the patient 
survives. Particularly important to mention is that 
most all pressure cycled ventilators deliver higher 
oxygen concentrations than one would suspect. A 
common misconception is that on the air dilute setting 
these ventilators deliver 40 % oxygen. Therefore, one 
must set up this type of respirator by measuring 
oxygen delivery to avoid oxygen toxicity. This is 
done either by operating the pressure cycled ventila-
tor with compressed air and adding oxygen, or by 
adding compressed air to an oxygen-driven machine 
while monitoring inspired oxygen percentage. One 
must be aware that as the pattern of the patient's 
breathing changes, there will be varying percentages 
of oxygen delivered by these types of ventilators. 
Infection is a major problem with mechanical 
ventilators since the warm, humid inspired gases, tub-
ing, nebulizers, and humidifiers provide good culture 
media for many gram negative organisms. Me-
chanical ventilators have been found to be a source 
of gram negative infection in many hospitals. In our 
experience in culturing respirators, we have found 
that no respirator had organisms cultured from it 
prior to the organism being grown from the patient's 
sputum. Thus if respirator tubing is changed at least 
daily and sterilized properly prior to each use, the 
probability that these machines will result in spread 
of infection decreases. The practice of using a ma-
chine on more than one patient must be condemned 
unless everything from the respirator head out to the 
patient is changed between patients. Infection is 
managed with proper identification of the organism 
and specific therapy. 
Inadequate humidification of inspired gases is 
one of the major problems in the use of mechanical 
ventilators. At room temperature (70 °F), a gas 
saturated with water vapor contains approximately 
20 mg of water per liter of gas. At body temperature, 
44 mg of water are required to saturate a liter of 
gas. Since normal tracheal air is 100% humidified 
at body temperature, it is practically impossible to 
provide adequate quantities of water to equal the 
normal condition without passing the inspired gas 
mixture through a heated humidifier or nebulizer. 
This fact makes the use of heated humidifiers or 
nebulizers absolutely necessary with ventilators to 
avoid drying and damaging airway mucosa and ob-
struction of airways with inspissated secretions. 
Most patients who have chronic respiratory 
failure wi ll have a compensated respiratory acidosis. 
As carbon dioxide is removed with an efficient me-
chanical venti lator, severe post-hypercapneic meta-
bolic alkalosis may be produced. The ability of 
di ssolved carbon dioxide to traverse the blood brain 
barrier with great ease and the resistance of bicar-
bonate to cross th e same barrier may result in cen-
tral nervous system alkalosis if PaC02 is too rapidly 
reduced. This can lead to convulsions, coma, and 
death, and must be considered in all patients who 
are being placed on mechanical venti lators. For this 
reason, the arterial pH rather than the PaC02 should 
be the controlled variable. There is evidence to in-
dicate that patients on mechanical ventilators will 
retain fluid , therefore , patients must be weighed daily 
and electrolytes must be measured frequently. 
A significant number of gastrointestinal compli-
cations are seen in patients severely ill with respira-
tory failure. The most life threatening is gastrointes-
tinal bleeding. This, while a significant problem, has 
not been too common in our experience . A more 
common problem is gastric distension or paralytic 
ileus in patients with severe lung disease. This may 
result in limitation of movement of the diaphram 
and a decrease in venti lation as well as basilar lung 
atelectasis. 
Technical and mechanical problems must al-
ways be considered. The ventilator which becomes 
disconnected from a patient or malfunctions is of no 
value to the patient. Thus there must be a positive 
connection between the patient and the respirator 
for the machine to function properly. We have 
adopted the use of the Morch tracheostomy tube and 
have had little difficulty with disconnection following 
this change. Since such problems may be life threat-
ening and each type of respirator has a particular 
set of associated problems, the therapist or physi-
cian must be familiar with the problems which are 
possible with a particular type of ventilator. Changes 
in ventilatory or oxygen requirements must always 
be considered in managing patients on ventilators. 
Therefore one must measure these modalities fre-
quently. Obviously, there are human errors in man-
agement and the scope of these is beyond this dis-
cussion. 
The miscellaneous complications which occur 
are multiple. Major cardiovascular problems, such 
as arrhythmias, digitalis toxicity, and pulmonary em-
boli are not necessarily related to ventilators; how-
ever, they must be recognized in patients on ventila-
tors. Pneumothorax and mediastinal emphysema 
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must be antic ipated, si nce they may cause marked 
difficulty and frequently occur in ventilator patients. 
The other major problem is weaning a patient 
from a ven til ator. There are several factors to utili ze 
in deciding when to begin weaning a patient: 
I. Oxygen requirement: alveolar-arteria l oxy-
gen gradient should be less than 300 mm 
Hg breathing 100% 0 2 
2. Tidal volume : grea ter than 10 cc per kg 
body weight off respirator 
3. Vital capacity: greater than twice the tidal 
volume 
4. R atio dead space to tidal vo lume (Yd per 
Vt): less than 0.5 
5. Tnspiratory negative pressure : more than 20 
cm H 20 negative pressure 
These a re obv iously not the only factors in weaning. 
The clinical judgment of the nurses and inhalati on 
therapists is of major importance and is relied on 
heavi ly in our respi ratory care unit. There are sev-
eral problems which we routinely see in patients 
who are difficult to wean from respirators. The pa-
tient must be ready emotionally as well as physio-
logically to be removed from the respirato r. He 
should have a rter ial blood gas values controlled 
near to those that he can support on his own without 
ass isted ventil ation. The pat ient should be cycling 
the ventilato r himself; although this is unnecessary , 
it is helpful. Adequ ate humidification must be pro-
vided at all times when he is off the ventilator or 
he will have further problems with secretions and 
airway obstruction. Hi s secretions shou ld be under 
optimal control. One shou ld begin with brief periods 
off the venti lator, that is, fi ve to ten minutes per 
hour. Time off the ventil ator is prolonged as the 
patient's tolerance increases. Even while the pat ient 
is off the ventil ato r, his lungs should be hyper-
expanded freq uently. Arte rial blood gases, vital signs, 
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and pati ent condition must be observed repeatedly 
during this period. We have always allowed the 
pa ti ent ini tia ll y to sleep on the ventilator and be 
weaned only during th e daytime; then he finally is 
all owed to sleep without ventil atory assistance. An-
other ve ry important aspect o f weaning the patient 
is emotional support. A patient who can communi-
cate vocally has a much b~tter opportunity for a 
reasonable emotional state. Our policy is to put in a 
ligh tweight pl as tic tracheostomy tube which can be 
plugged to a llow the patient to ta lk while he is being 
weaned. This procedure in many circumstances has 
been of great value. 
The proper use of mechanical ventilators is 
related to many problems; however, the primary one 
is the knowledge of the phys ician, nurse, inhalation 
therapi st, and other paramedical personnel with a 
given ventilator. It is important to remember that 
there are certa in inherent problems with all ventila-
tors. These probl ems must be carefully searched for 
and avo ided. 
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Postoperative Ventilatory Care* 
TERRING W. HEIRONIMUS, Ill, M. D. 
Associate Professor of Anesthesiology, University of 
Virginia School of Medicine, Director of Inhalation Therapy, 
University of Virginia Medical Center, Charlottesville, Virginia 
Postoperative ventilatory care implies that 
some significant percentage of surgical patients can-
not breathe adequately in the postsurgical state and 
need to be appropriately assisted in order to do so. 
It further implies that there may be some difficulty 
in or complication resulting from such care. Both 
implications are correct. 
However, if we are to deal effectively with this 
problem, that is, if we are to correct some defect in 
a physiologic fashion , we must understand how post-
operative ventilatory mechanisms and physiology are 
upset. 
While many forces, both pre- and intra-opera-
tive, come to bear on the immediate postoperative 
ventilatory status of the patient, the common 
denominator in virtually all instances is hypo-
ventilation. Unfortunately, for the patient's sake, 
this physiologic abnormality occurs at a time when 
normal protective reflexes and a fully alert state of 
consciousness are wanting. For some hours, or 
even days, the patient exists in a physiologic "twi-
light zone"-neither surgically anesthetized nor fully 
capable of protecting himself from his environment. 
What causes this hypoventilation? Obviously, 
many factors related to both the anesthesia and the 
surgery are responsible . 
Every known general anesthetic, barbiturate, 
narcotic, sedative, and tranquilizer is a central ner-
vous system depressant, and in sufficient dose will 
depress ventilation. Muscle relaxants, which fre-
quently produce a greater effect in the immediate 
postoperative period than we think they do, impair 
ventilation by their action. In addition, anesthesia 
even of relatively brief duration, predisposes toward 
the development of diffuse, generalized micro-
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atelectasis. A series of blood gas analysis routinely 
performed on young, healthy women immediately 
following elective uncomplicated D&C will soon 
convince even the most skeptical that something is 
amiss in the efficiency of breathing. Arterial oxygen 
tension in these circumstances is almost invariably 
depressed, even when the PC02 is normal. Now, add 
to this array of abnormalities the fact that some 
anesthetics produce a degree of metabolic acidemia, 
and that this in turn will adversely affect the metab-
olism and pharmacologic reversal of certain relax-
ants. The stage is now set for a potential disaster. 
Next come the adverse effects of surgery. The 
immediate postoperative effects on pulmonary func-
tions of elective upper abdominal surgery are typ-
ical. The patient is in pain ; he splints; he typically 
breathes rapidly, but shallowly. He either cannot or 
will not take a deep breath, and therefore, cannot 
cough effectively. Secretions tend to accumulate, 
and we have another reason to develop atelectasis. 
The upper abdominal procedure is more de-
pressant to the postoperative vital capacity than the 
lower abdominal operation . Non-abdominal (and 
non-thoracic) procedures are not associated with any 
significant change in pulmonary function related to 
the surgery per se. 
The type of anesthesia, whether conduction or 
general, has considerably less influence on the ade-
quacy of postoperative coughing ability than does 
the anatomic site of surgery. Upper abdominal opera-
tions are in fact slightly more debilitating in this 
regard than are intrathoracic procedures, so long 
as actual lung tissue is not excised . 
The highest incidence of postoperative pul-
monary complications occurs in elderly patients, as 
might be expected. Even though these data are 25 
years old, the situation has not changed markedly as 
far as the upper-age groups are concerned. Post-
operative pulmonary complications are also more 
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li ke ly to occur in obese patients, in chronic c igarette 
smokers, and (although not ag reed upon by all in-
vest igators) seem to inc rease as the durat ion of 
anesthes ia and surge ry increase. Needless to say, 
the existence of signi fica nt preexisting pulmonary 
d isease raises the probabili ty of postoperat ive prob-
lems. 
Preopera tive abnormalities in vita l capac ity 
and the FEV, a re related to the operati ve risk. When 
the preoperat ive vita l capac ity is less th an 80 % of 
the predicted , or when the FEV, is less than 60% 
of the total vital capac ity, or espec ially when both 
of these abnormalities coex ist, the ri sk o f surgery 
and anesthesia, parti cul arly surge ry of the upper 
abdomen, increases tremendously. 
Let us conside r an exampl e which is not un-
usual and , indeed , is being seen more and more fre-
quently by those of us with a busy clinical prac tice . 
A 50-year-old , 2 10-poun d male, who has smoked a 
pack and a half of cigarettes a day fo r 25 yea rs 
comes in fo r elec tive vagotomy and pyloroplasty. 
After three hours o f nit rous ox ide, oxygen, halo-
thane, and cu ra re relaxat ion he a rrives in the recov-
ery ward . His tida l volume is 350 ml , hi s vital 
capac ity is 600 ml. hi s Pa0 2 is 53, his PaCO, is 
49, and hi s pH is 7.29. 
Let us be sure that we de linea te the p roblem 
accurately: The question is not, " Will this patient 
develop significa nt hypoventilation and, fin ally, res-
piratory fa ilure?" The question is, "When?" He is 
already seriously hypoventil ating, is hypoxemi c, and 
is developing a respi ratory acidemi a. He is over-
we ight and probably has signific ant chro nic b ron-
chiti s. All too frequently, we see this patient who 
becomes febrile within 24 hours of surgery and 
develops pneumonia . Hi s hospitali zation is pro-
longed, his convalescence complic ated , and he has 
inherited an inc reased ri sk of mortal ity. He has 
joined that ever growing group of patients who sha re 
the most common of all pos topera ti ve problems-
pulmonary complications. 
Knowing that anesthes ia may impair ventila-
tion, knowing that surge ry adds insult on top of 
injury to the b reath ing mechanism, and knowing 
that preexisting lung disease adds two strikes before 
surgery is eve n contempl ated, one cannot escape the 
c lear indica ti on fo r prophylax is. Indeed , the hall-
mark of pos to perati ve ve ntil ato ry care is pre-
o perative pulmonary preparatio n. It is now c learly 
demonstrated that appropriate pre-, int ra- and post-
operati ve care of pat ients wi th chronic pulmonary 
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d isease can result in morbidity and mortality rates 
simil ar to those in patients with no pulmonary 
disease, trea ted in the usual fashion, that is, largely 
ignoring the pulmonary system unless complications 
occur. 
Preopera ti ve pulmonary prepara tion requi res 
that someone, usually the operating surgeon or the 
initi al refe rring phys ic ian, be aware that the patient 
has some respi rato ry di ffic ulty, e ither potenti al or 
ex istent , and that this d iffic ulty poses a threat to his 
postsurgical surviva l. With this in mind , the fo llow-
ing preoperative program is suggested: 
Which diseases or symptoms should concern us? 
a) Ac ute respiratory in fec tion obviously should 
be elimina ted prio r to electi ve surgery. In 
the emergency case we have to go ahead 
with anesthes ia and surgery, and this is ac-
ceptable, but it inc reases the ri sk fo r the 
patient. Otherwise elec tive surgery should be 
postponed. 
b) C hronic bronchitis- a history of c igarette 
smok ing, cough with production of sputum, 
espec ially purulent sputum, is enough to 
make the d iagnos is of thi s disease. 
c) Emphysema-this d isease cannot be cured 
o r even reversed to any great ex tent , but it 
is often assoc iated with considerable b ron-
chial spasm and/ o r infec tion, both of which 
should be eliminated or decreased in severity 
prio r to anes thes ia . 
d) Asthma-we are concerned here with the 
patient who is ac tu ally wheezing with dysp-
nea. T hese patients should be rendered 
symptom-free prio r to elec tive surgery if at 
all poss ible. 
e) Bronchiectas is-these patients always pro-
duce sputum. T hey must be able to cough 
and hopefull y should not get superinfection. 
f) Dyspnea as a symptom should never be 
igno red. Its o rigin may be e ither respi ratory 
o r cardiovascul a r. The sys tem which is re-
sponsible fo r its genesis should be deter-
mined and evalu ated as to the actual diseases 
present. Thi s is obviously eas ier sa id than 
done, but in the presence of uncompensated 
heart fa ilure, vigorous diures is is a relatively 
benign yet fa irly effec tive way to improve 
thi s situation. 
How do you diagnose these diseases? The 
po in ts in phys ica l and clinical diagnosis are not 
needed in this discuss ion as they are no doubt 
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well appreciated by all of us. What is needed, I 
think, is one simple reminder. We must consider 
smouldering, lingering, or occult pulmonary disease 
in each patient we contemplate sending to surgery. 
We must suspect it and look for it, otherwise some-
body will develop a serious pulmonary complication 
or perhaps die in the postopera tive period-some-
body who would otherwise return to some years of 
further productive life. The presence of cough with 
yellowish or greenish sputum regardless of how scant 
in quantity , means pulmonary infection, bronchitis 
probably, but perhaps bronchiectasis. 
"All that wheezes is not asthma," is sound 
albeit aged advice . On the other hand , wheezing 
should suggest asthma since this disease cannot exist 
without this sign. 
Obstructive airways disease carries greater post-
operative morbidity than does restrictive disease 
due to the limited abi lity of effective coughing. A 
quick, fairly reliable , and quite unsophisticated 
qualitative appraisal of airway obstruction is the 
match test. The one-second and 0.5-second FEV 1, or 
timed vital capacity. is obviously more accurate. A 
point to remember is this: Severe emphysema and 
bronchitis can exist in the presence of a normal 
chest x-ray and with no increase in anterior-posterior 
diameter of the chest. Do not rely on these signs as 
the tip-off to the presence of pulmonary disease . 
The relationship of pulmonary function tests 
and arterial blood gases to postoperative prognosis. 
Pulmonary function studies such as vital capacity, 
timed vital capacity, and max imum mid-expira-
tory flow rate are sensitive but not specific tests 
(they may be abnormal in all who do poorly 
postoperatively, but they also may be abnormal in 
those who do well) . The PaC02 is quite specific but 
not particularly sensitive as it invariably predicts 
postoperative difficulty if elevated preoperatively. 
But the patients with this abnormal test in the pre-
operative per iod are very few of all those who are 
operated upon . Both the pulmonary function test plus 
the blood gas analysis and the response of both of 
these to preoperative respiratory preparation are 
the best indication of the postoperative course and 
the patient's tolerance of surgery and anesthesia. 
How do we prepare the patient for surgery? 
Once the diagnosis of plumonary disease is made 
and some quantification of this function is achieved, 
our entire efforts are aimed toward one simple 
goal-getting the patient in as good a shape as 
possible before surgery. Regardless of the severity 
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of his pulmonary disease we should be satisfied that 
he can be improved no further before elective sur-
gery and anesthesia is undertaken. This includes: 
a) the eradication of acute infection 
b) the control of chronic infection 
c) the relief of bronchial spasm 
d) a n improvement in the sputum clearance 
and bronchial drainage 
e) the reversal of uncompensated congestive 
heart failure on the basis of corpulmonale, 
if such is present. 
f) all steps to improve muscular power for 
coughing and deep breathing (nutrition, elec-
trolytes, and humidification of airway) 
g) a familiarization with inhalation therapy 
equipment li kely to be used in the post-
operative period, ventilators, etc. 
h) a familiarization with chest physiotherapy 
techniques for effective coughing, sputum 
production , and exercises. 
Even if all this produces little detectable im-
provement in the patient, we have the advantage 
of knowing that his disease is largely irreversible 
and th at his tolerance for extensive surgery and pro-
longed anesthesia will be minimal. 
What is the best anesthetic technique or agent? 
It has been repeat edly de mon strated th a t the 
drug used or the technique employed in producing 
anesthesia for such patients is of considerably less 
importance than is the sk ill with which the particular 
drug or technique is applied. In other words, the 
anesthetic is not what is important, it is the anesthe-
siologist. 
What are the details of postoperative care? 
This is a continuation of the preoperative regime, 
that is : 
a) awareness of the possibility of complications 
and actively looking for them. 
b) maintenance of adequate alveolar ventila-
tion (as determined by arterial blood gases) 
without excessive energy expenditure (mea-
surement of tidal volume, vital capacity, min-
ute ventilation, and frequency of ventila-
tion). 
c) maintenance of an unobstructed airway. An 
endotracheal tube may be used in these cir-
cumstances if needed . 
d) meticulous STERILE tracheobronchial suc-
tion as necessary. 
e) effective humidification-both in the airway 
and parenterally . 
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f) frequent ches t physiotherapy to help in 
coughing, deep brea thing, and secretion re-
moval. 
g) establishment of ass isted ventilation if pul-
monary fun ction tests and arterial blood 
gases deteriora te beyond a certain poi nt , or if 
one has reason to think th at they will de-
teriorate beyond a certain po int , that is, a 
PaC0 2 above 50, a PaO, below 200 on 
100% oxygen, a tidal volume less than 3 ml 
per kg, a vital capacity less than 10 ml 
per kg, o r a respiratory frequency of grea ter 
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than 35 per minutes in adults. 
If the possibility of preoperati ve pulmonary 
disease is suspec ted ; if it is diligently sought for ; if 
a degree of functional impairment as well as pa-
thologic di agnosis is establi shed; and if the patient 
is rendered as symptom-free as poss ible with respect 
to infection, sputum c learance, ability to cough, and 
freedom from bronchi al spasm, he will tolerate his 
surgery and anesthes ia as well as modern medical 
care can allow him to. And if postopera tive ventila-
tory care is necessary, it will be antic ipated and 
utili zed appropriately. 
Pulmonary Function Testing for Preoperative Study 
of Patients for Anesthesia and Surgery* 
ORHAN MU REN, M. D. 
Associate Professor of Medicine, 
Medical College of Virginia , Richmond, Virginia 
Pulmonary complications are the most prevalent 
causes of morbidity and mortality in patients who 
undergo surgical procedures. Simple pulmonary 
function tests which can detect pulmonary dysfunc-
tion may be perfo rmed preoperatively. If prope r 
measures are taken ( chest physiot herapy, pos-
tural drainage, bronchodilating agents , antibio tics, 
humidification of inspired gases, cessation of c igarette 
smoking), morbidity and mortality can be reduced 
significantly. 
Pulmonary function tests are especially im-
portant in patients with borderline pulmonary rese rve 
who need major surgery. After object ive evaluation , 
the anesthesiologist and the surgeon ca n prov ide 
better care for the pat ient. These stud ies may also 
suggest the patients who are more likely to develop 
postoperative complications. 
In many patients, a thorough med ical history 
and physical examin ation. in addition to a complete 
blood count with differential, urin alysis, elec trolytes. 
BUN, and chest x-ray, ofte n will give sa ti sfactory 
information , and many patients will not need pul-
monary function testing prior to anesthes ia and 
surgery. 
Should hi story and physical exa min ation show 
that pulmonary function tes ts are indicated, they will 
also indicate the type of tests to be carried out. A 
history of chronic productive cough, dyspnea, pleu-
ritic chest pain , occupational respirato ry haza rds, 
frequent past episodes of pneumoni a, pleurisy, chest 
colds, and sudden reduction in strength should 
strongly suggest poss ible pulmonary dysfuncti on. 
Findings on examination of the chest such as 
prolonged expiration, diffuse or localized wheezing, 
absent breath sounds, rales , chest-wall deformities 
and scars, hypertrophy of scalene muscles, and pul-
• Presented a t th e 25th Annual Stoneburner Lecture 
Series, February 26 , 1972, at the Medica l Co ll ege of Vir-
ginia, Richmond. 
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monary osteoarthropathy aga in should suggest possi-
ble abnormalities in lung functi on, and proper pul-
mon ary function tests should be performed. 
There are a variety of pulmonary function tests 
which may be used to detect dysfunction . In gen-
eral , they can be divided into two groups: 
I. Those relating to the ventilatory function of 
the lungs and thoracic wall. 
2. Those relating to pulmonary gas exchange. 
Ventilatory Function Tests. Ventilatory func-
tion is determined by measurement of static lung 
volumes. These are somewhat indicative of the elastic 
resistance of the lungs and chest wall and dynamic 
lung compartments; these tests are mainly a reflec-
tion of nonelasticity. 
Static Lung Volumes. Static lung volumes are 
assessed by measuring the vital capacity which 
changes according to height , age, and sex. Full co-
operation of the patient during the procedure is 
essential. Integrity of the entire respiratory system 
( respiratory centers, th orax, the connections between 
these two, chest wall, pleura, lung paranchyma, and 
airways) is necessary fo r normal vital capacity. 
If a person has less than predicted normal vital 
capacity, by definition he has restrictive lung disease. 
Normal values range ± 15 % of the predicted. As an 
isolated test, vital capacity is of limited clinical value 
in differenti al diagnosis of diseases of the chest. 
However, serial measurements of vital capacity may 
be helpfu l in assess ing the degree of improvement or 
worsening in certain conditions such as neuro-
muscular disorders, or diffuse interstitial pulmonary 
fibrosis . 
Dynamic Lung Volumes. More important infor-
mat ion could be obtained by measuring timed 
vital capacity or forced vital capacity. A young 
or middle-aged normal person should be able to ex-
hale 80% of his vital capacity in one second and 
97 % in three seconds. If the ratio between one-
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second fo rced expiratory volume ( FEY,.,) , over 
fo rced vital capac ity ( FYC) is less th an 80%, he is 
considered to have obst ructive lung disease. Diminu-
tion in FEY,., to a liter or less ind icates severe 
impairment of ventilato ry function and a somewhat 
poor surgical risk. 
Expiratory fl ow rates can be determined at 
di ffere nt points during fo rced expi rato ry curve. The 
fo rces tending to reduce the size of a irways (peri-
bronchial pressure and the fo rce generated by con-
striction of bronchia l muscles) are balanced by those 
attempt ing to increase the size of airways (int ra-
luminal pressure and radi al traction of elastic fibers). 
During fo rced exhalation, the alveolar pressure and 
the intrathoracic pressure are greater than atmo-
spheric pressure. The int ramu ral pressure decreases 
gradu ally from peripheral a irways to atmospheric 
pressure at the a irway opening. At some distance in 
the airway, intralumi nal and pleural pressures a re 
equal. This is ca lled the poin t of equ al pressures. 
Beyond th is point , int raluminal pressure is less than 
pleura l pressure; this would tend to narrow airways, 
thus limiting fl ow. 
In patients with altered and more coll apsible 
airways, flow is limited at lower levels of pleural 
pressure. The max im al fl ow rate produced by fo rced 
ex halation depends upon the level of lung inflation. 
At maximum lung inflation, expi ratory flow increases 
as the pressure increases. At lower lung volumes, 
expi ratory fl ow increases as pressure increases up to 
a certain level, afte r which more effort cannot in-
crease and may even decrease flow rate. This expl ains 
why the maximum mid-ex pi ra tory flow rate ( MMFR 
or F EF 25 %-75%) is the most sensitive test for ex-
pi ra tory flow ra te determination since the initi al 
25 % of the FYC is primarily effo rt-dependent and 
the last 25% affected by diminished lung volumes . 
The MMFR measures the max imum rate of fl ow 
in the mid portion of F VC curve ( FEF 25% - 75% ) . 
(The length of time necessary to exhale the middle 
50% of the fo rced vital capacity is measured and 
flow rate is ca lcul ated.) Normal values are 3-4.5 L 
per second . It should be emph as ized th at small a ir-
ways ( 2 mm in diameter ) are only responsible fo r 
approx im ately 15%-20% of the total a irway re-
sistance, so marked increases in peripheral or small 
airways will not be detected by the convent ional tes ts 
such as FEV,,, or MMFR. 
In the ea rl y stages of chronic bronchitis, pul-
monary emphysema, and bronchiectas is there is a 
significant degree of involvement of the small a ir-
ways. In the early stages of these conditions , fre-
quency-dependent dynamic compliance and alveolar 
arterial oxygen tension gradient, A-a PO,, may 
detect pulmonary dysfunction. For clinical purposes, 
however, simple spirometric studies with measure-
ments of FYC, FEY,,,, and MMFR are sati sfactory. 
Improvements in fl ow rates after administration of 
bronchodilating agents suggest the presence of par-
ti ally reversible obstruction . One-second fo rced ex-
pi ratory volume x 30 gives indirec t measurement 
of max imum voluntary ventilation ( MYY ). 
If a bedside study of ventilatory function is de-
sired, a Wright Respirometer may be used for mea-
suring tidal volume and inspiratory capacity. A Peak 
Flow Meter may also be used for measuring peak 
flow rates . 
Failure to blow out a lighted match held six 
inches away from the wide-open mouth again sug-
gests significant reduction in flow rates. 
In general, patients with obstructive lung disease 
a re more prone to develop postoperative pulmonary 
complications such as atelectas is and broncho-pneu-
moni a. This is why pulmonary function testing is 
important fo r determining the type of phys iologic ab-
normality present so that proper measures can be 
taken to improve potentially reversible abnormali-
ties. 
Pulmonary Gas Exchange. One of the most im-
portant functions of the lungs is alveola r gas ex-
change which involves the following processes: 
1. Ventil ation 
2. Uniform distribution of inspired ai r 
3. Diffusion 
4. Pulmonary capillary blood fl ow 
Normal alveola r gas exchange maintains partial 
pressures of oxygen and carbon dioxide in the 
a rteri al blood within normal limits not only at rest, 
but also during increased physical activity and body 
metabo lism. Abnorm ality in any of the above proc-
esses or in any combinations of the four, results in 
hypoxemi a o r hypoxemia and hypercapni a if the 
person is breathing room air. 
Arter ial gas studies indicate : 
I . T he level of oxygenation (P02 in mm of 
Hg ) 
2. The level of ventil ation (PCO, in mm of 
Hg. ) 
3. The hydrogen ion activity (pH) 
The above dete rminations a re extremely important 
in all se riously ill patients. 
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It is often impossible to judge the levels of 
ventilation and oxygenation by clinical evaluation 
alone. There is much overlapping between signs and 
symptoms related to hypoxemia and hypercapnia: 
nervousness, headache, irritability, confusion, coma, 
altered blood pressure, tachycardia, etc. Sometimes 
signs and symptoms related to hypoxemia and hyper-
capnia are absent and only by measurements of 
arterial gas studies can the level of ventilation and 
oxygenation be determined and appropriate treat-
ment initiated. 
An A-a P02 gradient greater th an IO mm 
Hg on room-air breathing indicates a defect in blood 
gas equilibrium. The three primary mechanisms of 
increased A-a P02 gradient are impaired diffusion , 
venous-to-arterial shunting of blood, and abnormal 
ventilation/ perfusion ratios in the lung. 
The amount of true venous-to-arterial shunt is 
determined by having the person breathe I 00 % 
oxygen for 15 to 20 minutes. Normally, arterial 
PO, will increase to about 600 mm Hg. The observa-
tion of increased A-a P02 gradient on breathing 
room air and of a P02 greater than 550 mm Hg 
while breathing oxygen indicates that mismatching 
of the distribution of ventilation and perfusion in the 
lungs is the cause of hypoxemia. 
The observation of high A-a P02 gradient 
on room air in the presence of normal spirometric 
studies may also suggest peripheral airway disease . 
Whenever possible, arterial blood gas studies 
should be obtained at rest, after exercise, and some-
times after the administration of I 00 % oxygen 
for 15 to 20 minutes. The above studies may give 
valuable information in the evaluation and follow-up 
of patients with respiratory disease . 
Normal arterial blood O, at sea level is found 
in two forms: 
I. Dissolved 0 2 (0.3 ml per 100 ml per 100 
mm Hg) 
2. Oxyhemoglobin (Hb O, 19.7 ml per 100 
ml) 
Normally, the total O, content of arterial blood 
is approximately 20 ml per I 00 ml. The amount of dis-
solved 0 2 present is linearly related to arterial 0 2 
tension . If partial pressure of 0 2 in arterial blood is 
600 mm Hg, there is approximately 1.8 ml of physi-
cally dissolved 0 2 per 100 ml blood. 
On the other hand, the relation between oxy-
hemoglobin and partial pressure of 02 is S-shaped. 
If P02 is 100 mm Hg, oxygen saturation is 96% to 
98 %. If P02 is 60 mm Hg, oxygen saturation is 
approximately 90%. In the flat portion of this curve, 
a large decrease in 02 tension causes only a small 
drop in oxygen saturation . However, at the steep 
portion of this curve, a small reduction in 0 2 tension 
causes a large diminution of 0 2 saturation. 
For instance , a drop of O, tension from 40 mm 
Hg to 27 mm Hg causes a reduction of saturation 
or O, content of approximately 25 % . A high CO2 
tension and increased H ' ion ac tivity shifts this 
curve to the right. This is called the Bohr effect. In-
creased temperature and increased 2-3 DPG (2-3 
Diphosphoglycerate) of the red blood cells can also 
shift this curve to the right. A low PCO,, a high 
pH, a low temperature, and a low 2-3 DPG causes 
a shift to the left. Normally, a shift to the left in the 
lungs helps the loading of O, with hemoglobin. A 
shift to the right at tissue levels helps unloading of 
02 to ti ssues. 
There are four causes of hypoxemia on breath-
ing ambient air at sea level: 
I. Uneven V /Q 
2. Venous-to-arterial shunt 
3. Alveolar hypoventilation 
4. Impaired diffusion 
. . 
In clinical medicine, uneven V /Q is the most 
common cause of hypoxemia. However, in a given 
case, there is more than one factor responsible for 
hypoxemia. 
Arterial PC02 indicates the balance between 
CO, produced at the tissue level and CO2 eliminated 
by alveolar ventilation . 
vco, 
PaCO,oo VA 
Normally, alveolar ventilation is proportional 
to CO, production which is related to the rate of 
metabolism. In any given person at any given time, 
CO2 production is at a certain level and only alveolar 
venti lation could change arterial PCO,. In conclu-
sion, we can say that the level of PC02 indicates 
the level of ventilation. 
Hydrogen ion activity is determined by mea-
surement of pH. According to the Henderson-Has-
selbalch equation: 
pH PK'+ 1 (HCO,) 
og PCO, X 0.03 
24 
pH= 6 .1 + log Ll 
pH 6.1 + 
20 log 1 
pH 6. 1 + 1.3 = 7.40 
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The ratio of HCO:i and dissolved CO2 determine the 
pH. As long as this ratio is 20, the pH should be 
normal. 
There are four prim ary o r s imple ac id-base 
disturbances as we ll as combined or mi xed acid-b,1s~ 
disturbances. Primary increase or decrease in PC02 
indicates respiratory ac idosis or alk alos is respec-
tively. Primary increase or decrease in HCO:i in-
dicates metabolic alkalosis or ac idosis respec tive ly. 
The fo llowing a re some indica tions for pu lmo-
nary function testing: 
I . To determine the type of physiologic altera-
tion present. 
2. To quantitate the degree of functi onal im-
pairment. 
3. To initiate therapy on a more rati onal 
phys iological basis and objectively fo llow the 
efficacy of therapy. 
4. Preopera tive ri sks evalu ati on. R e : anesthes ia 
and surge ry. 
The fo llowing arte ri al gas studies were obtai ned 
on room ai r in a 60-year-old man with chronic ob-
structive pu lmonary disease (COPD ): 
P0, :60 mm Hg 
PC0, :55 mm Hg 
p H: 7.34 
HC0, :30 m Eq/ L 
The above studies indicate mild hypoxemia and 
partially compensated respiratory ac idosis. 
Spirometric stud ies revealed moderately severe 
airway obstructive disease. One day afte r admi ss ion, 
elect ive cholecystectomy was performed . One day 
after surgery , arte rial gas studies on ambient a ir were 
obta ined. 
P0, :45 mm Hg 
PC0, :80 mm Hg 
p H: 7.26 
HC0":35 m Eq/ L 
The above stud ies indicate severe hypoxemi a 
and partially compensated severe respiratory acidos is. 
It took approximately 12 days to correct arteria l gas 
studies and acid-base disturbance . 
On the other hand , in another patient wit h 
COPD and more or less the sa me arte ri al gas ab-
no rmaliti es, elec ti ve ga ll bladder surgery was post-
poned for seven days and the patient was given chest 
phys iotherapy, postural drainage, bronchod ilating 
agents. ant ibio tics. and humidified inspired air. He 
stopped smok ing. Postopera ti ve status was entirely 
unremarkable. 
In conc lusion , if hi story and physical examina-
tion indicate pulmon ary dysfunc tion, simple pulmo-
nary funct ion tests should be obtai ned and proper 
measures taken to reduce morbidity and mortality in 
surge ry pat ients, espec ially those with underlying 
chronic lung d isease. 
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Body Temperature During Surgery and Anesthesia* 
AMIR RAFII, M.D. 
Professor of Anesthesiology , 
Medical College of Virginia , Richmond, Virginia 
The recognition of fulmin ant hyperthermia and 
accidental hypothermia during anesthesia and sur-
gery has given a new impetus to clinical thermometry 
in the operating room. It is sugges ted that in order to 
recognize and avoid these conditions in the anes-
thetized patient, a routine of continuous monitoring 
of body temperature be added to our armamen-
tarium fo r patient care. 
One of the problems that has to be solved is 
the standardization and selection of a physiologically 
meaningful site fo r the monitoring of body tempera-
ture. In order to select such a proper site. a brief 
discussion of functional anatomy and physiology of 
body temperatu re is here presented . together with a 
discussion of the advantages and disadvantages of the 
traditional sites, placing emphasis on a new site-
namely the tympanic membrane . 
The relative constancy of body temperature was 
recognized by O aude Bernard as a part of the regu-
lation of the "milieu interieur" required fo r the 
health and proper functi oning of the cellular 
elements of warm-blooded anim als. The healthy 
man does not exist with internal body temperature 
much outside the normal range of 36°-38 °C , although 
during hard work and in febrile diseases he may 
tolerate fo r short periods of time temperature as high 
as 40°-41 °C. Denatu ration of vita l cellular proteins 
occur above 44 °C. Man may tolerate hypothermic 
states fo r short periods of time during which his body 
temperature is as low as 27 °-29 °C, but these tem-
peratures are incompatible with life except under 
the most careful medical supervision and even then 
not for periods longer than a few days. 
The center for regulation of body temperature 
is in the hypothalamus ( fig. I ) . In this area two 
• P resented a t the 25th Ann ua l Stonebu rner Lecture 
Series, Februa ry 26. 1972, at the Medica l Col lege of Vi r-
gini a, Richmond . 
MCV QUARTERLY 8(2) : 135-141, 1972 
regions, anterior and posterior hypothalamus, have 
been recognized. T he anterior region, also known as 
the " heat disposal" region in the event of total body 
heat gain , is involved in the initiation of thermoregula-
tory refl exes. These reflexes will activate the cardio-
vascular and respiratory system, cutaneous blood 
vessels, and sweat glands th rough the autonomic 
nervous system to help balance body heat through 
heat loss. 
Cold stimulates the cent ra l nervous system in the 
posterior hypothalamus and the endocrine system 
th rough the pituita ry gland . Its primary action on 
the periphery is to stimulate sensations of cold and 
possibly other cutaneous nerve endings which send 
thermoregulatory signals to the " temperature main-
tenance region." The posterior region of the hypo-
thalamus, on receiving "cold signals" through the 
"shivering center ," will activate the shivering reflex 
which is one of the most powerful physiological 
actions of the body in the production of heat. 
Hormonal action of cold takes place through 
the hypothalamus. By lowering the temperature of 
blood going to the bra in, cold stimul ates the hypo-
thalamus. which in turn affects the pituitary and the 
release of thyroid stimulating hormone (TSH ) 
and adrenocorticotropic hormone ( ACTH ). These 
two hormones promptly act on their target organs to 
release thyrotropic and adrenal hormones which 
serve to increase heat production in the body ti ssue 
( fig. I and fig. 2) . These hormones also serve to 
potentiate the direct effect of cold in producing 
extra body heat by shivering. There are interactions 
of the various endocrine glands on each other, and 
thus it is not easy to obtain a clear evaluation of 
the part played by a single glandular component 
( fig. 2 ). 
Monoamines in the hypothalamus act as medi-
ators of temperature response. Local infusion of 
5-hydroxytryptamine have been shown to raise tern-
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Fig. I- Functional ana tomy of ph ysio log ic temperature 
reg ul atio n. 
pera ture in cats. It is suggested th at the release of 
mo noamines and their relati ve local co ncentrations 
act on the tempera ture ce ll s of the ante ri or hypo-
thalamus. Norepinephrine a nd epinephrine a re con-
cerned with regul ating heat loss, and 5-hydroxy-
tryptamine is invo lved with hea t production. 
In fever, in response to leukocyte pyrogens. 
the pyrogens act direc tl y o n the ce ll s of the anterior 
hypothalamus. The magnitude of skin te mperature 
appears of little importance in the regul atio n of body 
temperatu re. Logica lly, it makes the most sense to 
have the sensor for warmth inside the core o f the 
body where the hea t-generating meta bolic act1 v1ty 
originates, and the sensor fo r cold o n the o utside 
where the cold environment is located . 
"Human Thermostat." T heodo r H . Benzinge r 
has p ro posed the conce pt of a " hum an thermostat" 
o r a " temperature eye" being loca ted in the hypo-
th alamus. The tempe rature eye will sense the bod y 
temperature, as the retina of the eye is ca pable of 
sensing light. The se t poi nt , 37 °C, of the human 
th erm osta t is loca ted in the hypoth alamus area . 
The shifting of the se t point fro m 37°C will cause 
th e ac ti va ti o n of thermoregul ato ry re fl exes and, in 
effec t, c rea te the constancy o f body temperature. 
Anesth eti c agents, by depress io n of the hypoth ala-
mus, can cause lowering of th e se t point. Th e same 
effec t has been attributed to asp irin , while it has been 
pos tul ated th at pyroge ne will ra ise the set point of 
the huma n thermostat. Considering the functio nal 
a natomy and cent ral regul a tio n of body temperature, 
it beco mes appa rent th at th e logical site to monitor 
the cent ra l temperat ure is located in the c ranium . 
Rectal Temperature. T he most widely used rectal 
tempe rat ure has been highly c ritic ized fo r not bei ng 
a true re present ati ve of core te mperatu re. In moni-
toring of rec tal temperature. o ne has to rea li ze that 
this area does not have any therm al significance of 
its own. There a re no th erm oreccpti ve ele ments in 
th e rect um . I t is fa r away fro m the ce nt ra l nervous 
system and docs not have direc t relationshi p with 
the crossroad o f circul atio n. th at is. hea rt and grea t 
vesse ls. Sir George Pickering has o bserved '· no clear 
relationshi p between cha nges in rec tal temperature 
and changes in vasomotor to ne." 
The re li a nce o n recta l tem perature fo r the last 
hundred yea rs has been responsibl e fo r the fa ilure of 
cl inicians to recognize a nd use the concept o f central 
thermorece ption in clinica l thermo metry. Our mea-
sure ments at the Med ical College of V irginia a nd the 
measureme nts of others in the a nestheti zed pa-
ti ent have show n th at recta l te mpera ture dev iates 
wide ly fro m tympa nic (cent ra l) measurements. Be-
Fig. 2-Flow d iag ra m of ho rmo nal res ponse to cold. ( Re-
pri nted with perm issio n fro m Masson et C ie [eds. ] Les 
Concepts de Claude Bern(/ rd Sur L<' Milieu l nu;rieur. Paris: 
Libra ires de L·Acade mie de Mecl eci ne. 1967. and f rom T. H. 
Benzinger.) 
RAFII: BODY TEMPERATURE DURING SURGERY AND ANESTHESIA 137 
cause of these ana tomica l a nd phys io logical aspects 
of the rectum, such devia tions make it nonreprese nta-
tive of core body temperature. 
Esophageal Temperature. As will be d isc ussed 
furth er, esoph ageal temperature in the anestheti zed 
patient who does not experience sudden hea t loss o r 
heat ga in somewhat represe nts core temperature in 
reference to central temperature . However, one has 
to rea lize, as J. D. Whitby and L. S. Dunkin have 
shown, that the esoph ageal temperature recorded 
in the anes theti zed and intubated patient depends 
on the site of the esophagus at which it is taken. 
The longitudin al va riation is greate r than the lateral 
and can be by as much as 6°C. The lowest tempera-
tures are found in the upper and middle third of 
the esophagus. Both longitudinal and lateral va ria-
tions level out in the lower third . The lower fourth 
of the esoph agus is both the warmest and the most 
stable. To reach this a rea, thermocoupl e leads should 
be inserted 45 cm from the nostril. This area is sit-
uated in the lower medi astinum below the pulmonary 
vein and between the heart and the descending part 
of the ao rta. Carlsten and Crimley have shown that 
the esophageal temperature closely fo llows the tem-
perature of intraca rd iac blood. 
Tympanic Temperature. The tympanic mem-
brane tempera ture, because of its prox imi ty and 
similar blood supply, is ve ry close to the central 
temperature. By plac ing a thermocouple in juxta-
position to the tympanic membrane, T . H. Be nzinge r 
has shown that its temperature accurately refl ec ts the 
temperature of blood coursing th rough the bra in 
(fig. 3) . With the use of gradiant ca lo rimetry. he has 
demonstrated that the changes in tympanic tempera-
ture a re concordant with one of the th ermoregul atory 
refl exes, namely the sweat rate , whereas skin tem-
perature changes do no t refl ect sweat rate and are 
paradoxical and discord ant. 
Figure 4 a, from Benzinger's study shows tha t 
when some subjects swallowed ice. crani al tempera-
ture decreased. At the same time, the sweat rate 
showed a parallel heat loss which was repeatedly 
constant. 
Figure 4b shows the sa me subjects. When they 
swallowed ice, their skin temperature increased while 
at the same time their sweat rate, o r hea t loss, de-
creased ( discordant relationship) . 
Clinical Thermometry in the Operating Room. 
In a group of about 30 patients ( mostly adult ) 
undergoing general anesthesia and surgery, con-
tinuous body temperature measurement was made 
from a thermocouple pl aced aga inst the tympanic 
membrane. Thi s source was compared with con-
tinuous and simul taneous measurements from the 
esophagus and rectum . The period of compari son 
ranged from 1.5 hours to 12 hours, depending on the 
length of the operation. and the time the pat ient 
spent in the recove ry room. For the rectum and the 
esophagus, a soft pl astic probe wi thout co tton cover 
was used. For the tympanic membrane, a probe with 
a special "Q-tip" was used . 
Each thermocouple was connected to a monitor-
ing recorder, and th ree temperatures being monito red 
were transcribed directl y to a Leeds and Northrup 
Company, Speedomax continuous writer.' 
F ig. 3-T ympa nic thermometer consisting o f disposab le 
thermoco uple int roduced into ex te rn al a udito r y cond uit. 
( Reprinted with pe rmi ssio n fro m Bild Der Wisse11scl,a/1. 
Vo lume Three, Jul y. 1964. a nd fr o m T . H. Benzin ge r.) 
• We woul d lik e to th a nk Leeds a nd Nor th rup Com-
pa ny fo r prov iding the mo nito rin g eq uipme nt . a nd also 
ack nowledge th e suppo rt o f Dr. Jo hn L. Patterson. Jr .. 
Directo r. Ca rd iopulmonary La bs a nd Resea rch. a nd Dr . C. 
Pa ul Boyan. C ha irman. Depa rtm ent o f Anest hesio logy. 
138 RAFII : BODY TEMPERATURE DURING SURGERY AND ANESTHESIA 
Figure 5 shows simultaneous monitoring of rec-
tal, esophagea l, and tympanic temperature in a pat ient 
during ope n heart surgery. Immed iately after the by-
pass there is a profound fa ll in body tempera ture. 
(From a tympanic temperature of 37 °C to 32 °C). 
let 
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This has prompted some cl inicians to advocate this 
technique in patients with fulmin ant hyperthermia 
to lower the body temperature . Figure 5 also shows 
the deviations of recta l temperature from tympanic 
and esophageal under the conditi ons of extracor-
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Fig. 4a- Co nco rdant pa tterns of swea tin g rate and cra ni al ( tympanic) temperatures obse rved during repeated ora l in gestion 
of ice. ( Repr inted wi1h perm ission from Masson et C ie !eds.] Les Concepts de Claude Bernard Sur Le Milieu lnterieur. Paris: 
Libraires de L'Academ ie de Medec ine . 1967. and from T. H. Benzinger.) 
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Fig. 4b- Disco rdant natterns o f swea ting a nd sk in temperat ures obse rved durin g repea ted oral in gestion o f ice. ( Reprinted 
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RAFII: BODY TEMPERATURE DURING SURGERY AND ANESTHESIA 139 
40 
38 
t 36 
~ ~ 34 
" i5 
" 
32 
'Ii 
~ 30 
28 
26 
20 
0 
BODY TEMPERATURE DURING E C C 
48WF • tlJ8 lbJ. 
&,.Pon 
40 60 
' ' 
M / TRAL OAII SSUROTOM Y 
OPCRATI NG ROOM 2$ j •( 
Wo""illQ OttF\lmp Clotur, 
- £AR ORUM 
- - - IIC"CTA L 
- ESOPHAGEAL 
80 I()() 120 140 160 180 
TIME (Minutes ) 
TIME (Hours) 
Fig. 5-Simultaneous monitoring of recta l, esophagea l. a nd 
tym panic temperatures o n a patient undergo ing open hea rt 
surgery. 
poreal circula tion. It represents the fact tha t myo-
cardial temperature , which is more in line with 
tympanic and esophagea l temperature, can be much 
lower than rectal temperature at the terminati on of 
the by-pass . It also demonstrates that sole reli ance 
on rec ta l temperature will result in not recognizing 
the cold myocardium , and this may cont ribute to the 
difficulty in recove ry of the hea rt during open heart 
surgery. 
Figure 6 shows another example of a patient 
undergoing o pen hea rt surge ry with multiple "crash 
cooling" and " rewa rm ing" peri ods during extracor-
po rea l circulation. A simila r deviation between rec tal 
and esoph ageal. and tympanic temperature is noticed. 
Figure 7 shows the rewarming period and acci-
den tal overh ea ting of a pa ti ent under ex tracorporea l 
c ircula tion with multiple "crash cooling" periods. It 
can be see n th at in case of accidental overheat ing, 
the devi ations between diffe rent sites of temperature 
d iscussed in figure 5 can exist. 
Hypothermia During Anesthesia and Surgery. 
During clinical thermo metry we noticed, as others 
have, that under modern operating room conditions 
( humidity of about 50 % and temperature between 
68 °F and 75 ° F) the majo rity of patients undergoing 
diffe rent types of surgery had some degrees of fall in 
body temperature . Depending on th e type and length 
of the operation , some pati ents could develop pro-
fo und hypothermi a. 
Man being a homothermic animal has the 
ability to maintain his norm al body temperature re-
gardless of environm enta l temperature . An anesthe-
ti zed man loses this ability. He becomes somewhat 
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poikiothermic and follows the environmental tem-
perature which, in such circumstance, is th at of the 
operating room. 
By depress ing the central nervous sys tem, anes-
thetic agents depress the center of temperature regu-
lation thus decreas ing body temperature and contri-
buting to the fa ll of temperature in the anestheti zed 
patient. Sir George Pickering has emph as ized this 
fac t, by saying, "The best way to cool a patient is to 
anesthet ize a patient. " 
Anesthetic agents cause cellul ar depress ion and 
decreases in metabolism and heat production . The 
effec t of these agents on the "shivering center" and 
on the periphery in concert with mu scl e relaxants 
will block the act of shi vering, and as long as the 
pat ient is anesthetized and para lyzed. no compensa-
tory mechanism for heat gai n ex ists. The fact that 
peripheral circulat ion has lost the capability of con-
striction will contribute further to the magnitude of 
heat loss in the anest hetized patient. 
Premed ication with any of the usual drugs has 
the effect of relax ing muscle tone, thus making the 
patient more susceptible to a fa ll in body tempera-
ture when taken into a cold operat ing room. On re-
covery from anesthes ia, thermostatic refl exes appear, 
and if the body temperature is lowered , shive ring and 
cutaneous vasoconst rict ion occur with a concomit ant 
rise in oxygen consumption. The grea te r the fa ll in 
temperature, the grea ter the oxygen consumption 
during the recovery period. 
In comparison with other anesthetic agents used, 
halothane can cause more heat loss during anes-
thes ia, more shivering at the termin ation of anes-
thesia, and more rise in oxygen consumption . 
The importance of increased postoperative oxy-
gen consumption may be considerable, particul arly in 
patients with preexisting respiratory or circulatory 
disease. 
In the event that a postoperative airway obstruc-
tion ex ists , the patient will not be able to tolerate 
anox ia if, because of increased oxygen consumption 
due to shivering, the ventilation demand is increased. 
In patients with abdominal incisions and thoracot-
omy, increase in ventilatory demand may present 
postoperative difficulties. 
Increase in oxygen requirement will also increase 
demands on circulation. Pati ents with cardiovascular 
problems and unreplaced blood loss will be further 
handicapped in dealing with thi s. During recovery 
from hypothermia, the rewarming acidosis can con-
tribute greatly to morbidit y of heat loss during 
anesthesia. 
Robert M. Morris' study on the relationship be-
tween operat ing room temperature and the tempera-
ture of the anesthetized patient shows th at a signifi-
cant linear correl ation exists between the patient's 
esoph ageal temperatures and their operating room 
temperatures. He class ified the operating rooms ac-
cording to their effect on patients' temperature : (I) 
rooms below 21 °C in which all patients became 
hypothermic ; (2) 21 ° to 24 °C (70 ° to 75 °F) rooms 
in which 70% of the patients remained normother-
mic and 30% became hypothermic ; and (3) 24 ° to 
26°C (75 ° to 79 °F) rooms in which all patients 
remained normothermic. H e concluded that , 2 1 °C 
can be class ified as the "critical ambient tempera-
ture" for lightly anesthetized paralyzed adults. 
Boyan and his assoc iates have shown that if, 
in addition, large amounts of cold blood are trans-
fused, the fa ll in temperature can be greater. A con-
tributing fac tor to this is the cold solution used for 
prepping. Deep anesthesia (with o r witho~t muscle 
relaxants) can also cause great heat loss. Since basal 
heat production decreases with age, the resultant heat 
deficit is greater in the elderly . 
In addition to heat loss, secondary to vasodila-
tion and decreased heat production, the opening of 
the abdominal cavity is an important factor with 
the anesthetized patient. Inside the peritoneal cavity 
is a large surface from which much heat can eva-
porate, and irrigation of the peritoneal cavity with 
cold solutions leads to increased heat loss. At a com-
fortable operating room temperature (20° to 22 °C) , 
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Fig. 8-Body tempe rature during anest hesia and operat ion. (Intra-a bdomina l) 
most pa tients experience a fall in body tempera ture. 
Figure 8 emphasizes the effects of age ( 85 years 
old), the type of operation (intra-abdominal). the 
length of proced ure ( 5 1/ 2 hours), and cold ambi ent 
temperature ( operating room temperature 21 . 1 °C) 
on the extent of the fall in body temperature. At 
times during the procedure, by means of a warm 
blanket, an effort was made to warm the pati ent. 
In spite of this effort , the drifting of hypothermia 
took place, and the patient rega ined a normal body 
temperature only after he was taken to the recovery 
room (temperature 26.6°C). 
This is in concert with the obse rvation of 
Robert M. Morris and his associates that a warm 
blanket under the paralyzed and anesthetized ad ult 
is no substitute for a warm operating room. One can 
see from this experim ent that in the event of slow 
and progressive heat loss, there are minimal devia-
tions in the monitoring of the different sites of body 
temperature. But under clinical circumstances when 
one can expect sudden heat gain and heat loss, we 
believe that it seems more important to use tympanic 
or esophageal monitoring of tempera ture. 
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Nitrous Oxide-Curare Anesthesia: Reappraisal* 
RICHARD L. KEENAN, M. D. 
Chairman, Department of Anesthesiology, 
The Roosevelt Hospital , New York , New York 
Of the many inhal ation drugs available today, 
nitrous ox ide is the only one which is both non-
ex plosive and non-tox ic. Although the compound is 
rarely listed as a primary agent , it is used on almost 
every patient. The usefulness of nitrous oxide tends 
to be dismissed because it is considered to be rela-
tively weak. However, with the continuing trend 
toward lighter anesthesia see n during the past qu ar-
ter century, this viewpoint is no longer reasonable. 
The fac t th at MA C for haloth ane can be reduced 
to one third by the addition of 70 % nitrous oxide 
attests to the drug's potency. 
The ex perience of many prac ticing anesthetists 
throughout the United States indicates that anesthetic 
administration currently is more striking in its simi-
lar ities than in its differences. It may even be said 
that a universal modern anesthetic sequence has 
evolved ( fig . I ) . First, almost eve ryone uses thio-
MOD ERN ANESTH ETI C SEQUENCE 
I . T HIOPENTAL INDUCTION 
2. N ITROUS OXIDE 
J. MUSCLE RELAXANT 
4. (ADJUNCT I VE AGENT) 
Fig. I- Modern anes theti c seq uence. 
pental or some other barbiturate for induction , as a 
soc ial necess ity. Second , nit rous ox ide in a concen-
tration of 50% to 70% is invariably empl oyed dur-
ing the mai ntenance phase of anesthesia. Third, a 
muscle rel axant is use·d in most major cases, both to 
facilitate intubation and to produce surgical rel axa-
tion. Deep anes thesia is almost never relied upon. 
Finally, some other drug, perhaps halothane, ether, 
* Prese nted at th e 25th Annu a l Stoneburner Lecture 
Series, February 26 , 1972 , a t the Med ica l Co llege o f Vir-
ginia, Richmond. 
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or Innovar may be adopted-in conjunction with 
nitrous oxide-for the maintenance of anesthesia. 
According to tradition this is called the primary 
agent. But with the aforementioned trend toward 
very light anesthesia, more often than not, this agent 
is adjunctive in nature. In fact, in some instances, 
an adjunctive drug is not used at all . 
In the I 950's the British developed a technique 
in which very large doses of curare were used in 
combination with nothing more than nitrous oxide 
to produce the condition of anesthesia. No other 
adjunctive drug was used for maintenance. In this 
way, explosive agents were avoided. The process 
became known as the "Liverpool Technique" (Ged-
des and Gray, 1959). Part and parcel of the Liver-
pool Technique was the intentional production of 
respiratory alkalosis by hyperventilation. It was felt 
that alkalosis increased the depth of anesthesia. In 
recent years, however, the depressant effects of this 
condition have been questioned and, indeed, alka-
losis itself has been shown to be not without its 
hazards. 
During the past four years, we at Roosevelt 
Hospital have been increasingly interested in avoid-
ing not only explosives but also potentially toxic 
agents. We have adopted essentially the Liverpool 
Technique (that is , nitrous oxide without supple-
mentation, and curare) and modified it in two major 
aspects: we have employed normal ventilation, and 
we have modified the curare dosage. To date this 
technique has been applied to approximately 3,200 
patients. 
Technique. Figure 2 is a step-by-step descrip-
tion of the technique as we have employed it. Pre-
medication has been variable, but we prefer a 
narcotic in the usual clinical doses. Thiopental is 
used for the induction of anesthesia in a dosage 
sufficient to abolish the lid reflex. One hundred per-
cent oxygen is administered by mask for about two 
minutes, e ither prior to or immediately after the 
thiopental, and then after intravenous succinyl-
M CV QUARTERLY 8(2): 14 2,147 , 197 2 
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}. PREMEDICATION : NARCOTIC PREFERRED 
2. THIOPENTAL, 4-8 mg / kg 
3. o, 100' '0 2 MIN. 
4. SUCCINYLCHOLINE I mg / kg 
5. INTUBATION 
6. N ,O 3.5 L. O, 1.5 L. 
7. VENTILATOR, MV = 90 ml / kg 
8. CURARE: BY DOSAGE SCHEDULE 
9. REVERSAL: NEOST IGMINE 2.5 mg 
ATROP INE 1.0 mg 
I 0. DEC,SION TO EXTUBA TE 
Fig. 2-Rooseve lt Hospital's adapta tion of the Live rpoo l 
Tech nique. 
choline, endotracheal intubation is carried out. Im-
mediately after intubation, nit rous ox ide 3.5 liters 
and oxygen 1.5 liters are allowed to fl ow into the par-
tial rebreathing ci rcle system. This fl ow is then main-
tained throughout the remainder of the operation . 
A mechanical ventil ator is employed in all instances 
promptly after intubation. The ventil ator is set to 
deliver a calculated minute volume of 90 ml per kg. A 
relatively slow respiratory rate , approx im ately 8 to 
10 per minute, with a relatively large tidal volume 
is preferred. The minute volume is routinely checked 
with a Wright vent ilometer. With signs of returning 
muscle power following succinylcholine, curare is ad-
ministered by a dosage schedule described in figure 5. 
Full curarization is maintained th roughout the pro-
cedure. At the termination of the surgical procedure, 
reversal of curare is accomplished with the use 
of neost igmine 2.5 mg and a tropine l mg given 
simultaneously intrave nously and repeated once if 
necessary. Finally, a decision to extubate is made 
by clinical means. If the patient is capable of cough-
ing vigorously on the endot racheal tube and of usi ng 
his upper intercostal muscles to take a deep breath, 
and can lift his head off the table, the endot racheal 
tube is removed. If not, the patient is taken to the 
recovery room where mechanical ventilat ion is con-
tinued until full motor power returns spontaneously. 
It should be noted that the above desc ription of 
the nitrous ox ide-curare technique contai ns nothing 
really extraordinary. Mechanical ventil ation perh aps 
is not commonly employed , but it is generally ac-
cepted in modern anesthesia. Everything else on the 
list is very much a part of standard practice every 
day everywhere th roughout the United States. In-
deed, this sequence is really an example of the basic 
structure on which an anesthetic in this day and 
age is often built. What is surpri si ng about the list, 
therefore, is not what is on it but what is missing 
from it. Note that there is no ad junctive drug listed. 
Or to use the more traditional terminology, there is 
no prim ary age nt. Once the nit rous oxide is begun 
and the cura re is given, no other agent is admin-
istered , ei ther int ravenously or by inhalation. Nitrous 
oxide is relied upon totally to produce unconsc ious-
ness, and curare is relied upon totally to keep the 
patient on the table. 
Memory. The most significant question about 
this technique is whether 70% nitrous oxide by itself 
is enough to produce unconsc iousness reli ably in all 
patients. The only way to answe r thi s is with the 
evidence of extensive ex perience . As mentioned 
earlier, we have used this technique fairly widely 
in all age groups on approxim ately 3,200 adult 
patients and in all types of surgery with the excep-
tion of intrathoracic procedures. Approximately two 
thirds of the cases were intra-abdominal. The tech-
nique has been used in operations ranging from one 
hour in length to well in excess of 6 hours, with an 
average of th ree hours, and it has been adopted for 
patients representing all grades of ASA physical 
status from I to 5, although the majori ty were either 
2 or 3. As of this date , we know of no pat ient of the 
3,200 who were ac tually receiving 70% nitrous 
ox ide, who had any pain or any other conscious 
memory of the surgical procedure. 
We did have five pat ients who remembered 
certain things due to a break in technique. Four 
of the five remembered either intubation or extuba-
tion. As a result , we have begun to use liberal 
amounts of induction thiopental and to continue 
nit rous oxide up to the moment of curare reversal. 
In one patient, a bri ef period of memory did occur 
during the operation. This patient remembered 
severe pai n and a conversation which we knew did 
occ ur. On further investigation, howeve r, we found 
that just before the period of memory the anes-
thetist had disconnected the endotracheal tube for 
suctioning for approximate ly 20 seconds. During 
this time the ventil ator continued to operate . It 
emptied itself of nitrous oxide and drew air into 
the system through the open connector. For the next 
several minutes the patient received air instead of 
nitrous oxide. 
We conclude that nitrous oxide in a concentra-
tion of 70%, does prevent memory totally and in all 
patients. However, the slightest break in technique 
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can result in memory and must be gua rded against 
continuously. 
Ventilation. A mechanical ventil ator has been 
utili zed in all cases in our experience. In addition, 
a Wright ventilometer is routinely used to verify the 
presence of proper minute volume. We have selected 
a figure of 90 ml per kg body weight fo r est imation of 
the minute volume on the bas is of prior experience, 
both in the operating room and in our respirato ry 
intensive care unit where a rteri al blood gas analysis 
revealed a PaC0 2 of between 35 and 45 mm H g in 
most patients. This fact has also been documented 
in a study independent from ours (Ocbo and T erry, 
1969) . 
Our real conce rn , however, was whether, with 
normocapnea, adequate a rterial P02 levels could be 
reliably p roduced. We fo und in our early stud ies on 
healthy patients undergoing abdominal surgery, that 
PO/s in excess of I 00 mm Hg were produced rou-
tinely. However, in an attempt to look at the worst 
poss ible c ircum stance, we also studied 16 patients 
unde rgoing abdomin al ao rti c graft procedures with 
70% N20-cura re anesthes ia. Serial blood gas deter-
minations during surgery yielded the results li sted 
in figure 3. In no case was the P02 eve r below 60 
Abdomina l Ao rt ic Grafts 
Mean Age 68 - 7 (S.D.) 
ASA Sta tus 2 - 4 
Lowest PaO, N umber 
Under 60 0 
60 - 69 4 
70 - 79 6 
80 - 89 
90 - 99 3 
100 + 2 
Total 16 
Fig. 3- Serial blood gas de term inat ions during surge ry with 
N :O·curare anesthesia. 
mm Hg, and in 12 of the 16, the lowest P02 recorded 
was above 70 mm Hg. While this does not indicate 
lush oxyge nation, these P02 va lues p roba bl y do 
represe nt th e no rm al levels fo r this age group. The 
average PC0 2 in this se ri es was 38 mm Hg. It is 
worth repea ting that a ve ry slow ventil ato ry rate, 8 to 
IO per minute with a rela ti ve ly high tida l volume, was 
employed. It has bee n our ex perience that this venti -
30 
20 
20 
NUMBER 
OF 15 
PATIENTS 
10 
.26-.30 .31 - .35 .36 - .40 '.41- ... 5 .46-.50 .51-.55 .56 - .60 
INI TIAL CU RARE , mc;i /k9 
Fig. 4-Graph showing study o f cu rare dosage necessary 
to prod uce para lys is. 
latory pattern yields consistently higher P02 values 
than a rapid , shall ow pattern . 
We conclude that with normocapnea, adequate 
oxygenation can be produced, so long as the ventila-
tory pattern is p roper, and so long as patients with 
severe int rapulmonary shunt ing, such as occurs in 
intra tho rac ic surgery, are avoided. 
Curare Dosage. Traditionally, a clinically effec-
ti ve single dose of cura re is sa id to be in the range 
of 0.5 to 0.6 mgm per kg body weight. In a se ries of 
I 00 cases of patients undergoing elective surgery 
with thiopental-N20-0 , anesthes ia , we found that a 
dose of 0.3 mg per kg produced a clinically adequate 
degree of paralys is in about half the patients, as seen 
in figure 4 . 
F rom this expe rience we developed the curare 
dosage schedule outlined in figure 5 . A dose of curare 
is calculated on the bas is of 0.3 mg per kg and is ad-
mini stered to each patient. If this is not suffic ient to 
CU RAR E DOSAGE SCH ED U LE 
J. IN IT IAL 
a) 0.3 mg / kg 
b) IF INSUF FIC IENT. I ml INCREMENTS 
2. SUBSEQUENT DOSES 
a) G IVEN rj 20- 40 MIN 
b) EACH DOSE = /; PREVIOUS DOSE 
Fig. 5- 0 utl ine o f curare dosage sc hed ul e. 
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24 
CURARE, 
mQ 12 
TIME, HOURS 
Fig. 6- Dosage schedule of cura re adm ini st ratio n. 
abolish all coughing and respiratory ac tivity , add i-
tional curare is administered in I ml (3 mgm) incre-
ments until all gross motor ac tivity ceases. The total 
amount of curare is noted at this point, and becomes 
the basis for a ll subsequent doses. Each subsequent 
dose needs be only one half its previous dose , and it 
is required eve ry 20 to 40 minutes when signs of 
returning muscle activity occ ur. When a dose of 3 
mgm is reached, it is repeated , without halving, as 
necessary. An example of a dosage schedule in a 
typical case is shown in figure 6. 
Using this dosage schedule, we have been able to 
1.7 
1.5 
1.3 
I.I 
TOTAL 
CURARE 
m9/k9 .9 
.7 
.5 
.3 
. I 
Y• .37+ . 002 X 
R• ,667 
"• 100 
. . 
. 
.. 
. . 
. . .. . . . 
• • ~ • • • I 
. . .. . .. 
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. . .... 
::,·: 
. :• 
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ANESTHESIA TIME, MINUTES 
Fig. 7-Graph showing total curare dose as measured 
against duration of anesthesia in I 00 cases. 
reliably produce adequate continuous curarization 
with reasonable total curare doses. Figure 7 is a plot 
of the total curare dose in one hundred consecutive 
cases aga inst the total duration of anesthesia . Total 
dose was clearly related to time. More important , 
the average dose was approximately 0.7 mg per kg 
which, for the average patient , represents a total of 
50 mgm curare during a 3-hour anesthetic. This 
compares very favorably with the ex perience of the 
British . 
Blood Pressure Changes. Significant hypoten-
sion incident to the ad mini stration of clinical doses 
of curare has been reported (Thomas, 1957). Tn our 
ex perience, however, this has not been a problem. 
Figure 8 is a compilation of the lowest and highest 
blood pressures noted in I 00 patients, as measured 
by the cuff method, during the twenty minutes fol-
lowing the initi al curare dose. While some patients 
responded with very low-and some with very high 
- blood pressures, the majority showed only mild 
changes, and no definite trend of clinical significance 
could be discerned. 
Figure 9 is a plot of the degree of hypotension 
seen in those 55 patients in the series who suffered 
a fa ll in pressure, versus the dosage in each case. We 
could discern no dose-response relationship . We con-
clude that while curare has been reported by others 
to cause hypotension it does not do so to a clinically 
significant degree in the dosage range employed in 
this se ries. 
Curare Reversal. Early in our experience we 
noted an occasional patient who was unable to main-
tain adequate spontaneous ventil ation following the 
ad ministrat ion of neostigmine, even though these 
patients had not received excessive doses of curare . 
This was surpri sing in view of the well-documented 
fact that neostigmine is a highly predictable antago-
nist for cu ra re (Bridenbaugh and Churchill-David-
son, 1968; Katz, 1967) . However, review of these 
cases disclosed the fac t that many had received 
intraperitoneal antibio tics of the type known to pro-
duce mu scle paralysis ( Pittinger, et al .. 1970) , and 
all the others had been eith er hypothermic or hypo-
volemic a t the time of attempted curare reversal. 
These factors have been shown to delay significantly 
the redistribution of curare (Dal Santo, 1964 ) . Fol-
lowing this discovery we instituted the practice of 
omitting neostigmine reversal in those patients who 
had received intraperitoneal antibiotics, who were 
hypoth ermic, or in whom a hypoperfu sion state was 
judged to be present. The endotracheal tube was left 
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Fig. 8-Blood pressure readi ngs of 100 patients fo ll owing induct ion of cura re. 
in place, and muscle powe r was allowed to return 
spontaneously while the pati ent was ventil ated me-
chanically in the recovery room. After the institution 
of this prac tice, experience in 100 consecutive pa-
ti ents was reviewed and is summarized in fi gure I 0. 
Eighteen patients were intentionally not reve rsed ; of 
these, six had unde rgone procedures, such as ab-
domin al aortic grafts, in which pos to perative me-
chanica l ventilation is utili zed in our institution as 
70 - . . 
• . . 
~~lJi~~i 50 L •• . 
Foll , mm H9 
.... . .. 
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Fig. 9-Graph showi ng degrees o f hypote nsion in pat ient s 
as measured aga in st ind ivid ua l c urare do sage. 
a matter of course. H ypoperfusion , hypothermi a, the 
use of intraperitoneal antibiotics, or a combination 
of these, were present in all other instances. 
Of the 82 cases in which neostigmine was em-
ployed, only one fa iled to develop adequate spon-
taneous ventil ation, and in this one case, severe 
hypovolemia from unrecognized surgical blood loss 
was noted sho rtly the reafter; spontaneous ventilation 
returned with the transfusion of two units of whole 
blood. We conclude that neostigmine is indeed a 
predictable antagonist for curare so long as the pa-
thologic conditions noted above a re excluded . 
Conclusions . 
1. Seventy percent N20 , as a sole depressant 
agent , is adequate to prevent pa in -and mem-
ory in 100% of cases. There is no evidence 
CU RA R E NOT R EVERSED : 18 PATI ENTS 
I. PLANNED POSTOP. VENTI LATION 6 
2 . H YPO PERFUS ION 7 
3. H YPOTHERM I A 6 
4. I. P. ANT IBIOTIC 7 
Fig. I 0-Results of rev iew where cura re was no t reversed. 
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that it is ever inadequate as an anesthetic, 
even in deep intra-abdominal operations. 
Therefore, with this technique, the use of 
other potent depressant agents either by in-
halation or by vein is unnecessary. Major 
organ toxicity is thus avoided, and recovery 
from anesthesia is prompt. Furthermore, 
major cardiovascular abnormalities occur-
ring during surgery can be assumed to be 
due to factors other than anesthesia, since 
neither N20 nor curare alter cardiovascular 
function significantly. 
2. Curare dosage need not be excessive . When 
used according to the recommended sched-
ule, it is well within the range known to 
be successfully antagonized with neostigmine 
and below the level known to produce sig-
nificant hypotension. 
3. Hypoxia need not occur, so long as me-
chanical ventilation is properly applied and 
meticulously measured. Whenever there is 
doubt, arterial blood gas analysis should be 
available. 
4. Curare reversal has proved to be successful 
in all cases except in those instances in 
which there is some pathologic process 
which delays curare redistribution such as 
hypovolemia, or hypothermia, or in those 
instances in which intraperitoneal antibi-
otics are used. In those cases, one must be 
prepared to utilize postoperative mechanical 
ventilation . 
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Myocardial Infarction After General Anesthesia* 
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A survey by the Na tional Center fo r Health 
Stati stics estim ated th at there were 111 . 1 million 
adults in the United States be tween 18 and 79 yea rs 
o f age during th e yea rs 1960 to 1962. Of these, 3. 1 
million had definit e, and 2 .4 million had suspected , 
coronary heart disease . Definit e myocardial in fa rc-
tion had occurred in an es timated 1.4 million adults 
( USN C HS, 1965 ). The number of pati ents with coro-
nary heart disease. or myocard ial in fa rction, who 
require some fo rm of surgical opera tion will increase 
steadily as th e popula tion increases . Considering th e 
stress o f anesthes ia and surgery. these pa tients pre-
sent problems related to their specific cardi ac pa-
thology. 
In spite of these la rge numbers. few stati sti cs 
are ava ilable about the inc idence of primary o r re-
current myocardia l in fa rction after anes thes ia . Mor-
tality rates and their re lation to age and sex , and to 
type and duration of anesthes ia in ex ist ing reports. 
are based on a relati ve ly small number of cases . Thi s 
revi ew attempts to provide additional da ta on these 
ques tions by analyz ing a 2-yea r experience in a large 
anestheti c practice . 
Material and Method. During the yea rs o f 1967 
and 1968 , 32,877 patients 30 yea rs o f age and over 
underwent some fo rm of ope ration o r di agnostic p ro-
cedure under general anesthes ia at our instituti o n. 
Cardi ac o perations were not included . A mong these, 
422 pati ents had evidence of previous myoca rdia l 
infa rction by history or by elec trocardiography be-
fo re opera tion. Their distribution fo r these yea rs is 
shown in T able I . T wenty-e ight o f them ( 6.6 % ) re-
* Deli vered by Emerso n A. Moffitt. M .0. a t the 25t h 
Ann ua l Sto neb urne r Lec ture Se ries, Feb ura ry 26. 1972 . a t 
the Med ical Co ll ege o f Virgi ni a. Rich mo nd. Reprint ed with 
permissio n from the Journal of the American Medica l As-
socia1io 11 , 220: 1451 - 145 4, 1972. 
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infa rcted after operation during the fi rst week, as 
indicated by clinical sy mptoms, elec trocardiogram 
( ECG) . enzyme studies, or postmortem examina-
ti on. Forty-three other patients also had infa rctions 
during this sa me postoperative period-0.13 % of all 
patients without previous history of myocardial in-
fa rction, having anesthes ia ( T able I). 
The rela tionship of patients with previous myo-
ca rdi al infa rction to surgical po pulation by age and 
sex, and their rein fa rction rat io, is shown in T able 2. 
Myocardial infa rction is primarily a disease of men. 
O f every 1,000 anestheti zed , 12.8 patients had had 
a p revious myocardial infa rcti on. Fifteen of 28 pa-
tients died afte r reinfa rction ( 54 % ) , with 12 of 
these dea ths occurring during the fir st 4 8 hours after 
myocard ial infa rction ( 80 % ) ( T abl e 3 ) . F orty-three 
o f th e 7 1 pati ents who infa rcted had no previous evi-
dence of myocardia l infa rction, but 16 had known 
coron a ry hea rt disease with angina. The other 27 had 
no history of coronary disease, but 6 of them were 
TA BL E I. Incidence o f myocardia l infa rc tio n rela ted to 
previous in fa rction. 
History 
Previo us 
myocardia l in fa rctio n 
1967 
1968 
To tal 
No previous 
myocardial infarction 
1967 
1968 
Tota l 
Genera l 
anesthesia 
(no.) 
2 18 
204 
422 
15. 597 
16.858 
32 . 455 
I 
Myocard ia I 
in farct ion 
I Set wk post op 
1~ -1-~-
13 6.0 
15 7 . 4 
28 6 . 6 
19 0 . 12 
24 0. 14 
43 0 . 13 
M CV QU ARTERLY 8(2): 148- 153. 1972 
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TABLE 2. Relation of myocardial infarction to previous infarction and to surgical population. 
Total previous 
General myocardial 
anesthesia infarction / 1,000 
Age (no.) anesthetics 
30 to 39 4 .081 0 . 7 
40 to 49 6 ,906 3.6 
50 to 59 8 ,825 10. 5 
60 to 69 8.375 20.9 
70 to 79 4 .051 27.9 
so+ 639 20 . 3 
Total 32. 877 12 .8 
diabetic and IO had hypertension requiring treat-
ment. The mortality rate of these first infarctions is 
also high . 
The patients received a variety of general anes-
thetic agents and muscle relaxants (Table 4) without 
influencing the incidence of reinfarction. Duration of 
anesthesia ranged from 20 minutes to 6 hours , yet 
the incidence of reinfarction did not change as time 
increased (Table 5). 
The relationship of site and type of operation 
to recurrence of myocardial infarction is shown in 
Table 6. When analyzed by the chi-square test , the 
reinfarction ratio in operations of the thorax and 
upper abdomen was significantly higher (P < 0.001) 
than for other types of operation (Table 6). 
The relationship of incidence of postoperative 
infarction to interval since previous myocardial in-
farction is shown in Table 7 . Thirty-seven percent of 
patients operated on within 3 months of myocardial 
infarction had postoperative reinfarctions. This de-
creased to 16% in patients between 3 and 6 months 
Myocardial infarction Myocard ial infarction 
in men in women 
Previously ,-~~~-Previously Again postop 
3 
24 2 I 
75 5 18 
147 13 28 
90 6 23 I 
10 I 3 
349 27 73 I 
after infarction, and remained 4 to 5 % in patients 
more than 6 months after previous infarction. 
The figure depicts the distribution of myocardial 
infarction on various postoperative days. There were 
significant day-to-day differences in the frequency of 
myocardial infarction , the third day being highest 
(P < 0.01) . 
Six of the 28 patients did not have chest pain 
with reinfarction . Suspicion of an acute infarct came 
from the postoperative ECG, or from clinical findings 
such as irregular pulse, leading to a full investigation. 
Discussion. Coronary heart disease may begin 
early in adult life, but rarely manifests itself before 
45 years of age. Myocardial infarction is much more 
common in men than women, and its prevalence 
rises with age, the 65 to 74-year-age group having 
the greatest incidence . This was also true in the 
surgical population, yet the reinfarction ratio did 
not change significantly in our study for older age 
groups. Our present study also indicates that pa-
tients with previous myocardial infarction who have 
TABLE 3. Preoperative heart disease and myocardial infarction after general anesthesia. 
Myocardial infarction in first wk postop 
Deaths 
In 48-hr-postoperative 
Total myocardial infarction 
Preoperative 
status Cases No. % No. % 
Myocardial infarction 28 15 54 12 80 
Coronary heart disease 
Known 16 14 87 9 64 
Unknown 27 15 56 11 73 
Total 71 44 62 32 73 
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general anes thesia and surgery have a SO-times 
greater chance of rein fa rction th an those who do 
not have a history of myoca rdial infarction. 
R eports on rates of postoperative myocardia l 
infarction differ widely . Bae r, et al ( Bae r, et al., 
1965) report that 41 of 150 patients older than 30 
yea rs of age had myocardia l infa rction after opera-
tion. Walker and Macdess i (Walker and Macdessi, 
1966) found evidence of myocardi al infa rction 
among 26 of I 00 patients older th an 65 yea rs. 
Patients in both these studies were ra ndomly selected 
and some had previous myocardial infarction or evi-
dence of coronary heart disease. Kn app, et al 
(Knapp, et al., 1962) reported that among 427 pa-
tients with a previous hi story of coronary occl usion, 
26 had reinfarctions. Arkins, et al (Arkins, et al., 
1964) collected a series of 240 patients with previous 
myocardial infarction, of whom 54 died during the 
first 2 months postoperati ve ly. Mauney et al ( Mau-
ney, et al., I 970) relates a prospec tive study in which 
30 of 365 patients, age 50 yea rs or over. had myo-
cardi al infarction afte r operation, with l 6 dea ths. 
Comparing these figures is difficult because of 
th e wide variety of factors in vo lved such as age , type 
of hospital , methods of diagnosing myoca rdi al in-
farction, other preex isting illnesses, kind of o pera-
tion , and postoperative care. However. one conclu-
sion is common to all report s : the high incidence of 
postoperati ve myocardia l in fa rction in patients who 
had had previous infarction , even when the infarc-
tion was long before operation. 
Fifty-four percent o f our patients who had pre-
vious myocardial in fa rction d ied as a result of re-
current myocardi al infarction (similar to the 53 % 
mortality cited by Mauney, et al [M auney, et al., 
I 970]). By comparison the morta lity rate from myo-
cardi al in farc tion in a genera l hospital is approxi-
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TABL E 4. Relation of myocardial infarctio n to anesthetic 
agents . 
Myocardia l infarction 
Agents and mi xtures 
-1--1---Previ- Again '1o 
o usly postop again 
Thiopenta l. 0 ,. N ,0 , tubocurarine 
With methoxyfiura ne 57 5 8.8 
With halothane 268 18 6. 7 
With ether 66 4 6. 1 
With pen tazocine 
Thiope nta l. 0 ,. N ,O 21 
With ha lot hane, galla mine 
With gall am ine 
With cyclo propa ne 
Thiopenta l. d iazepam 2 
Thiopenta l. 0 ,. surgica l infiltrate 
lnnovar. 0 ,. N ,O, t uboc urar ine 
To ta l 422 28 6.6 
mate ly 30% and in a coronary care unit this may be 
reduced to I 5 to 20 % ( Logue and Hurst, 1970). So 
myocardial infarction, o r recurrent infarction, after 
anes thesia and a major operation, is more serious and 
leth al than myocardi al infarction alone. 
Others have reported that the shorter the inter-
va l from previous myocardial in fa rction to major 
o peration, the grea ter the haza rd of reinfarction 
(Knapp, et al., 1962) . In the series of Arkins et al 
(A rkins, et al., 1964 ), 27 patients had infa rction 
under 3 months old ; I ! of them ( 40 % ) died during 
o r after operation. In IO of these pat ients the cause 
of dea th was directly related to myocardial infarc-
tion. In our se ri es the reinfa rction rate was 37 % 
among the patients with in farct ion less than 3 months 
previously; the inc idence d ropped to 16 % when the 
myocardial infarction was 3 to 6 months old . Be-
cause the reinfa rction rate was stable at 5 % after 6 
TABL E 5. Duration o f anesthesia an d myocardial infa rctio n after ge neral anesthesia . 
Myoca rd ia l infarctio n in men Myoca rdia l infarction in women Myoca rdia l 
I I 
infarctio n 
Anesthesia. Aga in Again again ( 0 ;,J 
min Previously posto p Previously postop (M + W) 
0 to 59 35 3 JI 6.5 
60 to 119 66 4 12 5. I 
120 to 179 39 4 14 7. 5 
180 to 239 20 I 4 4 .2 
240 to 299 12 3 I 6. 7 
300 to 359 2 
Tota l 174 12 44 1 6. 0 
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TABLE 6. Relation of myocardial infarction to site and type of operation. 
Myocardial infarction in men 
I Again Site and type of operation Previo usly postop 
Thorax & upper abdomen ( 113) ( 15) 
Great vessels 49 5 
Lung 14 5 
Other intrathoracic 4 3 
Biliary, upper abdomen 46 2 
Other (236) (12) 
Extraperitoneal abdominal 5 I 
Endoscopic: oral 8 2 
perinea! 5 2 
Perinea! GU 48 2 
Anorectal 7 I 
Vertebral column 14 I 
Extremities, bone 18 2 
Head and neck 13 I 
Miscellaneous 11 8 
Total 349 27 
• Difference between groups is significant (P < 0.001). 
months, elective surgery should be postponed be-
yond this time. Only life-threatening emergencies 
should be considered for surgery less than 6 months 
after a myocardial infarction. 
About one third of patients having myocardial 
infarction alone die in the first 48 hours ( Shapiro, 
et al., 1969). However, 80% of our postoperative 
patients died within 48 hours after myocardial in-
farction, which suggests that arrhythmia, rather than 
a low cardiac output due to myocardial failure, may 
be the primary cause of death . Since these infarcts 
occurred in hospitals , one can reasonably assume that 
a lower mortality rate could be obtained if all those 
Myocardial infarction in women Myocardial 
----i---- infarction Aga in again( % ) 
Previously postop (M + WJ 
(18) (I) (12.2)* 
5 9 
36 
75 
13 I 5 
(55) (4.1)* 
2 14 
25 
40 
4 
14 
2 6 
5 9 
5 6 
41 
73 I 6.6 
patients with previous coronary heart disease and 
myocardial infarction were monitored carefully and 
early measures taken to treat rate and rhythm dis-
turbances. Intensive monitoring and care are needed. 
Several factors may precipitate myocardial in-
farction during and after operat ion, such as tachy-
cardia, hypoxemia, hypotension, hemorrhage, and 
lowered cardiac output ( Dack, 1963). These com-
plications are more frequent after surgery of the 
great vessels, lung, and the upper abdomen. As a 
group, these more major kinds of operation were fol-
lowed by three times more infarctions than any 
other type of operation. This fact indicates the need 
TABLE 7. Relation of myocardial infarction to interval from previous myocardial infarction . 
Myocardial infarction in men Myocardial infarction in women Myocardial 
--::::-1 infarction Again Again again( % ) Months Previously postop postop (M+WJ 
0 to 3 8 3 37 
4 to 6 15 3 4 16 
7 to 12 31 2 11 5 
13 to 18 26 4 
19 to 24 19 I 2 5 
25+ 186 10 46 5 
Old 64 7 9 10 
myocardial infarction , 
age not recorded 
Total 349 27 73 6.6 
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fo r close attention to maint aining optimal blood 
volume and pressure in the postoperat ive period. 
Si x of 28 of our pati ents had silent rec urrent in-
farction discovered electrocard iographically or clinic-
ally after operation. Chest pain at th is time may be 
absent or obsc ured beca use of narcot ics and seda-
tives. Serial electrocardiograph ic tracings daily fo r 
up to a week after operat ion, for compari son with a 
baseline ECG taken prior to operation. are indicated 
in patients who have hypert ension. coronary disease . 
and previous infarction. 
Hypoxe mia when breathing air occurs to some 
degree aft er most general anestheti cs and major op-
erations. We have found in a different study that aft er 
abdomin al surge ry art eri al oxygen ten sion decreases 
for at least 3 postoperat ive days ( 2 % . I I % and 12 % 
respec ti ve ly) . largely clu e to miliary atclectas is. pul-
monary shunting, and possibl y decreased ca rdi ac out-
put (Tarh an. er al., 1969). Another reason, then, for 
hav in g patients who ha ve had previous infa rction, 
and those who have coronary disease, in intensive 
care areas postopera ti ve ly is that they ca n be oxy-
genated better. They need not onl y an increased in-
spired oxyge n tension fo r several days but also 
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speci al attention to chest phys iotherapy-coughing, 
deep breathing, chest pounding, regul ar turning, and 
dangling of the legs. By these mea ns, atelectasis may 
be minimized, myocardial oxygen suppl y kept ade-
quate, and infarction avoided. 
Th at th ere is a tendency for excessive th rombus 
fo rm ation in men who have had previous myoca rdi al 
infarction has bee n suggested ( Goldenfarb, et al., 
1971 ) . The coagulability of bl ood is increased during 
th e second to seventh postoperative days (Grigoryan 
and Alimov. 1969). Res ults of prolonged anticoagu-
lation to prevent recurrent myocardi al in fa rction 
have been controve rsial in the pas t (Sea man. et al., 
1964 ) , yet short-term ( up to I week) prophylactic 
anticoagul ati on fo r postoperati ve recurrent myocar-
di al in farction has not been tried to our knowledge. 
The significance of the combined effects of all 
these factors on the incidence of myocardial infarc-
tion after operation, espec iall y during the third post-
operati ve day (fig. I) . is not clearly documented. 
Cert ainly these high-risk patients should be watched 
closely and treated agress ively. postoperatively, in an 
attempt to make anesthesia and surgery safer for 
them. 
Distribution of MI's to postoperative days 
35 22 
25 
% of infarcts 
15 
5 
0 2 3 4 5 6 
• N um be r of pa ti ent s Postoperative days 
F i~. I - Distribution of myoca n..li al in fan.: ti ons to postoperative days. 
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Progress of Congenital Heart Disease: The T earn 
Approach as It Includes the Anesthesiologist* 
CAROLYN M. McCUE, M.D. 
Professor of Pediatrics , 
Medical College of Virginia, Richmond, Virginia 
Historical Background. No branch of medicine 
has progressed more rap idly and dramatically in the 
last 35 years than Pedi atric Cardiology. Harvey's 
description of the circulation in 1628 (Harvey, 
1628) and Leonardus Botallus' (Noback and Reh-
man , 1941) report on the fetal circulation were 
milestones in clarifying our understanding. Isolated 
clinical and pathologic descriptions of specific lesions 
written with amazing accuracy appeared in the 17th 
and 18th centuries. Sandi fort (Sandifort, 1777) in 
1777 presented details of a clinical examination cor-
related with necropsy findings in a cyanotic 12-year-
old boy with pulmonic stenosis and a ventricular 
septa I defect long before Dr. F allot's famous report 
( Fallot, 1888). Chauveau and Marey ( Chauveau 
and Marey, 1863) performed a right heart catheteri-
zation in 186 1, but the technique was fo rgotten until 
Walter Forssman (Forssman, 1929 ) , a urologist, 
reviewed it in 1929. Forss man even attempted an 
angiocardiogram, but the contrast injected was too 
dilute to be visualized and he was told by his as-
sociates that his work qualified "for a circus not 
a clinic." Despite such criticism, with Cournand and 
Richards, Forssman received the Nobel Prize in 
195 6. 
The modern era of Pediatric Cardiology began 
with Dr. Maude Abbott, whose meticulous Atlas, 
published in 1936, presented precise descriptions of 
I 000 cases of congenital heart disease which she 
had personally examined from a pathologic stand-
point (Abbott , 1936 ). She added a review of the 
development and compara tive anatomy of reptilian, 
amphibian, and mammalian hearts. After reviewing 
* Presented a t the 25th Annual Stoneburner Lecture 
Series, February 26, 1972, a t the Medical Coll ege of Vir-
ginia. Richmond . Portions of this stud y are reprinted with 
permission from the Virginia M edical Monthly 98:408, 
August 1971. 
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the world literature related to the pathology of con-
genital cardiac malformations, she added her cases 
and published many comprehensive reports of in-
dividual les ions. As a result of her work, a few 
clinicians began to diagnose specific congenital heart 
les ions, although usu ally therapy was hopeless. Sud-
denly in 193 8, the modern era of cardi ac surgery 
began when Dr . Gross first successfully ligated a 
patent ductus arteriosus (Gross and Hubbard, 
1939 ) . Munro of Boston had suggested ligating a 
patent ductus as early as 1907 (Munro, 1907) , but 
it was 30 years later before Strieder (Graybiel, et al., 
1938) attempted the technique. While Crafoord 
( Crafoord , 1965) in Sweden was ligating a patent 
ductus , the suture severed the vessel. It was neces-
sary to cl amp the aorta for 28 minutes. To his sur-
prise, the patient did well and he recognized that 
thi s occlusion could be tolerated both by the heart 
and nervous system. Soon thereafter, in 1944, he 
successfully repaired a coarctation of the aorta in 
an I !-year-old boy ( Crafoord and Nylin, 1945) . 
Successful surgery was a great stimulus to the 
diagnosis of acyanotic congential heart disease. 
About this time, Dr. Park , Professor of Pediatrics 
at Johns Hopkins, assigned Dr. Helen T aussig to 
the cardiology clinic suggest ing that she accumulate 
data and correlate clinical information and path-
ologic findings on chi ldren with congenital heart 
disease. She quickly noted the repetitive patterns of 
developmental malformations and learned to make 
amazingly accurate diagnoses. Her monograph, pub-
lished in 194 7, was the first textbook on congenital 
heart disease (Taussig, 1947) . Dr. Alfred Blalock 
recalled a small conference where he was discussing 
ex perimental production of pulmonary hypertension 
in animals using a systemic artery to pulmonary 
artery anastomosis. Dr. Taussig asked if he could 
increase the pulmonary blood flow in patients with 
pulmonic stenosis in the same way (Blalock , 1966). 
MCV QUARTERLY 8 (2) : 154-161, 1972 
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She was thinking of the many cyanotic children with 
decreased pulmonary blood flow as observed in 
tetralogy of Fallot or pulmonary atresia. No one 
knew the answer to three major questions: (I) 
Could a blue child tolerate anesthesia? (2) Could 
one occlude a pulmonary artery temporarily, espe-
cially in a blue child? ( 3) Would the arm tolerate 
ligation of the subclavian artery? Many animal ex-
periments were carried out to attempt to answer 
these questions before they recognized that the 
answer to each was yes. The first Blalock-Taussig 
shunt for a tetralogy of Fallot was created success-
fully in 1944 ( Blalock and Taussig, 1945) . Modifi-
cations of the shunt procedure ( Potts, et al., 1946; 
Waterston, 1962) and Sir Russell Brock's ( Brock , 
1948) alleviation of valvular pulmonic stenosis fol-
lowed quickly. Scott (Scott, 1955) at Vanderbilt in 
1954 achieved open correction of a tetralogy with 
hypothermia, but it remained for Lillehei (Lillehei, 
Cohen, et al., 1955) and Varco in Minneapolis, 
utilizing cross circulation, to first close a ventricular 
septa! defect and completely remove right ventricular 
obstruction in 1955. 
Gibbon had been working on a heart lung ma-
chine since the early I 930's and performed the first 
successful operation closing an atrial septa! defect 
by this method in May, 1953 (Gibbon, 1954) 
Crafoord visited Gibbon in the late I 930's and his 
group simultaneously worked on a heart lung ma-
chine and developed a disc oxygenator. The advent 
of open heart surgery made possible accurate cor-
rection of the many complex congenital heart de-
fects. Dr. Crafoord (Crafoord, 1965) considers the 
development of the Engstrom-Bjork respirator for 
anesthesia and postoperative ventilation a milestone 
in operative and postoperative care . 
Developments in the physiology laboratory. in-
cluding refinements in the technique of cardiac 
catheterization and particularly the addition of angio-
cardiography, as introduced by Robb and Steinberg 
(Robb and Steinberg, 1938), made precision in 
diagnosis possible. Improvements in the toxicity of 
contrast media made cineangiography less dangerous 
for small infants. Improved electronic equipment for 
recording and monitoring pressures and utilization 
of colorometric methods for rapid determination of 
oxygen saturations and indicator dilution increased 
the safety and efficiency of diagnostic cardiac cath-
eterization. Rapid measurement of blood gases and 
electrolytes added another safety feature . 
Transposition of the great arteries was first pal-
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li ated in infancy in 1940 by Blalock and H anlon 
( Hanlon and Blalock, 1948) , by creating an atrial 
septa! defect. This gave only temporary and mod-
erate relief, but the frequency of this defect and its 
leth al characteristics were a continuing challenge to 
devise corrective surgery. Baff es ( Baff es, 1956) at-
tempted to reverse venous return. Senning (Senning, 
1959) reported the first correction by plastic re-
vision of the atria to reverse venous inflow in 1959. 
Mustard's ( Mustard , 1964) use of an intra-atrial 
pericardia! patch for total correction has vastly im-
proved the prognosis in this previously hopeless 
lesion. In 1966, Rash kind and Miller ( Rashkind and 
Miller, 1966) described the catheterization balloon 
technique for creating a large atrial septa! defect, 
permitting survival through the critical neonatal 
per iod. 
The achievement of success in correcting a com-
plete truncus arteriosus or a complete atrio-ventric-
ular canal captured the imagination of Rastelli and , 
based on a vast knowledge of anatomy, embryology, 
and physiology, has been achieved (Rastelli, Weid-
man, and Kirkland, 1965; Rastelli , Titus, and Mc-
Goon, 1967). The eight major congenital heart 
lesions now have excellent corrective procedures 
with acceptable mortality rates, which have dimin-
ished as preoperative diagnosis, surgical skill, and 
postoperative intensive care have improved . Rarer 
lesions are more hazardous and difficult to correct, 
especially in the younger child. The neonate, whose 
complex varieties of heart disease lead to cardiac 
fai lure and cyanosis early, needs early, aggressive 
diagnosis to avoid a 75 % mortality. With ideal treat-
ment , about 1/2 of the deaths can be prevented. 
Auxiliary aids in the care of a child with con-
genital heart disease lie in the fields of anesthesi-
ology, hematology, biochemistry, and electronics. 
Landsteiner's ( Landsteiner, 190 I) description of 
blood groupings was essential for transfusions. A 
purified heparin, which allowed standardization and 
control of coagulation of blood, was a prerequisite 
to modern cardiac surgery. Pacemakers, defibril-
lators, prosthetic valves, and patches, now used 
routinely, have all been developed in the last few 
years. 
The Medical College of Virginia assumed a 
position of leadership in modern aspects of cardio-
vascular and thoracic surgery under the direction 
of Dr. I. A . Bigger. There have been times, especially 
as open heart surgery began in the I 950's when this 
was a difficult role to maintain. The success of the 
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surgical effor t is d ramatica lly illustrated by the 
analys is of mortality stati stics from the Uni versity 
of Minnesota for all open heart procedures on pa-
tients with congenital heart disease (Lillehei, Varco, 
et al., 1967 ) 
Progress o f O pe n Heart Surgery for 
Congeni ta l Hea rl D isease 
U ni versit y of Minnesota 
1954- 1957 
1958- 1962 
1963- 1966 
Opera ti ve 
Num ber of Cases Mort a lity 
386 
986 
419 
At the Medical College of V irgini a, my col-
leagues ' have participated with me in a recent study 
to determine the incide nce, morbidity, and morta lity 
of surgically corrected conge nital heart lesions over 
a six-year period . O ur fi ndings are stated below. 
Materials and Methods. All patients, pri vate or 
sta ff . who had surgery for correc tion or pall iat ion of 
a conge nital cardi ac defec t from birth to 20 yea rs 
of age at the Med ical College of V irgin ia Hospitals 
be tween January I, 1966 and Janu ary I, 1972 a re 
incl uded in thi s report. T his six-year interval presents 
a complete evaluation of our recent surgical result s. 
Every patient had a complete card iac evalu at ion , in-
cl uding a hi story, phys ica l examination, chest roent -
genogram and electrocard iogram. Cardiac ca thete ri-
za tion and angiocardiography were done except in 
child ren with a pa tent ductus arteriosus in whom 
these d iagnostic procedures were frequentl y omitted . 
Decis ions fo r surge ry were made at a weekly con-
ference in which the pedi atric card iologists, physi-
ologists , rad io logists, pathologists, and surgeons 
participated . Surgical procedures were d ivided ap-
proxim ately equal ly be tween the two surgical teams. 
During these six yea rs, there were : 
11 . 83 1 ped iat ric ca rd io logy o ut-patient visits 
2. 985 hospita l patients 
557 chil dren un dergoi ng surgery for conge nital 
cardiac defects 
593 to ta l surgica l proced ures fo r conge nit a l 
cardiac lesions 
45 deaths 
.1 Dr. H . Page Ma uck. J r .. Dr. Jo n B. Ti ngel stad . Dr. 
Lo ui se W . Robe rtson. and ou r surgeons. Dr. Richard R . 
Lowe r a nd Dr. Lewis H. Bosher. J r. 
McCUE: PROGRESS OF CONGENITAL HEART DISEASE 
Results. Five hundred fifty-seven children had 
major surgical procedures with the distribution as 
shown in T able I. The mortality for the common 
defec ts will be considered individually. An y death 
within the fi rst month postoperati vely is considered 
as surgical mortality. For the 593 procedures, there 
was a 7.58% mortality. 
A trial Septa/ Defects. Even a small atrial septa] 
defect makes a preschool child a candidate for 
surgery. This was the most frequently corrected left 
to right shunt and was seen in 98 patients divided 
into the fo llowing types: 
Secund um 72 
Primum 15 
Wit h Partial Ano malo us 9 
Pulmo nary Veno us Return 
Single Atri um 2 
A ll were catheterized and patients with a pulmonic 
to systemic fl ow ratio grea ter th an 1.4 : I were re-
fe rred fo r surgery at an appropriate age. The span 
was I I months to 20 years. One infan t with heart 
fa ilure was correc ted at 11 months. The mean age 
fo r correction was 6 yea rs. There were no deaths 
in this group. 
Ventricular Septa/ Defects. Eighty patients had 
closure of a moderately la rge ventricular septa! de-
fec t which was the major les ion. The types are as 
noted (T able II) and include two wi th more than 
one defect and fi ve with a L V-RA shunt. There 
were many assoc iated defects, including atrial septa! 
defects, aortic insufficiency, and patent ducti. Seven 
infa nts with intractable cardiac failure had pul-
monary artery banding to decrease pulmonary blood 
flow caused by a large left to right shunt through 
the defect. Seven children required removal of a 
previously pl aced pulmonary artery band , in addition 
to closure of the defect. Two children have been re-
operated fo r closure of a residu al shunt. Severe 
aortic insufficiency from a redundant aortic cusp 
led to one surgical death . Of the seven infa nts under 
one year of age who required pulmonary artery band-
ing, only four have good surgical palliation . Asso-
c iated intra and extra cardiac defects complicated 
their course. 
Patent Ductus A rteriosus. A patent ductus 
a rteriosus has been interrupted in 90 patients be-
tween the ages of 3 months and 19 yea rs. Almost 
all have been seen postoperatively and discharged as 
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TABLE I 
INCIDENCE CONGEN ITAL DEFECTS 
Defect 
Acyanotic 
Atrial Septal Defect 
Ventricular Septal Defect 
Patent Ductus Arteriosus 
Coarctation 
Pulmonic Stenosis 
Aortic Stenosis 
Vasc ular Rings 
Miscellaneous Acyano1ic 
Cyanotic 
Tetralogy of Fallo! 
Shunts 61 
Open Correction 63 
Thoracotomy 
Pacemaker 
Transposition of Great 
Vessels 
Palliative 17 
Mustard Procedure 4 
Rare Cyanotic Lesions 
cured. Two children, one an infant , died of technical 
problems during surgery. Because of cardiac failure 
and marked cardiomegaly, eleven infants were sur-
gically corrected under one year of age. Ideally, 
surgery is deferred until the child is greater than 2 
years of age. Several premature infants on whom 
the diagnosis was confirmed had spontaneous closure 
of their ductus. 
Coarctation of the Aorta. Coarctation of the 
aorta was corrected in 34 patients at a mean age 
of 6 years. All patients had preoperative aortography . 
Four patients required surgery in infancy for in-
TABLE II 
VENTRICULAR SEPTAL DEFECTS (87) 
Types: 
Corrected 
Single 
(Removal of Bands 7) 
Multiple 
LV-RA Shunts 
Banded Pulmonary Artery 
Ages : 
Deaths: 
Correction 
Pulmonary Artery Bands 
73 
2 
5 
80 
7 
2 (2.5 % ) 
2 (28.5 % ) 
6 Weeks-20 Years 
4 (4.6% ) 
MCV 
Patients Mortalit y % 
(557 Patients) Expired (8.07 % ) 
(593 Procedures) (45) (7.58) 
98 0 0 
87 4 4.6 
90 2 2 . 2 
34 I 2 .9 
36 0 0 
15 0 0 
5 I 20 
3 0 
11 8 
8 13. I 
3 4.7 
0 0 
0 0 
21 14 .2 
3 17 .6% 
0 0 
50 23 46 
tractable congestive fai lu re , of whom one infa nt died . 
Successful correction of a complete interruption of 
the aortic arch has been done on two occasions. 
Pu/manic Stenosis. Pulmonic stenosis is com-
monly associated with other defects, but was seen 
as the primary problem in 36 children who had an 
intact ventricular septum and a right ventricular to 
pulmonary artery systolic gradient between 50 and 
160 mm. Hg. The age span was 11 days to 18 years 
and two infants were less than I year of age . The 
types are as follows: 
Valvular 
Supravalvular 
Primary lnfundibula r 
Ru bella with Valvular 
Pulmonic Stenosis and 
Peripheral Pulmonic 
Stenosis and Patent 
Ductus Arteriosus 
28 
I 
4 
Associated defects included atrial septa! defect and 
peripheral pulmonic stenosis in five. An associated 
rubella syndrome with a patent ductus occurred in 
three babies. Secondary infundibular obstruction re-
quired surgical alleviation in about V2 of the valvular 
cases. All survived and were improved. 
A or tic Stenosis. Although 80 cases of aortic 
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stenosis were studied in the cardiac catheterization 
laboratory in this six-year period, only 15 were re-
ferred for surgery. The age span was 3 years to 19 
years. The types were as fo llows: 
Valvular 
Subvalvular Membrane 
Idiopat hic Hypertrophic 
Su baortic Stenosis 
Supravalvular 
With Severe Aortic 
Insufficiency 
IO 
2 
Criteria for operation were a gradient in excess of 
60 mm Hg and elec trocardiographic evidence of 
left ventricular hypertrophy and strain. This age 
group is older than for most other lesions and in-
cluded no infants. Those wi th valvular stenosis un-
derwent valvuloplasty; only one prosthet ic va lve 
was utilized in a 15-year-old girl with severe aort ic 
insufficiency. A teflon patch was employed to widen 
the boy's supravalvular aortic stenosis. Fou r patients 
with aortic insufficiency initi ally continued to mani-
fest mild valvular incompetence. 
Vascular Rings. Five patients with an aortic 
vascular ring were repai red under 8 months of age . 
One infant with a left pulmonary artery ari sing from 
the right pulmonary artery causing a vascular sling 
did not survive the surgical procedure. All others 
had relief of their stridor and have improved after I 
to 5 years. One infant also had a shunt for severe 
tetralogy. 
Misce/kmeous Acyanotic Lesions. An anom-
alous right coronary artery ari sing from the pul-
monary artery was repaired successfully by direct 
anastomosis to the aorta in a 12-year-old boy. An 
arterio venous fistula between the external carotid 
artery and the internal jugul ar ve in was also repai red 
last year. 
Tetralogy of Fallot. One hundred eighteen 
children had 126 primary surgical procedures fo r 
tetralogy of Fallot (Table III) . In general, a Water-
ston 's shunt ( ao rta to right pulmonary artery an-
astomosis) was the procedure of choice in the first 
three months of life, a Blalock-Taussig shunt (sub-
clavian to pulmonary artery) being preferable if one 
was required in a slightly larger child . Thirty-six 
infants had shunts created within the first year of 
life, of whom twenty eight survived . In 1970, six 
infants with a complete pulmonary atresia with a 
ventricular septa! defect had emergency surgery at-
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TABLE Ill 
TETRALOGY OF FALLOT 
(126) Primary Procedures 
( 11 8) Children 
Types: 
Shunts 
Open Correction 
Previo us Shunts 
No Previous Shunts 
Thoracotomy 
Pacemaker 
Secondary Procedures 
Revision of Shunts 
Secondary Repairs 
Deaths : 
Mortality Shunts 
Mortality Correction 
Total 
7 
4 
28 
35 
61 
63 
JI 
8 (13 .1 %) 
3 ( 4.7%) 
II ( 8.8 %) 
tempted in the first few weeks of life; only two sur-
vived. There were no deaths in children who had 
shunt procedures over I year of age. The mortality 
for the shunt , including those with pulmonary atresia, 
is 13 .1 % . Seven pat ients required revision of their 
shunt a t some time postoperatively. The majority 
were trea ted with digita li s in the postoperative pe-
riod, since cardiac fa ilure was a frequent transient 
complication. 
Open correction of tetralogy in 63 patients was 
successful in 60, giving this a mortality of 4.7%. 
This surgical procedure is generally reserved for 
those over 40 pounds wi th an age distribution as 
noted in fig. I . The youngest child was 3 years old 
and weighed 27 pounds. Of the 63 children under-
going open correction, 35 had no previous shunt. 
Twenty-eight had shunting surgery in the past and 
8 had both procedures during the six years of study. 
Transient cardi ac fail ure postoperatively occurs fre-
quently, but responds well to digitalis and diuretics. 
Perm anent complete heart block occurred in 2 chil-
dren ; one died suddenly soon after the operation ; 
the other now has a pacemaker implanted. Four 
children have required reoperation fo r res idual ven-
tricular defects or inadequate relief of their pul-
monary stenosis. All have been fo llowed postop-
era tively and IO recatheterized. Ma ny have major 
extra cardiac les ions involving the brain , kidney, 
gastrointest inal tract , or skeleton. 
Transposition of the Great Arteries. In many 
series, transposition has comprised up to 20% of 
necropsy cases in cyanotic congenital heart disease 
under I year of age. Twenty-one cases of trans-
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Fig. 1-Tetralogy of Fallot surgical therapy according to age. 
position of the usual variety occurred in our series. 
Others associated with a single ventricle, bilocular 
heart, or tricuspid atresia are included with miscel-
laneous cyanotic lesions (Table IV) . 
All infants with transposition of the great 
arteries had palliative procedures in infancy, usually 
a balloon septostomy or a Blalock-Hanlon septec-
tomy. In only two did the initial balloon septostomy 
produce adequate mixing. Usually the Blalock-Han-
lon surgical procedure followed within a few weeks. 
Infants with associated ventricular septa! defects re-
quired a concomitant pulmonary artery band and 
one with an associated ductus had it ligated. A 
palliative shunt was performed on two infants with 
associated pulmonic stenosis. The palliative pro-
cedures had a high risk . There were no deaths di-
rectly related to the balloon procedure. Four chil-
dren have thus far had complete correction by the 
Mustard technique and improved postoperatively. 
One boy with residual pulmonary hypertension died 
this month, 33 months after the correction . 
Miscellaneous Cyanotic Lesions. Fifty children 
with rarer cyanotic congenital defects were seen, of 
whom thirty-six were less than one year of age 
(Table V). Of the eleven cyanotic children with 
tricuspid atresia, nine were infants and two were 
older, with an age span from 1 day to 17 years. 
TABLE IV 
TRANSPOSITION OF THE GREAT VESSELS (21) 
Procedures Expired Mortality % 
Catheterization II 0 0 
Balloon 
Surgical 
Palliative 15 17.6% 
Blalock- Hanlon 11 2 
Blalock- Hanlon and 2 1 
Banded Pulmonary 
Artery 
Shunts 2 0 
Correction 0 
Mustard 4 
Total Surgical Procedures 30 10% 
Total Patients 21 14.2% 
160 
TABL E V 
MISCELLANEOUS CYANOTIC LESIONS ( 50) 
Defects Patient s 
Tricuspid Atresia II 
Total Anomalous Pulmonary 3 
Venous Return 
Single Ventricle 6 
Banded 4 
Shunt with Pulmonic 
Stenos is 
Thoracotomy 
AV Canal 5 
Splenic Syndromes 
Multiple Mixed 20 
Pulmonary Atresia 4 
Mitra! Atresia 
Hypoplastic Right Heart 
Truncus 4 
Double Outlet Right 2 
Ventricle 
Ebstein's 
Hypoplastic Left 2 
Heart with M itra l Stenosis 
Multiple Defects . I 
Tota l 50 
Expi red 
I 
2 
2 
2 
2 
14 
23 
Nine req uired shunts to increase pulmonary blood 
fl ow, but two cases with unusually la rge pulmonary 
blood fl ow were palli ated by banding the main pul-
monary ar tery. The two older children had their 
second shunt crea ted during the past year; one a 
17-year-old high school seni or has won a trip to 
Europe this summer on a singing tour . 
The others a re a discouraging group most of 
whom have been pa lliated by shunts or banding the 
pulmonary artery. A balloon septos tomy did not 
significantly improve the condition of one child with 
pulmonary atresia . One atrio-vc ntricula r canal was 
corrected and survived. A boy of 17 with a truncus 
arteriosus, T ype I, had an attempted Rastelli pro-
cedure, but had irreversible pulmonary hypertension . 
The to tal mortality was 46 % , but 36 were less than 
one year of age. 
Conclusion. During the last six years , 557 chil-
dren have had 593 surgica l procedures fo r correction 
or palli a tion of th,eir congenital heart defec ts with 
a mortality rate of 7.58 % . One hundred fourteen 
patients were less than one yea r of age . Of the 368 
acyanotic patients, 2.16 % died at surgery or of re-
lated causes in th e following month. Tetralogy of 
Fallo! was the most favo rable cyanotic les ion with 
a morta lity for shunts in ea rly childhood of 13 % 
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and fo r open correc tion of 63 patients it was 4 . 7 % . 
Cooley's (Cooley and H allm an, 1966 ) recent re-
view of his experience over a I 0-year period reports 
the morta lity fo r shunts as 7 .2 % and for open cor-
rection 15 % . At Johns H opkins University H ospital , 
187 patients, ages 2 to 40 yea rs, underwent complete 
correction of tetralogy in the las t five years with 
a 9.6 % morta lity (Bender, et al., 1970 ) . 
Our study showed 18 of 21 children with trans-
position of the grea t arteries survi ved. Whi le other 
children with complex cyanotic lesions had a 46 % 
mortality, this included many hi gh-risk infants in 
whom an aggressive approach for palliation was 
justified because thei r prognosis was, otherwise, 
hope less. 
Advances in cardiac surgery have be.en great 
in the last 30 years, but furth er progress is antici-
pated , es pec ially in infa nts. A cooperative effort in-
volving referring physicians, pediatric cardiologists, 
physiologists, anesthes iologists, surgeons, and inten-
sive care nurses is required to continue this trend . 
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and effectiveness 
' f'h e a 11 tia 11 x ie ty effecti ve ness of Librium 
(chlo rdi aze pox ide I-I CI) has been demon-
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Librium usuall y provides prompt , dependable 
rel ief of mild to severe cl inically signifi ca nt 
;i nxie ty. lt is indica ted when reass ura nce and 
co unseling a re not enough and until , in th e 
physicia n 's judgment, anxiety has bee n 
red uced to to lerable, appropri ate levels. 
Effec t on mental acuity: Usua ll y minim al 
on pro per maintenance dosage. (See vVarnings 
in summary of prescribing in forma ti o n .) 
Safety: An excellent clinica l record. In 
ge nera l use, the most common side effects 
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information , a s umm a ry of which follows : 
Indications: Ind ica ted when anx iety, ten sio n a nd 
apprehension are sign ifi ca nt co m po nents of the 
c lin ical p ro fil e. 
Contraindications: Pa tients with known hyperse n-
s it iv ity to the drug. 
Warn ings: Caution pa tients about possibl e co mbined 
effec ts w ith alcohol and other CN S depressa nts. As 
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a lertness (e.g., operat ing machinery, driving). 
Though physica l and psychologica l dependence 
have rarely bee n reported on recomme nded doses, 
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renal or hepatic func tion. Paradoxical reactions 
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